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Abstract 
 
A stroke can impair both motor and cognitive functioning, reducing the automaticity of 
walking and increasing susceptibility to motor-cognitive interference (MCI). There is 
also some evidence of an association between susceptibility to MCI and the 
increased incidence of falls in stroke. Functional Electrical Stimulation (FES) is 
commonly used for correction of foot drop due to stroke. At the start of the PhD, 
studies had shown FES increases walking speed. However, questionnaire-based 
studies found that users rated a reduction in effort and a reduced risk of tripping or 
falling as the two most important reasons for using FES. In these studies, the term 
‘effort’ was not defined, but the results from a qualitative study suggested that the 
questionnaire respondents may have been referring to both physical and mental 
components. Based on this evidence the following research question was posed 
“Does FES reduce motor-cognitive interference during gait in people with foot drop 
following stroke?” 
The question was first examined in a questionnaire study which collated FES user 
opinion from thirty current users. Respondents identified a statistically significant 
reduction in concentration required when walking with FES compared with walking 
without the device. Furthermore, the majority noted that walking without thinking 
about walking was easier with FES. 
The second study developed and piloted a dual-task based methodology to assess 
the impact of FES on MCI during gait. Two participants with foot drop following stroke 
were evaluated over 14 weeks following first use of FES. In one participant, cognitive 
task performance was maintained at a similar level when walking with FES, compared 
with seated performance, and reduced without FES. The effects were less clear in the 
second participant. However, the study demonstrated the feasibility of the proposed 
methodology and provided the first quantitative evidence that FES can reduce MCI 
during gait. 
In the final study of the thesis, a similar methodology was used to study the effects of 
MCI in a larger cohort of sixteen established FES users. Outcomes suggest that 
although FES can reduce the motor-cognitive interference experienced during a dual-
task situation in some participants, when analysed as a group, the results did not 
support the existence of this effect. 
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Chapter 1 – Introduction 
 
Functional Electrical Stimulation (FES) is the electrical stimulation of nerves to 
provide muscular contraction in such a way as to produce functionally useful 
movement. FES is a commonly used technique for correction of foot drop of central 
neurological origin and typically involves stimulation of the common peroneal nerve to 
elicit dorsiflexion and slight eversion of the foot during the swing phase of walking. 
The effectiveness of the intervention in terms of improving walking speed is well 
supported by evidence and a recent report by the National Institute for Health and 
Clinical Evidence (NICE) approved its use in clinical practice. However, at the start of 
this PhD there were few reports on the effects of FES on other components of gait, 
functioning and ability, and the NICE guidance of 2009 recommended that ‘further 
publication on the efficacy of FES would be useful, specifically including patient-
reported outcomes’.  
 
Of the limited literature describing the effects of FES on outcomes other than gait 
speed, there were a small number of studies that investigated user perceptions of 
FES. Users reported factors other than walking speed to be the most important 
reasons for using FES, with a reduction in effort being cited as the principal reason. A 
reduced risk of tripping or falling was also highly rated by users. A reduction in the 
effort of walking, that is clearly seen as important by FES users, could be interpreted 
both as a reduction in physical and mental effort and at the start of the PhD there was 
some support for this concept from a qualitative study of FES users.  
 
At the same time an emerging area of research was showing that walking is not an 
automated process and that its control involves higher level cognitive functions. 
Evidence for this comes from both brain imaging studies and gait studies in which 
participants are asked to perform a concurrent cognitive task whilst walking (i.e. dual-
task paradigm). There were a small number of studies showing that the combined 
effects of motor and cognitive impairments that are common following a stroke may 
make participants particularly susceptible to motor-cognitive interference during 
walking. There was also some evidence that this effect may contribute to the 
increased incidence of falls in stroke. 
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The patient-reported effects of FES, including a reduction in effort and reduction in 
trips and falls required further investigation, particularly in the light of the importance 
placed on these effects by users. While there is some evidence that use of FES leads 
to a reduction in compensatory actions, such as hip hitching and circumduction, 
frequently used by people with foot drop to avoid foot-ground collisions during the 
swing phase of walking, this may not completely explain the reported reduction in 
effort. Similarly, although there is some evidence of improved toe clearance, this may 
not fully explain the reported reduction in risk of tripping and falling. There is also 
evidence that FES use has impact on areas of the brain serving both motor and 
cognitive functions. It is therefore possible that FES use may have a more complex 
effect than can be seen from studies of FES gait kinematics and energetics. 
Specifically, the user reports suggest it may reduce motor-cognitive demands during 
gait thus improving the ability to respond to challenges to stability and/or freeing up 
cognitive resources.  
 
To explore this hypothesis, firstly, the thesis focused on building on the small number 
of questionnaire and qualitative studies published at the start of the PhD, by 
development of a questionnaire to further explore the patient-perceived effects of 
using FES. In particular, the questionnaire study aims were to substantiate or refute 
the suggestion in the literature that FES for foot drop is perceived to impact on motor-
cognitive interference during gait and, if confirmed, to inform the design of 
subsequent experimental studies that would allow for the exploration and testing of 
this hypothesis.  
 
The second aim of thesis was to investigate this hypothesis through the use of dual-
task based studies. The gait laboratory studies were designed to assess the impact 
of FES on the cognitive control of gait. Furthermore, the aim was to collect gait 
parameters associated with stability to explore the contribution of FES to stability. 
 
Thesis overview 
 
Chapter 2 of the thesis provides a review of the background to the work. This 
chapter discusses the key components and functions of the neuromuscular system, a 
description of normal gait and concepts about the contribution of cognitive processes 
to the control of normal gait. A section on stroke then follows, providing an overview 
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of the most common effects, including a description of the effects on motor, sensory 
and cognitive systems. The effect of stroke on gait is then covered, highlighting the 
increased risk of falls and the circumstances of these. A discussion of the interaction 
of damage to motor and cognitive areas of the brain follows, including how this 
manifests in gait disturbances and are evident in dual-task study outcomes. 
 
Chapter 2 then introduces FES, describing the device and its effects on nervous 
tissue to produce functional movement. The emerging evidence of its effect on brain 
plasticity and spinal mechanisms of motor control are discussed. This is followed by a 
review of the effect of FES, with a detailed focus on gait measures related to stability 
and fall risk and a critique of the literature reporting patient-centred outcomes. The 
chapter concludes with a discussion of the thesis aims. 
 
Chapter 3 describes the development and implementation of the questionnaire study 
to explore the concept of ‘effort’ of walking. The chapter describes the process of 
formulation of the questionnaire content in relation to previous studies, including 
piloting work. Results from respondents are presented and analysed, in relation to 
the aims of the study. The conclusions drawn from the results, and their limitations, 
are discussed and their influence on the choice of tests used in the gait laboratory 
study is outlined 
 
Chapter 4 describes a longitudinal gait laboratory-based of new users of FES. The 
study design includes a novel dual-task protocol, informed by the results of the 
questionnaire study reported in Chapter 3. The impact of FES on gait and 
performance of a cognitive task are reported.  
 
Chapter 5 presents the results from a cross-sectional study of existing FES users, 
based on the same protocol as used in Chapter 4.   
 
Chapter 6 discusses the results and draws conclusions in the context of limitations of 
the studies and suggests future approaches in this field of work. 
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Chapter 2 – Literature Review  
 
2.1 Introduction 
 
This chapter begins by briefly describing the key components and functions of the 
neuromuscular system that contribute to normal gait. This is then followed by a 
description of normal gait outlining the gait cycle, the spatial and temporal 
parameters and the main events of the gait cycle, also describing the main actions of 
the muscles and joints. Concepts about the contribution of cognitive processes to the 
control of normal gait are then defined and discussed, introducing the emerging 
evidence to support the interaction between the motor areas of the brain and those 
associated with cognitive functions.  
 
A section on stroke follows, providing a brief overview of the most common effects, 
including a more detailed description of the effects on motor, sensory and cognitive 
systems. The effect of stroke on gait is then covered, describing the typical deviations 
from normal gait and, in particular, highlighting the increased risk of falls and the 
circumstances of these amongst the stroke population. This section is concluded by 
discussing the interaction of damage to both the motor and cognitive areas of the 
brain caused by stroke, and how this manifests in gait disturbances and evidence of 
increased susceptibility to cognitive interference. 
 
The next section of the chapter introduces FES, describing the device and its effects 
on nervous tissue to produce functional movement. The emerging evidence of its 
effect on brain plasticity and spinal mechanisms of motor control are also discussed. 
This is followed by a review of the effect of FES on traditional outcomes of gait speed 
and energy cost, followed by the effect on the kinematics of gait. A more detailed 
review of the effects on gait measures related to stability and fall risk is provided. This 
is followed by a critique of the literature reporting patient-centred outcomes and the 
conclusions drawn from this are presented. 
 
Finally, the chapter concludes by outlining the thesis aims. 
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2.2  Gait and its control 
 
2.2.1 Functional anatomy of the Neuromuscular System 
 
Gait is a complex behaviour, involving the coordination of many muscles and joints 
and processing of multiple sensory inputs for its control and adaptation (Shumway-
Cook and Woollacott, 2007). Gait is controlled at various levels of the central nervous 
system (CNS) and the following provides an overview, based on current 
understanding of the functional anatomy of the nervous system, of how gait is 
initiated and controlled. 
a) Brain 
 
Several areas of the brain contribute to the control of gait, including the prefrontal 
cortex and the motor cortex; the latter comprising of the primary motor cortex, the 
supplementary motor cortex and the premotor cortex. Planning and preparation of 
coordinated, multi-joint movement is organised in the prefrontal cortex, premotor 
cortex and supplementary motor cortex (Kalat, 2004), with the aid of information 
about body position and the environment provided by the posterior parietal cortex 
(Rizo, 2004). Both the premotor cortex and supplementary motor cortex areas send 
axons (i.e. the process of an upper motor neuron that conducts nerve impulses) to 
the primary motor cortex, brain stem and spinal cord (Matthews, 2000). The primary 
motor cortex is functionally located at the end of the motor control processing 
scheme (Rizo, 2004) and thus outputs the motor commands, initiating movement 
(Kalat, 2004). Nerve fibres from the primary motor cortex form the corticospinal tract 
which directly controls spinal motor circuits (Matthews, 2000). 
  
The motor cortical areas send axons to the brain stem in the corticobulbar tract 
(Matthews, 2000). The brain stem plans and executes anticipatory actions to stabilise 
the body ahead of voluntary movements (i.e. maintenance of posture) (Crossman 
and Neary, 2005) sending commands to the spinal cord via three major tracts of 
descending axons, that run parallel with the corticospinal tract. Firstly, the 
reticulospinal tract makes synaptic connections with motor neurons (and 
interneurons, which reside entirely within the spinal cord) throughout the spinal cord, 
providing excitory inputs that drive the central pattern generators (see section 2.1.1b 
following) of the spinal cord during locomotion. Secondly, the vestibulospinal tract 
promotes extension of the limbs and inhibits flexion. Thirdly, the rubrospinal tract 
promotes flexion of the limbs and inhibits extension (Crossman and Neary, 2005). 
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Thus, the balance of activity in the tracts will govern the equilibrium of the limbs 
(Matthews, 2000). 
 
The motor cortex also sends axons to the basal ganglia. Feedback is indirectly 
achieved via the thalamus. The basal ganglia, thalamus and substantia nigra form 
three interconnected feedback loops, acting via the thalamus, allowing the basal 
ganglia and substantia nigra to influence the motor outputs by the motor cortex 
(Matthews, 2000, Rizo, 2004). The basal ganglia play a particularly important role in 
planning, initiating and regulating skilled movements that are normally mostly 
automatic (Tyldesley and Grieve, 2002), adjusts biases that allow movement to be 
initiated and inhibits movements that would be detrimental, thus organising 
sequences of movements into a smooth automatic whole (Rizo, 2004, Crossman and 
Neary, 2005). The basal ganglia are also involved in the acquisition of motor skills 
(Rizo, 2004). 
 
The cerebellum is another motor area of the brain. It applies incoming sensory 
information (e.g. from vision and proprioceptors) (Rizo, 2004) and combines this with 
copies of motor commands sent by the motor cortex and brain stem (Matthews, 
2000) to effect continual adjustments during an ongoing movement to ensure 
accuracy and smooth motion (Rizo, 2004) and maintain balance – by sending 
feedback to the brainstem and the motor cortex via the thalamus (Crossman and 
Neary, 2005). The cerebellum also plays a role in motor learning (Matthews, 2000). 
b) Spinal cord  
 
The spinal cord provides sensory, autonomic and motor innervation to the trunk and 
limbs. It consists of grey matter in the centre which is comprised of nerve cell bodies, 
and is surrounded by white matter, containing ascending and descending nerve 
tracts (i.e. fibres). The neurons (i.e. nerve cells) that contribute their axons to the 
descending tracts (e.g. corticospinal) of the spinal cord, and originate from the motor 
cortex are referred to as upper motor neurons (Crossman and Neary, 2005). When 
the corticospinal tracts – one from each hemisphere of the brain - pass through the 
medulla (i.e. the brain stem) approximately 75-90% of the fibres decussate (cross 
over to the other side) and enter the contralateral lateral corticospinal tract whilst the 
remaining 10-25% of the fibres do not cross and enter the ventral corticospinal tract 
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(Crossman and Neary, 2005). This means that movement on one side of the body is 
largely controlled by the other side of the cerebral cortex (see Figure 2.1). 
 
The axons in the descending tracts extend without interruption to their target neurons 
in the spinal cord. These are the lower motor neurons with their body in the grey 
matter and their axons (i.e. nerve fibres) directly innervating muscle. They are the 
final part of the pathway via which the nervous system controls movement 
(Crossman and Neary, 2005). Some motor function can be served via an indirect 
pathway (i.e. corticospinal fibres reach the tract by synapsing in the midbrain) but fine 
motor control requires intact input of the direct pathway from the primary motor cortex 
to the spinal cord (Rizo, 2004). Most movement requires input from both pathways.  
 
 
Figure 2.1: Pathway of upper and lower motor neurons (Damjanov, 2000). 
 
The basic pattern of locomotor output is produced by spinal central pattern 
generators that do not require sensory input or input from the brain to generate the 
motor pattern (Matthews, 2000). However, without input the movements are 
stereotyped and easily disrupted, unable to support the body and not functional. 
Sensory input about joint position and muscle tension is required to adapt the pattern 
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to normal walking conditions. Furthermore, the brain is the normal activator of these 
neural circuits (Enoka, 2008).  
c) Motor units 
 
The functional unit of skeletal muscle is the motor unit. It consists of a lower motor 
neuron together with all the terminal branches of the axon and the muscle fibres that 
they innervate. The number of muscle fibres that are innervated by a single axon will 
vary, from a few to 2000, per motor unit and will depend on the size and function of 
the muscle. When the neuron transmits a message all of the fibres in the motor unit 
will contract (Watkins, 2009). 
 
 
 
Figure 2.2: Relationship between kinaesthetic sense and proprioception 
(Watkins, 2009). 
d)  Kinaesthetic sense and proprioception 
 
The CNS receives sensory information from a wide range of sensory organs about 
body position and body movement. Sources of information about the sensations of 
effort and heaviness, timing of movement of individual body parts, the position of the 
body in space, joint positions and joint movements can be regarded as the 
kinaesthetic sense (Watkins, 2009) (see Figure 2.2). Proprioceptors are those group 
of receptors located in the skin and musculoskeletal tissues that provide the sense of 
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joint position and movement. Within joint capsules there are two main types of 
proprioceptors that signal joint angle and particular information at the end ranges of 
joint movement: Ruffini corpuscles which appear to be mainly responsive to tension, 
and Pacinian corpuscles which respond to compression (Watkins, 2009). Within 
skeletal muscles, a number of muscle fibres will be enclosed in a capsule to form a 
muscle spindle, supplied by sensory nerve endings, which respond to muscle stretch 
(Crossman and Neary, 2005). At the junction between skeletal muscle and its tendon, 
Golgi tendon organs occur and provide information about the tension exerted by the 
muscle (Matthews, 2000). 
 
2.2.2 Gait kinematics and muscle activations 
 
Human walking is a method of locomotion involving the use of two legs in an 
alternating pattern, to provide both support and propulsion. It is characterised by a 
smooth and efficient progression of the body’s centre of mass and distinguished from 
running by having at least one foot in contact with the ground at all times (Whittle, 
2003). The components of gait (manner of walking) and the specific contribution of 
the lower limb muscles and joints to achieving this motion are described in the 
following paragraphs. 
 
Gait is a cyclical movement pattern and the gait cycle can be defined as the time 
interval between two successive occurrences of one of the repetitive events of 
walking, typically initial contact (or heel strike) of one foot is chosen as the defining 
event. The gait cycle can be divided into stance phase, when the foot is on the 
ground, and swing phase when the foot is moving forward through the air. There are 
also periods of single support when the alternate leg is in swing phase and double 
support when both feet are weight-bearing (see Figure 2.3). At normal walking 
speeds, the stance phase for each leg lasts for 60%, and swing phase for 40% of the 
gait cycle. Each double support phase lasts for 10% of the cycle time, at the end of 
each stance phase. The speed of walking will affect these proportions, with the swing 
phase increasing and the stance and double support phases decreasing as speed 
increases (Whittle, 2003).  
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Figure 2.3: Timing of phases of gait during the gait cycle 
(from http://media.lanecc.edu/users/howardc/PTA104L/104LAmbAids/104LAmbAids_print.html) 
 
Gait can also be described in terms of spatial parameters, as shown in Figure 2.4 
showing step length (i.e. the distance between two consecutive heel strikes) and 
stride length (i.e. the distance between two consecutive heel strikes of the same 
foot). Stride width is determined by the distance between the bisection of each heel 
(Richards, 2008). 
 
 Figure 2.4: Spatial parameters of gait. 
(from http://atec.utdallas.edu/midori/Handouts/walkingGraphs.htm) 
 
Figure 2.5 shows the pattern of muscle activity during gait of the major muscle 
groups that act on the lower limb. Concentric contractions are those in which the 
force generated by the muscle exceeds the forces opposing the motion and hence 
the resultant force acts to shorten the muscle. Eccentric contractions are those in 
which the force generated by the muscle is exceeded by the opposing forces and 
hence the muscle elongates (Richards, 2008). The lower limb joint angle trajectories, 
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in the sagittal plane, of the ankle, knee and hip joints during the gait cycle are shown 
in Figure 2.6. 
 
 
Figure 2.5: Activation patterns of major muscles during gait (2004). 
 
 
Figure 2.6: Sagittal plane joint ankles during a single gait cycle of the ankle, knee and 
hip joints (Whittle, 2003). 
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The following describes the gait cycle in terms of the major events, the action of the 
major muscles and the motion at the major joints. The description is a summary of 
the cycle as described by several authors (Trew and Everett, 2001, Whittle, 2003, 
Richards, 2008). At the beginning of the gait cycle the heel strikes the ground, with 
the ankle close to its neutral position (i.e. 0°) with the angle between the foot and the 
ankle at about 90° and the heel slightly inverted with the forefoot slightly supinated. 
The tibialis anterior is active at this point, having maintained dorsiflexion during swing 
phase. The knee is almost straight just before heel strike and begins to flex 
immediately with the aid of contraction of the hamstrings, having aided prevention of 
knee hyperextension at the end of swing phase. Contraction of the hamstrings and 
the gluteus maximus at heel strike begins extension of the hip. 
 
The double support phase (i.e. the period between heel strike and toe off of the 
opposite limb) is the period during which the foot is lowered to the ground and fully 
loaded. The ankle plantarflexes via eccentric contraction of the tibialis anterior and is 
accompanied by pronation of the forefoot and internal rotation of the tibia. The knee 
flexes from its almost fully extended position accompanied by eccentric contraction of 
the quadriceps to limit the speed and magnitude of flexion. The hip begins to extend 
via eccentric contraction of the hip extensors, gluteus maximus and hamstrings. 
 
At the end of the double support phase, when the opposite toe off occurs, the first 
period of single support begins. At this point the foot is flat on the ground, and as 
soon as this occurs, the ankle motion changes from plantarflexion to dorsiflexion as 
the tibia moves over the stationary foot. Forefoot pronation and internal tibia rotation 
reach a peak at about this time and then begin to reverse. Contraction of the tibialis 
anterior ceases and the gastrocnemius and soleus begin to contract. The knee 
continues to flex and the hip continues to extend. 
 
After opposite toe off and before heel lift, the cycle enters the midstance phase, 
during which the tibia externally rotates and the foot supinates, reaching a peak, after 
which it reverses again towards pronation. The knee also reaches a peak of flexion 
and then begins to extend initially through eccentric contraction of the quadriceps. 
The hip continues to extend via inertia and gravity, rather than continuing contraction 
of the gluteus maximus and hamstrings. During midstance and as heel lift is 
approached there is significant muscle activity about the hip joint in the frontal plane 
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as its position is essentially maintained (except for a slight downward dip on the 
opposite side) by contraction of the hip abductors. 
 
As the heel rises and the opposite foot strikes the ground, the toes remains on the 
ground and extension occurs at the metatarsophalangeal joints. The rearfoot inverts 
as the forefoot also becomes increasingly supinated and the tibia externally rotates, 
locking the midtarsal joints creating a stable foot for load bearing. The ankle moves 
into plantarflexion with concentric contraction of the soleus and gastrocnemius, with 
the latter aiding flexion of the knee, and the rectus femoris contracts eccentrically to 
prevent rapid flexion. At opposite foot strike the hip is in maximum extension and the 
motion reverses to hip flexion with the adductor longus acting as the primary hip 
flexor. 
 
Toe off signals the beginning of the swing phase of the gait cycle. The forefoot 
remains slightly supinated during swing phase. Just after toe off, the ankle reaches 
its peak of plantarflexion at 25°. The tibialis anterior then begins to contract to 
dorsiflex the ankle contributing to toe clearance as the leg swings through, with knee 
flexion contributing most of the required leg shortening to achieve clearance. The 
knee reaches its peak of flexion during swing phase of between 60-70°, with the 
major part of flexion being facilitated by flexion at the hip. The knee then rapidly 
extends to close to full extension, in preparation for heel strike, with eccentric 
contraction of the hamstrings preventing hyperextension. The hip continues to flex at 
toe off, aided by contraction of the rectus femoris and iliopsoas. As the tibia reaches 
vertical during the swing phase, hip flexion ceases and the position is maintained by 
contraction of the hamstrings. At the end of the swing phase heel strike occurs and 
signals the completion of the gait cycle. 
 
2.2.3 Aspects of behaviour believed to be associated with cognitive control 
of gait 
 
Gait has traditionally been regarded as a largely automatic or reflex controlled motor 
activity involving minimal or no higher cognitive input (Dietz, 1997, Shik and Orlovsky, 
1976). However functional gait requires an ability to respond to the variability of the 
everyday environment and to adapt to the requirements of individual’s goals. In 
recognition of this, a large number of recent studies propose an alternative to the 
model of gait as an automatic activity and have demonstrated that gait is a task 
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involving higher level cognitive control (Sheridan and Hausdorff, 2007). This section 
will discuss this concept by firstly defining and describing the cognitive processes that 
are associated with gait control. This will be followed by a discussion of the evidence 
for and nature of the contribution of cognitive control of gait.   
 
The outcome or product of all neural processes is behaviour. Cognitive control of gait 
refers to the contribution of neural processes that are not exclusive to the process of 
motor control, but also affect the everyday functioning of the individual (i.e. other 
aspects of behaviour). In order to explain the model, the reader is first introduced to 
the two aspects of behaviour believed to be involved in cognitive control of gait; 
cognition and executive functions (Lezak et al., 2004).  
a) Cognition 
 
Cognition is the information-handling aspect of behaviour and can be classified as; 
receptive functions, memory and learning, thinking and expressive functions.  
Receptive functions involve the ability to select, acquire, classify and integrate 
information. Thus, these functions will exploit the sensations received from the five 
senses (i.e. sight, hearing, touch, taste and smell), as well as those associated with 
movement, space, balance and effort (Berthoz, 2000). Processing of the sensations 
received involves perception, which is a complex process engaging activities such as 
awareness and recognition. 
 
Memory and learning refer to information storage and retrieval. Memory is central to 
all cognitive functions (Lezak et al., 2004) and can be considered as either explicit 
(i.e. a conscious, intentional process) or implicit (i.e. performance of knowledge 
without awareness) (Squire, 2000). The first can be regarded as remembering 
information, objects and events and the latter as acquiring cognitive and motor skills 
(e.g. walking). Explicit memory engages stages of processing memory, of which one 
is short-term memory, which involves temporarily holding information. When this 
information is held in the mind, internalised and used to guide behaviour it is referred 
to as working memory (Lezak et al., 2004). 
 
Thinking can be defined as any mental operation that relates two or more pieces of 
information explicitly or implicitly (Fuster, 2003) and includes a large number of 
complex cognitive functions e.g. reasoning, abstracting and problem solving. It is 
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regarded as a function of the entire brain rather than a localised area (Lezak et al., 
2004). Expressive functions are the sum of observable behaviour, from which 
mental activity is inferred e.g. speaking, writing and movement (Lezak et al., 2004). 
 
The efficiency of cognition is affected by the level of consciousness, activity rate and 
attentional functions. Consciousness generally concerns the level at which a person 
is receptive to stimulation (i.e. awake) although definitions can vary. Activity rate 
relates to the speed at which neural processes and motor responses are performed 
(Lezak et al., 2004). Attention refers to several different capacities or processes, that 
are related aspects of how the person becomes receptive to stimuli and begins 
processing incoming or attended-to excitation, whether internal or external (Lezak et 
al., 2004). There is an agreed assumption that there is a finite capacity for attention 
(Woollacott and Shumway-Cook, 2002). Attention can be categorised as follows 
(Grieve, 2000, Lezak et al., 2004):  
 Focused or selective – capacity to orientate to the relevant stimuli whilst 
suppressing awareness of irrelevant stimuli, and is commonly referred to as 
concentration. 
 Sustained – capacity to maintain attention over a period of time. 
 Divided – ability to respond to more than one task at the same time or to 
multiple elements within one task, and is thus very sensitive to attentional 
capacity. 
 Alternating – capacity for shifting of attention from one task to another. 
b) Executive functions 
 
Gait performance is also associated with executive functions; the capacities that 
enable a person to engage successfully in independent, purposive, self-serving 
behaviour (Lezak et al., 2004). They refer to a variety of higher cognitive processes 
that use and modify information from many cortical sensory systems in the anterior 
and posterior brain regions to modulate and produce behaviour (Yogev-Seligmann et 
al., 2008). Executive functions can be regarded as having four major components; 
volition, planning, purposive action and effective performance (Lezak et al., 2004). 
Impairment of one or more of the components of executive functions may impact on 
an ability to walk effectively and safely e.g. loss of mobility due to reduced motivation 
or reduced inhibition and poor decision-making causing risk-taking.  
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c) Evidence for higher level control of gait 
i) Evidence from neuroimaging studies  
 
Research in the area of brain neuroimaging supports the contribution to gait of areas 
of the brain, as well as those described in section 2.1.1a, that are also related to 
higher cognitive control. Empirical evidence from brain imaging studies have shown 
that during gait areas of the brain (e.g. prefrontal area) associated with higher 
cognitive functions are activated (Harada et al., 2009, Suzuki et al., 2004). These 
studies assessed changes in the haemoglobin oxygenation of the cortices, using a 
near-infrared spectroscopic imaging technique, whilst participants walked.  
Furthermore, these areas are also activated during imagined gait, with one study 
using positron emission tomography (PET) (Malouin et al., 2003) and another using 
functional magnetic resonance imaging (fMRI) (Bakker et al., 2008) to define active 
brain areas. Further studies of simulated gait (Francis et al., 2009, Sahyoun et al., 
2004), also used fMRI, determining brain activity, in areas associated with higher 
cognitive function, during extension and flexion of the ankle; a movement normally 
associated with gait. Whilst the outcomes of the studies of imagined gait and of 
individual joint movements associated with gait, support the outcomes from the 
studies by Harada et al (2009) and Suzuki et al (2004) they should be viewed with 
some caution. Simulated or imagined gait will obviously not fully represent the neural 
processes involved in gait. For example, the study by Sahyoun et al (2004) restricted 
motion to the ankle joint whilst seated.  
  
In addition, in a review of studies on the relationships between ageing and motor 
control by Seidler et al (2010) the authors suggested  there is an age-related shift of 
movement control mechanisms, from automatic (lower level) control reliant upon 
peripheral sensorimotor systems, to attentional (higher level) control using central 
mechanisms. It is therefore possible that central control mechanisms are even more 
important than the peripheral sensorimotor system in maintaining postural stability in 
older adults (Seidler et al., 2010). 
ii) Evidence from gait studies 
 
There is also growing evidence, from gait studies, to support the role of the higher 
level cognitive systems in the control of gait (Al-Yahya et al., 2011, Sheridan and 
Hausdorff, 2007). The suggestion that gait was largely an automatic task (Dietz, 
1997, Shik and Orlovsky, 1976), also implied that minimal attentional resources were 
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used. However, there is strong evidence to support the contribution of attention, a 
key factor in the efficiency of cognitive functions, in gait control via numerous studies 
amongst both healthy and impaired populations. In particular, dual-task research 
methodologies have been widely used (Segev-Jacubovski et al., 2011) to assess the 
contribution of cognitive resources to gait. Dual-task protocols employ the 
simultaneous performance of two tasks (e.g. walking and cognitive task). Thus, if 
attentional capacity is limited and both gait and a secondary cognitive task are both 
demanding of attention, performance of at least one of the tasks will deteriorate when 
they are performed simultaneously.  
 
There are a number of review papers covering the growing number of studies using 
dual-task methodologies (Woollacott and Shumway-Cook, 2002, Yogev-Seligmann et 
al., 2008, Al-Yahya et al., 2011, Segev-Jacubovski et al., 2011). In dual-task studies 
of healthy adults, often the secondary task performance declined as well as the gait 
speed slowing (Yogev-Seligmann et al., 2008, Seidler et al., 2010) particularly if the 
performance indices were sufficiently sensitive (Seidler et al., 2010). Most studies of 
older healthy adults elicited the same response, although there are some studies that 
indicate the extent of deterioration in performance of the cognitive task during dual-
tasking increases with age (Yogev-Seligmann et al., 2008, Seidler et al., 2010). 
Furthermore, studies of gait in participants with neurological disorders have shown 
that the costs to gait and cognitive task performance increase in comparison to 
healthy controls (Woollacott and Shumway-Cook, 2002, Yogev-Seligmann et al., 
2008, Segev-Jacubovski et al., 2011, Al-Yahya et al., 2011). The results of these 
studies generally support the widely accepted view that gait control involves 
attentional processes. 
 
The relationship between executive functions and gait performance has also been 
demonstrated in several studies, suggesting that it is critical in complex gait situations 
(Ble et al., 2005, Holtzer et al., 2006). Furthermore, it appears that the relationship is 
stronger if the normal gait pattern is already altered, for example in patient 
populations (Liu-Ambrose et al., 2007, Springer et al., 2006). There is some evidence 
that a decline in executive functions may contribute to an alteration in walking abilities 
however, a causal link is yet to be definitively demonstrated (Yogev-Seligmann et al., 
2008).  
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2.3 Stroke 
 
2.3.1 Stroke overview 
 
A ‘stroke’ is defined as a clinical syndrome, of presumed vascular origin, typified by 
rapidly developing signs of focal or global disturbance of cerebral functions lasting 
more than 24 hours or leading to death (WHO, 1988). A stroke will typically be the 
result of either a bleed (i.e. haemorrhagic stroke) or blockage (i.e. ischaemic stroke) 
affecting the vascular supply to the brain leading to damage and death of nerve cells 
within the brain. A haemorrhagic stroke, affecting approximately 20% of cases (Rudd 
et al., 2000), occurs when a blood vessel either within or on the surface of the brain 
bursts. This type of stroke tends to be more severe and is associated with higher 
early mortality (Mant, 2011). An ischaemic stroke is the most common, occurring in 
approximately 80% of cases (Rudd et al., 2000), and is caused by a blood clot 
forming in the main artery to the brain, a blockage transported to the brain from 
another blood vessel in the body or a small blood vessel deep in the brain becoming 
blocked.  
 
Stroke affects between 174 – 216 people per 100,000 population in the UK each year 
(Mant, 2004) and its incidence is strongly associated with age, with 75% of stroke 
cases occurring in people over 65 years of age (DOH, 2005). There is no absolute 
end to recovery after stroke, however most improvement in functioning occurs within 
six months of onset (RCP, 2008a), although more complex aspects of physical 
recovery, such as speech, may improve over years (Mant, 2011). There are more 
than 900,000 people who have survived a stroke living in England (DOH, 2005) with 
approximately half of these people dependent upon on others for everyday activities, 
following a period of recovery. Stroke causes a greater disability impact than other 
chronic conditions and a greater range of disabilities than any other condition 
(Adamson et al., 2004).  
 
The clinical features of a stroke will vary between survivors and will be dependent 
upon the area and extent of the brain that is damaged and how quickly treatment was 
given after onset (Ebrahim and Harwood, 1999, Belagaje, 2010). Thus stroke can 
disrupt a wide range of neural processes and hence behaviours. Those affecting 
motor, sensory and cognitive processes will be discussed in section 2.3.2 and 2.3.3, 
whilst a summary of other common effects follows. 
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To illustrate the complexity of stroke as a condition, below are briefly listed the 
common secondary problems found immediately following stroke. These include 
dysphagia (i.e. swallowing difficulties) (Hamdy et al., 1997); incontinence (Carr and 
Shepherd, 2011); shoulder pain (Fawcus, 2000); apraxia which is usually associated 
with left hemisphere damage and is an isolated impairment of the ability to plan and 
execute skilled motor tasks (RCP, 2008a); and communication and speech problems 
(Warlow, 2007) such as aphasia; an impairment of the ability to form and understand 
words (RCP, 2004), and dysarthria; characterised by slow, weak, imprecise and/or 
uncoordinated movements of the speech musculature (Yorkston, 1996). 
 
It is also common for stroke to result in a disturbance of mood. In particular, 
depression may compound any cognitive impairments that concurrently exist (Carr 
and Shepherd, 2002). Anxiety is almost as common as depression, although it is 
frequently not recognised and can be focused on specific issues such as fear of 
falling and the risk of stroke recurrence (RCP, 2008a). Fatigue, an enhanced 
perception of effort and limited endurance for sustained physical and mental activity, 
is estimated to occur in 50% of stroke survivors (Harwood et al., 2011). The cause is 
poorly understood but may include depression, fear, loss of motivation, pain, sleep 
disturbance and deconditioning (Harwood et al., 2011, Duncan et al., 2012).  
 
2.3.2 Impact of stroke on key motor and sensory functions 
 
Loss of central control of the musculoskeletal system following stroke encompasses 
phenomena such as lack of coordination in movement, loss of selective movement 
and lack of motor control (RCP 2008). The severity can range from slight 
coordination problems to complete paralysis of the face and upper and lower limbs 
on one side of the body (i.e. hemiplegia or hemiparesis). Specific initial effects of 
impaired innervation to the muscles, caused by damage to the upper motor neurons, 
will include (Carr and Shepherd, 2011): 
- muscle weakness 
- reduced muscle activation and difficulty sustaining muscle activity 
- reduced muscle force generation and poor timing of peak forces leading to 
slow movements 
- poor control of synergistic muscle activity 
- lack of dexterity due to loss of fine motor control and impaired coordination. 
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After the initial effects of impaired motor control, other effects may emerge after 
several weeks. Spasticity is the most common and is typified by increased muscle 
tone, abnormal posturing and involuntary spasm that may cause discomfort and are 
particularly associated with higher levels of activity limitation (RCP 2008). Limitations 
to functional activity due to motor control impairments results in inactivity and this, 
plus weakness, leads to secondary adaptive changes to soft tissue and muscle. 
Furthermore, secondary neural and soft tissue changes may occur due to disuse and 
the weakness of certain muscle groups e.g. soft tissue contractures (Carr and 
Shepherd, 2011). Decreased activity will eventually result in a decline in physical 
fitness. 
 
Loss or alteration of various somatic sensations is present in at least 50% of people 
and the severity of loss is probably associated with the extent of motor loss so the 
importance of sensory loss as an independent factor is unknown (RCP, 2008a). 
Sensory loss involving discrimination and proprioception is more often noted than 
loss of pain, touch and temperature sensitivity (Carey, 2006) thus joint position sense 
can be affected. The coexistence of sensory deficits will add to overall motor deficits, 
due to the inter-relationship of the function of both systems. 
 
2.3.3 Effects of stroke on cognitive function 
 
Some cognitive loss is thought to be present in almost all people following a stroke 
(RCP, 2008a) and thus affects the ability of the brain to handle information (Lezak et 
al., 2004). Some of the most common cognitive impairments that can occur following 
stroke are as follows: 
 Impairments of attention and concentration are probably the most pervasive 
cognitive deficits, especially in early stroke and when the right hemisphere is 
affected. This impairment may affect other unimpaired processes as 
attentional processing is an essential prerequisite for many cognitive and 
motor functions (RCP, 2004, RCP, 2008a). 
 Memory problems are quite common and can be affected in several ways 
such as learning new information or skills, retrieving new information, 
remembering to do something in the future (prospective memory). Short term 
memory problems are the most common (CHSS, 2012). In fact, up to 25% of 
long-term survivors have such severe generalised impairment that they may 
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be diagnosed as suffering from dementia, with memory loss being a 
characteristic feature (RCP, 2008a). 
 Spatial awareness – i.e. a person’s awareness of the space around them and 
the space occupied by their body – can be affected by stroke. This impairment 
is also described as ‘neglect’, ‘visuo-spatial neglect’ or ‘inattention’ and is 
especially associated with right hemisphere stroke. In such cases a person 
may ‘neglect’ the left side of their body or fail to attend to things positioned on 
their left. Fatigue is particularly associated with this impairment (RCP, 2004, 
RCP, 2008a).  
 Perceptual disorders can have a varied impact. They can range from impaired 
distance perception (e.g. difficulty crossing the road) to an inability to 
recognise an object when seen (i.e. visual agnosia) (RCP, 2004, RCP, 2008a).  
 Apraxia or dyspraxia is a disorder of skilled voluntary movement that is not 
due to sensory or motor impairment. It is a conceptual inability to organise the 
actions required to perform the activity e.g. dressing. Some actions can be 
performed automatically, but not under voluntary control. It is more common 
after left cerebral hemisphere stroke (RCP, 2008a). 
 Executive functioning impairments can occur, especially when the frontal lobes 
are affected. Effects are seen in a person’s ability to plan a series of tasks, 
problem-solve and self-monitor behaviour. A striking effect on social behaviour 
can be associated with this impairment. It is relatively rare following stroke 
(RCP, 2004, RCP, 2008a).  
 
2.3.4 Effects of stroke on gait and falls 
a) Gait 
 
Gait impairments resultant from a stroke will vary due to the site, size and type of 
brain damage and will be affected by the time since stroke, with varying degrees of 
impairments occurring in approximately 70% of survivors (Jorgensen et al., 1995). 
Although stroke typically causes a primarily unilateral motor impairment, and is often 
described as resulting in a hemiparetic gait pattern, it is recognised that 
heterogenous, variable and bilateral gait disturbances do result from stroke (Morris et 
al., 2010). 
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Of those stroke survivors in the UK, around 20% will be affected by foot drop 
(Burridge et al., 1997a). It is characterised by reduced function in the muscles that 
serve to dorsiflex the foot (i.e. flaccid foot drop), and/or spasticity in the muscles that 
act to lower the foot (i.e. plantarflexors). Foot drop results in reduced ankle 
dorsiflexion during the swing phase of gait and at initial contact with a subsequent 
inability to achieve heel strike at the beginning of stance phase. Instead, at the end of 
swing phase, the foot lands plantarflexed, with the midfoot or forefoot contacting the 
ground initially instead of the heel. Furthermore, the foot can assume an equinovarus 
appearance, due to over-activity of the calf muscles (i.e. plantarflexors) compared to 
the tibialis anterior (i.e. dorsiflexors), where the foot is inverted and the forefoot is 
plantarflexed on the hindfoot. Evidence from one study suggests that this can occur 
in 18% of hemiparetic patients (Verdie et al., 2004).  
 
Despite these common features, there are wide individual variations in the deviations 
from the norm. For example, in a study of 15 participants with foot drop, a number of 
different variations of abnormal muscle activation were identified when compared 
with age-matched controls. According to the authors, in many cases inappropriate 
calf muscle activity may contribute to foot drop as much as, if not more than the 
inability to activate the tibialis anterior muscles (Burridge et al., 2001). The literature 
on post-stroke gait predominately focuses on hemiparetic gait, and there is a lack of 
data defining the specific characteristics of foot drop gait. Therefore, the following 
description of the post-stroke gait largely concerns hemiparetic gait. 
 
Hemiparetic gait is typically slow (Morris et al., 2010), with the average walking speed 
ranging from 0.23 m/s (SD = 0.11) to 0.73 m/s (SD = 0.38) (Olney and Richards, 
1996). Whilst a slower speed could be the result of any of the various gait deviations 
evident, one study of 26 participants with mild to moderate hemiparesis, has noted 
that gait velocity was mainly affected by weakness of the affected hip flexors and 
knee extensors (Hsu et al., 2003).  
 
Hemiparetic gait is also characterised by abnormal temporal and spatial parameters.  
For example, step and stride length are typically reduced (Morris et al., 2010) and the 
swing phase duration of the affected limb is typically longer (Olney et al., 1991, Chen 
et al., 2005) whilst that of the unaffected limb can be shorter (Chen et al., 2005). 
Subsequently, hemiparetic gait can exhibit greater swing time asymmetry than 
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normal gait (Chen et al., 2005, Morris et al., 2010). Step length asymmetry has been 
noted to increase but the direction of this is not consistent i.e. either limb can exhibit 
a shorter step length (Chen et al., 2005).  
 
Variability in temporal and spatial gait parameters is also a characteristic of 
hemiparetic gait. In a large study of 94 hemiparetic participants, who were compared 
to healthy controls, step length and stride time variability in the post-stroke group was 
greater (Balasubramanian et al., 2009). Furthermore, swing time variability increased 
and was greatest in the paretic leg. Although stride width increases in hemiparetic 
gait (Chen et al., 2005), variability of this parameter does not increase when 
compared to healthy controls (Chen et al., 2005, Balasubramanian et al., 2009). 
 
As one of the key requirements of gait is foot ground clearance during the swing 
phase, certain hemiparetic gait patterns, including foot drop gait, typically involve 
compensatory mechanisms at joints proximal to the ankle. A steppage gait, involving 
exaggerated knee and hip flexion, will lift the foot higher than usual to achieve 
increased ground clearance (Whittle, 2003). If there is diminished knee flexion, this 
strategy is not available, thus hip hitching (or hiking) or leg circumduction (Kerrigan et 
al., 2000, Chen et al., 2005), are required to clear the toe of the ground during the 
swing phase of gait. Finally, vaulting may be used to achieve foot clearance. This 
involves raising onto the toe of the unaffected side during stance, thus allowing the 
toe on the swing phase leg to clear the ground (Whittle, 2003). In common with the 
other compensatory mechanisms, these patterns do not contribute to forward 
progression of the body and are wasteful of energy (Whittle, 2003). Adoption of 
compensatory strategies may maintain balance and allow for the advance of the 
swing leg, however the energy costs can be significant (Olney and Richards, 1996, 
Chen et al., 2005). 
 
In summary, foot drop gait is typically slow, unbalanced and energy inefficient. As 
described in the following section, a related consequence of stroke is instability and a 
heightened risk of falls. 
b) Falls 
 
Stroke has been associated with a two to six-fold increase in the risk of falling by a 
number of prospective studies (Lord et al., 2007). A fall is defined as an unexpected 
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event where the participant comes to rest on the ground, floor or lower level (Lamb et 
al., 2005). The healthcare cost of falls annually in the UK are estimated at US$1.6 
billion, based on 2008 prices (Davis et al., 2010).  
 
Whilst high rates are reported during inpatient episodes, falls are also very common 
in community-dwelling survivors. The incidence varies dependent upon the time since 
discharge – 23-34% for 3-4 months (Smith et al., 2006, Jorgensen et al., 2002), 40-
73% for 6 months (Forster and Young, 1995, Yates et al., 2002, Hyndman and 
Ashburn, 2003, Hyndman and Ashburn, 2004, Soyuer and Ozturk, 2007, Harris et al., 
2005, Mackintosh et al., 2005a, Mackintosh et al., 2005b, Belgen et al., 2006) and 
43–70% for 1 year (Watanabe, 2005, Hyndman et al., 2002, Andersson et al., 2006, 
Lamb et al., 2003). Furthermore, fallers in the stroke population are more likely to 
become repeat fallers i.e. two or more falls in the last 12 months (Hyndman et al., 
2002) with reports of incidences of between 21–57% (Forster and Young, 1995, 
Watanabe, 2005, Hyndman and Ashburn, 2003, Hyndman and Ashburn, 2004, Harris 
et al., 2005, Mackintosh et al., 2005a, Mackintosh et al., 2005b, Belgen et al., 2006, 
Hyndman et al., 2002, Andersson et al., 2006, Lamb et al., 2003).  
 
The circumstances of falls amongst community-dwelling stroke survivors have been 
reported in several studies. The most frequently identified activity at the time of the 
fall was walking, most often whilst indoors, followed by transfers (Weerdesteyn et al., 
2008). People have described losing their balance or getting their foot stuck whilst 
walking or transferring (Forster and Young, 1995). Another group of stroke survivors 
reported that impaired balance or other personal factors were causative factors. 
(Jorgensen et al., 2002). Other studies found reasons for falls to be dressing, mis-
stepping, their foot getting stuck and imbalance (Belgen et al., 2006) plus self-
perceived balance problems, including dizziness and spinning sensations, whilst 
dressing (Lamb et al., 2003). 
 
Finally, in a study that described the circumstances of falls and near falls amongst a 
community sample of people with stroke (Hyndman et al., 2002), participants cited 
losing their balance and their foot dragging as causes. This study also reported 
participants describing reasons for their fall as: “Someone started talking and that 
distracted me”; “I didn’t concentrate enough on what I was doing”; and “I didn’t get my 
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brain into gear”.  Furthermore, participants described the suspected cause of a near 
fall as: “I misjudged the distance of the step”; “I did not lift my foot up high enough” 
and “I wasn’t concentrating enough and my foot hit the curb”.  
 
It is recognised, from the extensive literature on falls in the general population, that 
the circumstances and possible causes of falls are multi-factorial, and much time and 
effort has been spent attempting to identify specific risk factors. According to Lord et 
al (2007), there is consistently strong evidence to support limitations of activities of 
daily living (ADL), impaired gait and mobility, reduced peripheral sensation, muscle 
weakness and impaired cognition as important falls risk factors. These are all 
possible consequences of stroke and heighten its impact as a stand-alone risk factor. 
In particular, the contribution of cognitive impairments to falls following stroke, as also 
indicated by the statements of participants in the Hyndman et al (2002) study, has 
attracted further research.  
 
A study of community stroke survivors (Hyndman and Ashburn, 2003) highlighted 
that attention deficits were common among the sample studied, and correlated with 
poor performance on functional measures and falls. Findings suggested that repeat 
fallers had greater attention deficits, plus greater balance and ADL impairments in 
comparison to those who did not report any instability. Therefore, results indicated 
that attention deficits might contribute to accident-prone behaviour and falls. In a 
study prior to this, general inattention was significantly associated with fall risk and 
impulsivity was suggested as an important factor (Rapport et al., 1993). Impulsivity, 
manifesting as initiating behaviours quickly and without consideration of the 
consequences may compound the impact of other post-stroke effects, such as poor 
spatial awareness. Fall risk has also been associated with the memory score on the 
Functional Independence Measure (FIM) (Wada et al., 2007). Finally, results from a 
study of stroke survivors six months after discharge noted that those with extensive 
involvement of the left hemisphere had a higher number of falls than those with 
similar involvement of the right. The authors attributed this to the greater impact on 
cognitive functions and reduced impact on motor functions with left, as opposed to 
right, hemisphere lesions (Alemdaroglu et al., 2012). 
 
The fear of falling has been reported to be as important as falling itself in stroke 
survivors (Kim et al., 2012) as it can act as a barrier to functional recovery and is 
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associated with reduced community reintegration (Schmid et al., 2011); one study 
noting that it was present in 88% of those who had fallen (Watanabe, 2005). As well 
as those who have fallen, fear of falling was also reported in people who had not 
experienced a fall (Schmid et al., 2009). It often leads to reduced physical activity 
through a complex process (Botner et al., 2005, Weerdesteyn et al., 2008). Fear of 
falling is also associated with loss of confidence and depression (Kim et al., 2012), 
which can contribute to a reduction in activity levels and social functioning 
(Weerdesteyn et al., 2008). Fear of falling has a complex relationship with the other 
factors associated with falls and Figure 2.7 gives an indication of its relationship with 
other factors for the individual. Figure 2.7 does not, however show the impact that the 
worries of carers of stroke survivors who have fallen may have on the range and 
frequency of activities performed by an individual following stroke (Forster and 
Young, 1995). 
 
In summary, the risk of falls is heightened as a result of stroke, which in itself can be 
an obstacle to re-establishing independent function. Figure 2.7 gives an example of 
the interactions between risk factors and consequences of falls. It is particularly worth 
noting the contribution of both physical and cognitive impairments as risk factors.  
 
 
Figure 2.7: Interactions between risk factors, falls and consequences of falls following 
stroke (Weerdesteyn et al., 2008). 
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2.3.5 Cognition and gait post stroke 
 
As has been described in sections 2.2.1 and 2.2.3, gait is initiated and controlled by a 
combination of the motor pathways and cognitive processes. Stroke will affect both 
motor and cognitive processes as a result of damage to the brain. In particular, the 
cognitive deficits that result from stroke are various as discussed in section 2.3.3. 
There is a growing body of evidence to support the importance of the effect of these 
deficits in gait abilities post-stroke. Apart from the research evidence indicating the 
contribution of cognitive deficits to falls, there are numerous studies that demonstrate 
the interaction between cognitive deficits post stroke and gait. 
 
Mulder (Mulder et al., 2002) proposes a persuasive model of the interaction between 
cognitive and motor function and its central role in functional recovery following 
nervous system damage. In line with much of the work described in sections 2.2.1 
and 2.2.3, he proposes that the two systems are closely interrelated and that 
measurement of one aspect alone is insufficient to characterise functional recovery. 
As an example, walking speed is a commonly used outcome to measure recovery or 
the effect of an intervention. However, use of this alone as an outcome measure will 
not necessarily uncover the adaptive and compensatory strategies being used while 
performing the walking test and hence the level of functional recovery. In post-stroke 
gait, in addition to conventional measures of motor performance, a measure of the 
concentration or mental effort required to walk may reflect the level of functional 
recovery i.e. the level of reliance on a conscious mode of motor control. To assess 
the level of functional recovery over time or the lessening need for compensation 
Mulder et al (2002) proposed two approaches; measurement of cognitive involvement 
or visual dependency.  
 
In line with Mulder’s proposal, and as discussed earlier, dual-task protocols require 
division of attention between walking and a cognitive task. Thus, attentional 
capacities are challenged and test the assumption that if motor control of gait is 
operating at a normal or optimal level, then simultaneous execution of an additional 
task should not affect gait nor performance of the additional task (Yogev-Seligmann 
et al., 2008). Conversely, if attentional capacities are limited, performance of at least 
one of the tasks will deteriorate (Segev-Jacubovski et al., 2011). Dual-task 
methodology is reflective and typical of real world situations where stroke patients are 
required to ‘walk and talk’, take note of their surroundings and remember and follow 
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directions. As discussed earlier, it has been widely used to investigate the cognitive 
effects on gait, balance and fall risk particularly amongst elderly populations 
(Woollacott and Shumway-Cook, 2002, Yogev-Seligmann et al., 2008, Segev-
Jacubovski et al., 2011).  
 
There are also a growing number of studies in post-stroke gait that have used a dual-
task design to assess gait. Several studies have used gait speed as an outcome, 
finding a deterioration in gait speed under dual-task conditions (Bowen et al., 2001, 
Canning et al., 2006, Hyndman et al., 2006, Plummer-D'Amato et al., 2008, Dennis et 
al., 2009, Pohl et al., 2011). Studies have also noted a reduction in performance of 
the cognitive task (Plummer-D'Amato et al., 2008, Dennis et al., 2009, Pohl et al., 
2011, Hyndman et al., 2006, Kemper et al., 2006). 
 
There are a small number of studies using other gait parameters as outcomes. The 
addition of a cognitive task had an adverse effect on balance with double-support 
time increasing in two studies (Bowen et al., 2001, Plummer-D'Amato et al., 2010). A 
small longitudinal study (Cockburn et al., 2003) compared stride duration initially after 
stroke and then 1-9 months later. Stride duration improved over time with recovery 
more so than cognitive performance during walking. A recent pilot study noted that 
paretic single limb stance time as particularly susceptible to dual-task interferences 
(Plummer-D'Amato and Altmann, 2012). Interestingly, in a dual-task study by 
Hyndman et al (2006) the participants were also assessed as fallers and non-fallers 
based on their fall history. Fallers coped less well with a competing cognitive task 
than non-fallers during walking, with a significant reduction in stride length.  
 
The interaction between cognitive function and gait is a growing area of research in 
healthy, older and gait-challenged populations, including fallers and those with 
neurological disorders. Thus, treatments for gait disorders as a result of central 
neurological dysfunction may require a consideration of deficits in cognitive function 
when assessing effectiveness. As has been discussed, stroke can result in both 
cognitive and motor impairments, with the latter manifesting in some stroke survivors 
as foot drop gait. Thus, the effectiveness of interventions to address this could be 
measured taking into account co-existing cognitive impairments. This point will be 
revisited following the next section which reviews one of the interventions available to 
those with foot drop following stroke. 
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2.4 FES 
 
There are a number of treatment options for foot drop as the result of stroke. Apart 
from physiotherapy, and the use of Botulinum Toxin (BoTox), there are two orthotic 
interventions, ankle foot orthoses (AFO) and functional electrical stimulation (FES), 
the second of which is the focus for the thesis. This section of the literature review 
firstly describes the most common application of FES to address foot drop and the 
function of each component. Secondly, the effect on the nervous system is described 
both at local and central levels. Finally, a comprehensive literature review of the 
effects of FES is provided, with a particular focus on patient-centred outcomes. 
 
2.4.1 Description of FES 
 
FES can be described as the electrical stimulation of either nerves or muscles 
deprived of appropriate nervous control, to provide muscular contraction and thereby 
produce a functionally useful movement (Sujith, 2008). When used to restore 
movement of upper or lower limbs the FES device works as a neuroprosthesis, 
operating as a bypass (i.e. replacement) of the impaired sensory-motor pathway 
(Popovic, 2004 ) and the benefit is realised when the system is actively stimulating 
(Kilgore, 2004). Since this thesis is focused on foot drop of central origin, the 
subsequent discussion is restricted to systems used to stimulate muscle innervated 
by intact lower motor neurons. 
 
FES systems comprise three basic elements; stimulator, sensors and electrodes 
(Lyons et al., 2002). The stimulator is used to generate and regulate stimulus pulses. 
The pulse and hence stimulation magnitude is adjusted by pulse width and 
amplitude. Sensors are used to gather command signals, typically based on the 
user’s motion or muscle activity, and electrodes provide the electrical interface with 
the body. Both implanted and surface electrodes are available, although systems 
based on surface electrodes are most common. A surface electrode usually 
comprises a wire to connect to the stimulator and a conductive woven backing mesh 
covered by a layer of highly conductive, adhesive hydrogel. 
 
By far the most common embodiment of FES for foot drop is the use of electrical 
stimulation of the common peroneal nerve (or its branches) to restore active 
dorsiflexion and/or eversion during the swing phase of gait. Stimulation is applied for 
a specific period in the gait cycle (typically from heel rise to heel strike) (Kilgore, 
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2004) and the initiation and termination of stimulation is controlled by one or more 
sensors (e.g. gyroscopes, accelerometers, foot switches) (Kilgore, 2004), the most 
common of which is the foot switch.   
 
An example of a foot drop device and electrode placement is shown in Figure 2.8. 
Although other arrangements are possible, in this case the cathode is placed on the 
skin over the head of the fibula bone, where the common peroneal nerve is most 
superficial and just before it bifurcates into the deep and superficial branches; and 
the anode is placed over the motor point of the tibialis anterior muscle (Sujith, 2008). 
Table 2.1 illustrates the muscles that are recruited and their actions by stimulation of 
the common peroneal nerve. This device uses a foot switch as the sensor to trigger 
stimulation, with the stimulator being worn either at the waist or in a trouser pocket. 
Other commercially available clinical systems use an accelerometer (Sujith, 2008) 
and a cuff housing the surface electrodes (see Figure 2.9). 
 
 
 
 
Figure 2.8: Example of a surface-based FES device (ODFS Pace). 
 
 
31 
 
Action Superficial branch 
of CPN 
Deep branch of CPN 
Peroneus 
longus 
Peroneus 
brevis 
Tibialis 
anterior 
Extensor 
hallucis 
longus 
Extensor 
digitorum 
longus 
Peroneus 
tertius 
Dorsiflexion   X X X X 
Plantarflexion X      
Inversion   X    
Eversion X X   X X 
 
Table 2.1: Actions of muscles innervated by two branches of the common peroneal 
nerve. 
 
 
 
Figure 2.9: Example of surface-based FES device in which electrodes are housed in 
a cuff. (http://www.hanger.com/orthotics/services/WalkAide/Pages/HowWalkAideWorks.aspx) 
 
 
Other foot drop devices have been developed that utilise implanted electrodes. 
These electrodes intimately connect to the relevant nerve itself, either in the form of a 
cuff electrode (Rushton, 1997) that wraps around the nerve or an intraneural or 
subepineural electrode that is located under the epineurium of the nerve (Kilgore, 
2004). An external stimulator unit stimulates the electrodes. Figure 2.10 depicts an 
example of a commercially available device that uses a nerve cuff electrode, as well 
as a wireless foot switch. 
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Figure 2.10: Example of an implanted FES device (Otto Bock). 
 
2.4.2 Action of stimulation on nervous system 
 
The stimulus generated by the FES device and transferred via electrodes to the body 
stimulates or excites peripheral nervous tissue. The stimulus will either be of the 
nerve directly or of the motor point of the nerve proximal to neuromuscular junction 
(Sheffler and Chae, 2007). The following section gives a background of nerve 
function and how FES stimulates the peripheral nervous system. There then follows a 
brief discussion of emerging evidence in support of the effect of FES on the CNS.  
a) Functional effect 
 
Nerves comprise bundles of neurons. The typical structure of a neuron is illustrated 
by Figure 2.11 showing the neuron cell body and myelinated axon. Multiple 
processes arise from the cell body. Firstly, the dendrites which conduct impulses 
towards the cell body from other neurons (Kalat, 2004). Secondly, the axon, which 
also arises from the cell body and conducts impulses away, and in most cases is 
longer than the dendrites. Neurons can vary in length from a few millimetres to more 
than 1 metre; axons of the motor neurons with their cell bodies in the spinal cord will 
extend for over a metre to the muscles in the lower leg and have several branches 
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which end in a presynaptic terminal - the point at which the axon releases chemicals 
that cross the junction (i.e. synapse) between one neuron and the next, or to muscle 
fibres (Kalat, 2004). 
 
Nerve impulses, called action potentials, are brief electrical discharges produced by 
an electrochemical process. When the resting membrane potential of the neuron is 
momentarily altered (i.e. depolarised from -70mV to 30mV) (Kalat, 2004) an action 
potential is generated. This is as a result of an ionic exchange between the inner part 
of the cell and the extracellular fluid, facilitated firstly by the permeability of the cell 
membrane to sodium and potassium ions, which is altered by the arrival of the 
stimulus, and secondly by sodium-potassium ionic pumps within the membrane 
(Watkins, 2009). Whenever the membrane is depolarised to the threshold value, an 
action potential of constant magnitude is produced (i.e. the ‘all-or-none’ 
phenomenon), and this travels along the cell membrane as a flow of electrical current 
as each adjacent region of the membrane is depolarised (Kalat, 2004). This in turn 
causes the release of neurotransmitters at the motor-end plate - the junction between 
the nerve endings and the muscle membrane (Crossman and Neary, 2005), which 
excites the muscle causing contraction. 
 
 
 
 
Figure 2.11: Typical neuron structure 
(http://andreeasanatomy.blogspot.co.uk/2011/04/you-need-to-step-up-on-step-to-reach_23.html) 
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The stimulus generated by FES is an application of an external electrical field to the 
individual nerve cells (i.e. neurons) via the cathode (negative) electrode and anode 
(positive) electrode. If the stimulus is of sufficient strength, it generates an artificial 
action potential, by causing a depolarisation of the neuron membrane near the 
cathode as sodium ions are attracted by the negative electric field, reducing the 
positive charge on the outside of the membrane. The properties of the artificially 
generated action potential resultant from FES are identical to the action potential 
produced by physiological processes (Sheffler and Chae, 2007). However, the action 
potential travels in both directions along the nerve axon membrane; both towards the 
muscle fibres along the axon away from the cell body (orthodromic impulse) and 
away from the synapse towards the cell body (antidromic impulse). When the action 
potential reaches the muscle fibres a twitch of activity results (Watkins, 2009). To 
achieve functional muscle activity that is longer than a twitch, stimulation is delivered 
as a train of pulses, characterised by stimulus frequency, as well as amplitude and 
pulse width (Sheffler and Chae, 2007). The frequency of stimulus, typically a fixed 
parameter in clinical stimulators of around 40 pulses per second, acts to summate 
the individual twitches and thus produce a sustained muscle contraction. The 
strength of the muscle contraction will be the direct result of the number of the motor 
units that are recruited at one time, which is determined by the amplitude and width 
of the stimulus pulses (Sheffler and Chae, 2007).  
b) Central nervous system effects 
i) Brain 
 
FES for foot drop at an appropriate level has a clear and immediate effect on 
muscles around the ankle, to produce dorsiflexion and/or eversion at appropriate 
periods during gait. However, there is also evidence, discussed in the following 
section, demonstrating that FES induces neuroplasticity (Chipchase et al., 2011) - i.e. 
changes in neural pathways and synapses due to changes in behaviour, environment 
and neural processes (Pascual-Leone et al., 2011). These changes in neural 
pathways may in turn partly explain the widely reported ‘therapeutic effect’ of FES. 
Originally this effect was referred to as the ‘carryover’ effect, as it was noted as 
lasting for a short time (i.e. minutes, rather than hours or days). However, with 
increasing numbers of studies, the therapeutic effect is more often used to describe 
the maintenance of changes in gait following removal of FES, that is sustained over 
long periods of time (Robbins et al., 2006, Stein et al., 2010, Laufer et al., 2009, 
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Embrey et al., 2010, Israel et al., 2011). Although there is little evidence in this area, 
these changes may be facilitated by changes in neural processes. 
 
Use of FES has been shown to impact on cortical activity patterns. Functional 
magnetic resonance imaging (fMRI) studies have shown activation of the 
somatosensory cortex and supplementary motor cortex in response to electrical 
stimulation of wrist extension (Han et al., 2003, Kimberley et al., 2004, Shin et al., 
2008). In addition, functional improvements seen in response to EMG-triggered upper 
limb stimulation therapy are associated with increased cortical activation patterns 
(von Lewinski et al., 2009). In the lower limb, an fMRI study reported that stimulation 
of muscles results in a dose-response relationship between stimulation intensity and 
volume of activation of relevant areas of the brain (including the primary sensory and 
primary motor cortex and the cerebellum) (Smith et al., 2003). A more recent study 
showed that regular use of FES for foot drop strengthens the activation of motor 
cortical areas and their corticospinal connections (Everaert et al., 2010). Finally, 
when FES is combined with voluntary ankle dorsiflexion, activity in the primary motor 
and sensory cortexes was increased compared with FES-only induced activity 
(Gandolla, 2012). 
ii) Spinal  
 
It is also possible that FES impacts on the functioning of the CNS via spinal 
mechanisms (Sheffler and Chae, 2007), and this has been hypothesised by Rushton 
(2003). In healthy subjects the conductivity of the synapse between the corticospinal 
tract cell and the anterior horn cell is maintained by normal neural activity of an intact 
system. Furthermore, the strength of the synapse is thought to be increased by the 
coincidence of presynaptic and post-synaptic activities. After stroke, for example, 
neural activity in the corticospinal tract may be severely depleted and synapses 
weakened. Rushton (2003) postulates that FES, in particular for foot drop, promotes 
functional recovery via stimulation of the anterior horn cells (i.e. the ‘motor’ part of the 
spinal grey matter) (Young et al., 2008). The nerve impulse generated by FES 
travelling towards the spinal cord (antidromic impulse), will reach the anterior horn 
cells. If the FES pulses occur at approximately the same time as the person attempts 
to initiate voluntary dorsiflexion, descending volleys from the motor cortex will arrive 
at the corticospinal tract/anterior horn synapse in synchrony. This effect over time is 
believed to strengthen the connectivity of the relevant synapses. The proposed 
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strengthening effect is based on the ‘Hebbian learning theory’ described by Donald 
Hebb (Hebb, 1949) in which a change in the strength of synaptic connections is a 
function of both the pre and postsynaptic neural activities.  Strengthening of the 
synaptic connectivity may manifest in subsequent functional recovery. 
 
Furthermore, effects of FES at the spinal level are thought to have an anti-spastic 
effect. Stimulation of paretic muscles via FES leads to reciprocal inhibition of spastic 
antagonists through the stimulation of spinal interneurons (Schuhfried et al., 2012).  
 
2.4.3 Effects of FES on gait and other recorded outcomes 
 
The effect of FES in stroke populations has been the subject of several reviews and 
many research studies. A search of research articles published was performed using 
MEDLINE and Web of Science electronic databases using the following keywords;  
(electric* OR stimulat*) AND (stroke OR ‘cerebrovascular accident’ OR hemipleg*) 
AND (gait OR walk* OR ‘drop* foot’) (Roche, 2009). Other evidence was obtained 
from conference proceedings. 
 
There are several studies that report the effect of FES combined with other therapies 
e.g. body-weight supported treadmill training, botox injections. The following review 
does not include these studies, but focuses on those concerning use of FES alone. 
a) FES early after stroke 
 
Several authors have hypothesised that the benefits of FES demonstrated in chronic 
stroke populations could be realised in earlier phases of stroke recovery (Granat et 
al., 1996, Robbins et al., 2006, Roche, 2009). There has been limited research of the 
effect of FES in the acute phase (i.e. less than 2 weeks) (Dunning et al., 2009, Yan et 
al., 2005, Kunkel et al., 2012) and only a small number of studies in the sub-acute 
phase (i.e. 2 weeks to 6 months) (Bogataj et al., 1995, Granat et al., 1996, Sheffler et 
al., 2007, Salisbury et al., 2012). They have not provided conclusive evidence to 
support widespread use in these phases of recovery. However, despite small 
numbers of participants, there is some evidence to indicate the feasibility of use 
during these phases and of a positive benefit. The vast majority of studies have been 
performed with participants in the chronic phase. This is the focus of work in this 
thesis, and these studies are discussed in subsequent sections. 
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b) Effects of FES on gait speed and energy cost 
FES is effective in improving gait speed in the chronic stroke population (i.e. 6 
months or more post-stroke) as evidenced by two systematic reviews and a meta-
analysis (Kottink et al., 2004, Robbins et al., 2006, Roche, 2009) and by studies 
published since these reviews (Shiels et al., 2011, Stein et al., 2010, Embrey et al., 
2010, Laufer et al., 2009). Kottink’s (2004) review calculated a pooled improvement 
in walking speed, when using FES, from six of the eight studies reviewed, of 0.13 m/s 
(0.07–0.2) or 38% (22.18%–53.8%). The authors noted that this could be regarded 
as a clinically relevant improvement. There have been a small number of studies of 
implantable FES devices (Burridge et al., 2007b, Kottink et al., 2007, Kenney et al., 
2002). These devices have been shown to be similarly effective at increasing gait 
speed as surface FES systems. 
 
A meta-analysis (Robbins et al 2006) studied the therapeutic effect of FES (i.e. 
changes occur and are maintained in gait after removal of FES, also referred to as 
the carryover effect) in contrast to the orthotic effect (i.e. changes in gait during use 
of FES) as reviewed by Kottink et al (2004). The analysis showed a positive 
therapeutic effect of previous use of FES on gait speed in participants post stroke. In 
contrast to this, the review by Roche et al (2009) concluded that research supporting 
this effect was less conclusive than for the orthotic effect. Since this review, a study 
followed twenty-six FES users over eleven months of use, measuring a continual 
increase in speed after removal of FES, reaching a 28% improvement (Stein et al., 
2010). Furthermore, a study not included in the review by Roche et al (2009) found a 
significant therapeutic effect upon speed amongst thirteen FES users after twelve 
months use (Laufer et al., 2009). A study that combined intensive, repetitive walking 
with FES applied to both dorsiflexors and plantarflexors also found that walking 
speed improved without FES use, and this was evident three months after FES use 
was discontinued (Embrey et al., 2010). A case series since this study suggested that 
FES used on a more limited basis of three times a week over six weeks produced a 
therapeutic effect measured as a decrease in time to complete the modified Emory 
Functional Ambulation Profile (mEFAP); a measure of walking ability consisting of 
five walking tasks (Israel et al., 2011). Whilst the review by Roche et al (2009) could 
not find conclusive evidence of the therapeutic effect of FES, several studies provide 
support for this effect that is noted by both clinicians and patients. 
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Kottink’s (2004) and Roche’s (2009) reviews also collated evidence from the few 
studies that have used physiological cost index (PCI) as an outcome measure, 
indicating that the energy cost of gait may be reduced with use of FES. Further 
studies since have agreed with this conclusion (Stein et al., 2010, Hausdorff and 
Ring, 2008) plus a therapeutic effect on PCI has been noted in one study with a 
significant decrease over time, measured over an eleven month period of FES use 
(Stein et al., 2010). In a study which provided FES as part of a daily rehabilitation 
program over 12 weeks, PCI reduced and cardiorespiratory responses (i.e. heart 
rate, oxygen consumption, carbon dioxide production) improved (Sabut et al., 2010). 
c) Effect of FES on kinematics of gait 
 
The most common application of FES for post stroke gait is to improve toe clearance 
by correcting swing phase foot drop, via stimulating only ankle joint dorsiflexors (i.e. 
single channel FES). This application is clinically effective at increasing ankle joint 
dorsiflexion with research evidence supportive of this observed outcome. Ankle joint 
dorsiflexion, in a group of experienced FES users, increased at toe off and during 
swing phase by an average by 9.9° (SD 4.2°) (Voigt and Sinkjaer, 2000). With use of 
an implantable device after twenty-six weeks use, ankle joint dorsiflexion during 
swing phase, whilst using FES, increased (i.e. a significant decrease in plantarflexion 
of 5.5°) (Kottink et al., 2012). Toe clearance was measured, using the maximal 
vertical displacement of a marker placed over the fifth metatarsal joint, in a group of 
new users, finding that FES resulted in a significant increase, although the origin 
could not be assumed to be changes in ankle joint dorsiflexion as this was not 
assessed (Robertson et al., 2010). In another group of new FES users the peak 
angle of ankle joint dorsiflexion was significantly increased during swing phase and 
ankle plantarflexion was found to be reduced at toe-off (Kesar et al., 2010). In a 
further study (Kesar et al., 2009) FES was delivered to both plantarflexion and 
dorsiflexion muscles (i.e. dual-channel FES), delivering stimulation of the 
plantarflexion muscles during the terminal double-support phase. Application of 
stimulation at this point in the gait cycle should improve forward propulsive force 
generated by the ankle plantarflexors, increasing leg kinetic energy at toe-off and 
thereby increasing knee flexion during swing phase. Increased ankle plantarflexion 
angles were achieved at toe-off, as well as an increase in peak anterior ground 
reaction force (GRF) and an increase in percentage contribution of the hemiplegic leg 
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to total propulsion. However, peak ankle joint dorsiflexion during swing was reduced 
compared with stimulating only the dorsiflexor muscles. 
 
It has been an accepted effect of FES that knee and hip flexion occurs during swing 
phase, as the sensory stimulus generated by FES facilitates a flexor withdrawal 
response at the knee and hip (Burridge et al., 1997b). In contrast to this anecdotal 
note, kinematic analysis of eight experienced FES users found no uniform effect was 
measured in the sagittal plane at the hip or knee (Voigt and Sinkjaer, 2000). Similarly, 
a study of an implantable device used by nine new users, found no change in hip or 
knee flexion after twenty-six weeks use, although this may be explained by the need 
for the use of less current to achieve adequate dorsiflexion and no cutaneous 
stimulation, and hence the withdrawal response may not be triggered (Kottink et al., 
2012). With stimulation of dorsiflexion alone, FES can result in a decrease in knee 
flexion during the swing phase (Kesar et al., 2010) rather than an increase. This 
effect is believed to be associated with decreased plantarflexion at the ankle joint at 
toe-off. When plantarflexion is also stimulated, knee flexion increased and 
counteracted the effects of dorsiflexion stimulation alone (Kesar et al., 2009). Finally, 
two recent case studies (van der Meulen, 2012) have noted improvements in pelvic 
obliquity (i.e. hip hiking) and hip circumduction with FES use, thus showing a 
reduction in compensatory strategies used to improve toe clearance.  
d) Effects of FES on stability, trips and falls  
 
An improvement in toe clearance due to FES is presumed to contribute to a reduction 
in the risk of tripping and the number falls experienced by users, and an improved 
ability of users to negotiate uneven surfaces and obstacles during walking. Despite 
this there are only a few studies that have addressed any of these issues. Walking 
speed and PCI were assessed in thirteen FES users over even and uneven ground, 
both with and without FES (Burridge et al., 2007a). A trend for greater improvement, 
with FES use, in speed and PCI over uneven surface was found. The authors 
suggested that the effect of FES on the effort of walking was important to users 
rather than increased speed. A study of sixteen FES users after one year of use 
again showed a trend towards a greater increase in speed when walking on carpet 
and speeds also increased when avoiding obstacles, compared with speeds without 
FES (Laufer et al., 2009). Two comparison studies with AFOs also used obstacle 
avoidance as an outcome measure. In the earlier study, when assessed using the 
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mEFAP (modified Emory Functional Ambulation Profile), FES significantly improved 
ambulation on carpet and there was a trend towards improvement on the obstacle 
test in comparison to use of no device (Sheffler et al., 2006). There was no difference 
between both carpet and obstacle tests when AFOs and FES were compared. In 
contrast, in a later study of twenty four AFO users who were fitted with FES, 
performance on an obstacle avoidance test whilst walking on a treadmill measured 
higher success rates with FES than with AFO and these gains were clinically most 
relevant for those participants with relatively low leg muscle strength (van Swigchem 
et al., 2012). 
 
The number of falls experienced by participants of a study by Hausdorff and Ring 
(2008) was collated two months prior to their entry in the study and during the two 
months of FES use whilst participating in the study. During participation in the study 
there was a 92% reduction in the number of falls. In a study prior to this (Daly et al., 
2006), using intramuscular electrodes to deliver FES during four sessions a week 
over twelve weeks, the Tinetti gait scale was used to assess co-ordinated gait 
components. This scale is a measure of falls risk. In this group of sixteen participants 
there was an improvement in the scale with FES use that equated to a potential 
reduction in the frequency of falls. 
 
A small number of studies have explored other spatiotemporal parameters which may 
be related to walking stability. In a study of eight experienced FES users, hemiplegic 
walking patterns were analysed with the use of FES in comparison to walking without 
(Voigt and Sinkjaer, 2000). Gait symmetry, evaluated by calculating the ratio between 
the stride length of both legs, was not improved by the use of FES. In contrast, a 
study using swing time to calculate gait asymmetry showed an improvement of 45% 
after two months use, which was maintained after one year of use (Laufer et al., 
2009). Furthermore, in the RCT by Kottink et al (2012) of an implantable device, 
significant changes were measured in gait cycle phases. Stance and double support 
phases were reduced on the paretic side whilst on the contralateral side single 
support phase increased with FES use of for twenty-six weeks. In a study comparing 
FES use with AFOs, gait asymmetry, calculated again using swing time, showed a 
15% improvement with FES (Ring et al., 2009). Finally, stride time variability, a 
measure of gait rhythmicity, was measured in twenty-four new users of FES at initial 
application, four weeks and eight weeks with reduction in variability by 23%, 27% and 
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33% respectively (Hausdorff and Ring, 2008) with the latter improvement being 
maintained after one year of use (Laufer et al., 2009). 
e) Patient-reported outcomes 
 
Roche’s review (2009) noted that over thirty different outcome measures were 
employed in the studies included, indicating that there is not a standardised approach 
to assessment of FES effectiveness in research. NICE guidance (2009) recommends 
that ‘further publication on the efficacy of FES would be useful, specifically including 
patient-reported outcomes’. This potential change in focus is supported by existing 
evidence and the following discussion reviews this evidence. 
 
Two important studies by Taylor et al (1999, 2004) collated user opinions from 
patients of a clinical service. Respondents to these postal questionnaires were 
current users of FES and were significant in number - 78 and 69 respectively. In the 
former study (Taylor et al., 1999b), reduced effort, reduced risk of tripping, increased 
walking distance and increased confidence were each chosen by over 65% of 
respondents as reasons for using FES. The primary reason for use was a reduction 
in the effort of walking (29% of respondents), with reduced risk of tripping and 
increased walking distance chosen by 15% and 9.4% respectively. In the second 
study (Taylor, 2004), reduced effort, long term improvement in walking, increased 
confidence and reduced risk of tripping were each chosen by over 60% of 
respondents as reasons for use. The primary reason was again reduced effort (27%), 
followed by therapeutic effect (i.e. carryover), long term improvement in walking, 
increased confidence, reduced risk of tripping and increased independence. 
 
Again in a study of patients of a clinical service, a quality of life measure (i.e. PIADS) 
was obtained as well as walking speed, from a group of twenty new users after 
eighteen weeks of use (Barrett and Taylor, 2010). The Psychosocial Impact of 
Assistive Devices Scale (PIADS) is a self-rating scale that is designed to evaluate the 
effect of assistive devices on perceived quality of life (QOL). It was developed to 
reflect the changing function and participation abilities as a result of an assistive 
device and measure psychological aspects of well-being such as self-confidence, 
enabling and liberating effects, impact on function, performance and productivity 
(Jutai, 2002). After 18 weeks of FES use, PIADS scores showed a positive effect on 
all aspects of well-being measured by the scale, suggesting that FES had a positive 
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effect on psychological well-being. There was no correlation of PIADS scores with 
improvements in walking speed.  
 
A trial which provided implanted dual channel FES, following fourteen participants for 
twenty-six weeks and comparing outcomes with a control group, measured health-
related QOL using the Short Form-36 and Disability Impact Profile (Kottink et al., 
2010). A significant positive effect was found in the physical functioning and general 
health domain of the former and in the mobility, self-care and psychological status of 
the latter. When another group of twelve implanted FES users were asked if they felt 
the device had improved their quality of life, the majority agreed (Burridge et al., 
2008). 
 
These studies suggest that the traditional measures of walking speed and PCI on 
their own do not provide a complete picture of the benefits of FES to users. They 
support the anecdotal reports from clinicians and users that the effects of FES 
routinely extend beyond objective measures of walking, with reasons for use, other 
than increased walking speed, consistently rated by users as more important. This 
may also explain why some users continue to use the device despite small gains in 
objective measures of walking. 
 
Further studies have used functional outcome measures to assess effectiveness. In 
two studies a shortened version of the Stroke Impact Scale (SIS) was applied. This is 
a self-reported measure of a wide range of physical functional limitations following 
stroke. In one study, of single channel FES after one year of normal use by sixteen 
participants, SIS measures showed a significant increase in both physical functioning 
as well as community participation (Laufer et al., 2009). In a second study, of dual 
channel FES used for one hour to walk over a six month period, the SIS was used to 
assess improvements without FES use (Embrey et al., 2010). Again in this second 
study there was an improvement in community participation. Evidence from 
qualitative studies supports these findings. In a small exploratory study of patient 
experiences using FES, for example, the authors concluded that the device had far-
reaching effects on patient’s lives, including an increase in social confidence, 
improved performance of activities of daily living and increased opportunities for 
work, social and leisure activities (Malone, 2002). A more recent study (Wilkie et al., 
2012) revealed that users felt their walking was much better, they were able to 
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resume previous roles, regain control of their life and their independence and that 
use of FES had some psychological effects in terms of positive feelings and improved 
mood.  
 
Several studies since those by Taylor et al (1999, 2004) have noted that the use of 
FES improves confidence. FES users from the Malone et al (2002) study described 
feeling more confident, as they felt the risk of falling was reduced. Furthermore, a 
study of an implanted foot drop stimulator found that one of the main reasons for 
satisfaction with the device was improved confidence during gait (Sinkjaer et al., 
2006). The authors note that further work is needed to define ‘confidence’. In the 
Wilkie et al (2012) study an improvement in confidence was also noted by 
participants. It is possible that improving confidence may in turn create a perceived 
increase in safety and furthermore, a perception of a reduced risk of falls. All of the 
participants in the study by Malone et al (2002) reported falling prior to use of FES 
and, as a consequence, described losing confidence with their walking. 
 
The commonly used alternative to FES is an AFO, and as such there are some 
comparison studies. However, small numbers of participants have been involved and 
the results of comparative gait measures have been contradictory, although there has 
been a fairly consistent user preference for FES. In a study of fourteen participants 
(Sheffler et al., 2006) the effect of AFO and FES on improving functional ambulation 
was comparable; however participants indicated a preference for FES. In contrast, a 
randomised controlled trial of twenty-nine participants, comparing an implanted FES 
device with AFOs, walking speed improved by 23% in the FES group in comparison 
to 3% in the AFO group (Kottink et al., 2007). In addition, when measures of gait 
stability were used in another study, FES was found to improve the gait asymmetry 
index by 15% and to reduce swing time variability when compared with AFO use in 
fifteen participants (Ring et al., 2009). Participants reported feeling more stable with 
FES and that gait looked more normal, declaring a clear preference for FES over an 
AFO. Again, in a more recent study (van Swigchem et al., 2010), despite no objective 
difference in gait measures or levels of physical activity, twenty-six participants 
expressed statistically significant preferences for FES over the AFO, particularly in 
regard to stability and effort. Furthermore, those participants who perceived improved 
stability also showed improvements in obstacle avoidance ability with FES (van 
Swigchem et al., 2012). Finally, the perceptions of users of both FES and AFOs were 
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captured in a study of nine patients (Bulley et al., 2011). Users preferred FES for a 
variety of reasons including a reduction in the risk of tripping, improved function and 
independence, and a perception of walking normally.   
f) Discussion and conclusions 
 
There is growing research evidence to indicate that measures other than walking 
speed and PCI are more important to FES users. These ‘patient-centred’ outcomes, 
which are consistently rated above objective measures as the primary reason for use, 
appear to explain the preference for FES use compared with AFOs. They also 
potentially explain continuing use of FES when objective measures do not support a 
significant or clinical benefit. From the two Taylor et al (1999, 2004) studies where 
large groups of FES users provided an insight into this issue, a reduction in effort was 
consistently rated as the primary reason for use, with increased confidence, reduced 
risk of tripping and increased walking distance as other main reasons. Whilst the 
authors note this reduction in effort as being consistent with observed reductions in 
the PCI in other studies, there is some evidence that ‘effort’ may be interpreted, by 
some respondents, as including both the mental, as well as physical dimensions.  
 
While it can be misleading to read too much into a dictionary definition, there is 
clearly a commonly accepted understanding that effort can encompass both physical 
and mental elements. One dictionary (1994) defines effort as ‘physical or mental 
energy needed to do something’. In another (1984) it is defined as ‘strenuous 
exertion, vigorous attempt, force exerted, special activity, or something accomplished 
involving concentration’. Thus, the interpretation of ‘effort’ by respondents could be 
one or many, and possibly not just in the physical context. 
  
The possibility that an effect on ‘effort’, in the context of a positive outcome of FES 
use, may be due to a discernible change in the amount of concentration needed to 
walk whilst using FES, has some support in the research literature. In the study by 
Malone et al (2002), participants described, prior to using FES, having to concentrate 
all the time when walking, including looking at their feet and overall becoming more 
tired. With use of the stimulator, they reported their walking as more normal and 
requiring less effort, as they did not have to concentrate as much on their walking. 
Similarly, participants from the Bulley et al study (2011) described their walking as 
requiring less conscious thought when using FES. Furthermore, in the study by 
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Burridge et al (2007) of performance over uneven ground, the measured perception 
score of participants showed concordance with PCI measures rather than walking 
speed, suggesting that the perceived benefit of FES on improvements in the effort of 
walking was more important. Thus, a perception of reduced effort may also be 
achieved whilst walking during circumstances when a trip or fall is a higher risk. 
 
2.5 Thesis aims 
 
This chapter introduced and discussed the concepts of motor control, reviewing the 
currently accepted model based on neuromuscular function primarily driven by the 
interaction of motor and sensory areas of the brain. However, there is strong 
evidence from growing numbers of papers from brain imaging and dual-task studies 
that support the contribution to normal gait of areas of the brain which also serve 
cognitive and executive function. Apart from evidence from studies involving healthy 
participants, there is support also from gait study literature of neurologically impaired 
populations. In particular these studies highlight the interference to the motor and 
cognitive interactions in the presence of suboptimal neural processes especially due 
to damage of central origin. 
 
As discussed in the chapter, a stroke damages brain tissue and consequently creates 
a large range of neurological impairments, the most common affecting motor and 
cognitive functions. One of the consequences of surviving a stroke is a heightened 
risk of falls, and although the reasons for a fall can be multifactorial, the contribution 
of motor and cognitive dysfunction is important. One of the outcomes of stroke, that 
undoubtedly contributes to fall risk, is a foot drop gait. FES is used to address this by 
improving dorsiflexion on swing through and foot placement on initial contact, thus 
reducing the potential for the toe to catch the ground when walking and a trip or fall to 
result.  
 
As discussed in the chapter, FES has traditionally been assessed for effectiveness 
by measuring improvements in gait speed and the energy cost of walking. However, 
increased speed is not as highly rated by users as several other perceived effects. In 
particular reduced effort is consistently identified as a primary reason for FES use 
with a reduction in the risk of tripping and falling also highly rated. A reduction in the 
effort of walking may include a mental component and may be plausibly explained by 
the contribution of cognitive function to motor control. Furthermore, whilst there is an 
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obvious functional improvement in walking that should reduce the risk of tripping, 
FES use may also reduce the demand of gait on both motor and cognitive control 
thus improving the ability to maintain safe and stable gait. 
 
The primary aim of this thesis is to explore the contribution of FES to the cognitive 
control of gait. Firstly, the idea that cognitive control was affected by the use of FES 
came from very small qualitative studies, although the two studies by Taylor et al did 
canvass nearly 150 users. Consequently, the first objective was to gather data to 
either support or refute the concept of perceived effects on the mental effort of 
walking. If sufficient support was collected, the second objective was to explore the 
concept of cognitive control further by via a gait laboratory study, based on a dual-
task approach.  
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Chapter 3 – Study of FES user reported effects 
 
3.1 Introduction 
 
As described in Chapter 2 (section 2.2.3c), a review of literature established the 
concept of a complex relationship between higher level cognitive function and gait 
(Sheridan and Hausdorff, 2007, Al-Yahya et al., 2011). Furthermore, impairments to 
the executive function and attention systems as a result of stroke, particularly when 
paired with physical impairments, may lead to increased competition for limited 
higher level resources (Woollacott and Shumway-Cook, 2002, Springer et al., 2006, 
Liu-Ambrose et al., 2007, Yogev-Seligmann et al., 2008, Segev-Jacubovski et al., 
2011). Building on this, there was also evidence from the literature on falls, both at 
the start of the thesis and since, as discussed in section 2.3.4b, that indicated the 
contribution of cognitive deficits, including attention and memory deficits, to fall risk 
amongst the stroke population (Rapport et al., 1993, Hyndman and Ashburn, 2003, 
Wada et al., 2007, Alemdaroglu et al., 2012). However, at the start of the thesis, 
there was no information on how FES may interact with such motor-cognitive deficits.  
 
In the FES literature there were a small number of publications describing the user-
perceived effects of FES for foot drop. As discussed in section 2.4.3e, two postal 
questionnaire studies of FES user opinion (Taylor et al., 1999b, Taylor, 2004) 
reported factors other than walking speed, traditionally used as an outcome measure 
of effectiveness, to be the most important reasons for using FES. A reduction in effort 
was the principal reason cited by the majority of users in both studies. Further 
principal reasons ranked below effort were, in the first study, reduced risk of tripping, 
followed by increased walking distance and finally increased confidence. These all 
preceded increased walking speed in the ranking of primary reasons for use by FES 
users. In the second study, five effects were ranked more highly as primary reasons 
for use, before walking speed. They were ranked behind reduced effort as follows: 
therapeutic effect (i.e. carryover), long term improvement in walking, increased 
confidence, reduced risk of tripping and increased independence. Thus, there are 
several effects of FES that users perceive as more important than walking speed, 
with reduced effort of walking consistently ranked as the primary reason. 
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At the time, there was a suggestion, from a small qualitative study (Malone, 2002), 
that effort in this context may not only relate to the physical effort, but may also 
include the mental effort of gait. Participants described walking prior to use of FES as 
requiring ‘concentration all the time’. Then, with use of FES, participants described 
feeling that their walking was more normal and required less effort, as they did not 
have to concentrate so much on their walking. Participants in this study thus 
suggested a link between the effort of walking and a level of required concentration 
when walking following a stroke that was directly improved by the use of FES.  
 
Furthermore, the findings from Taylor et al (1999b, 2004), that trips and falls appear 
to be reduced when using FES, could be interpreted in a number of ways. One 
possible explanation is that FES has a positive effect on gait stability through the 
biomechanical effects of lifting the foot during the swing phase and orienting the foot 
correctly at heel strike. However, it is possible to hypothesise that these 
biomechanical effects may also indirectly impact on the cognitive demands of 
walking, by reducing the need to pay visual attention to the foot during walking. 
Further, as discussed in section 2.4.2b, there is strong evidence that FES acts to 
change excitability of centres of the brain which serve both motor and cognitive 
purposes and also a suggestion that FES acts to modulate interactions between the 
CNS and PNS at the spinal cord. While the implications of this are entirely 
speculative, it is possible that such changes in neural connectivity may manifest in 
changes in the performance of demanding motor-cognitive tasks, such as trip or fall 
avoidance. Finally, the sensory stimulation associated with FES may also have an 
effect on the focus of attention during walking. It is therefore possible that FES may 
help users to avoid a fall by improving the cognitive resources available when walking 
is challenged. However, there were no studies exploring these effects. 
 
It was clear that further work was required to explore and substantiate these 
concepts, based on user perceptions, before experimental work with users of FES 
was justified. Furthermore, in order to design any subsequent experimental study, 
more information on the perceived effects of FES was needed. As described above 
there was strong evidence from the wider literature to support further investigation of 
these concepts.  
 
49 
 
At the beginning of the thesis there was a growing body of studies using dual-task 
methodologies to assess gait in the presence of gait impairments and cognitive 
disorders e.g. Parkinson’s disease (Woollacott and Shumway-Cook, 2002). Dual-task 
study designs, requiring a division of attention between walking and a cognitive task, 
are reflective and typical of real world situations where participants are required to 
‘walk and talk’, to take note of their surroundings and to remember and follow 
directions. Thus, studies available at the beginning of the thesis, using this 
methodology, indicated that there was a relationship between gait and higher level 
cognitive functions. However, despite growing numbers of dual-task studies, only two 
small studies of exclusively stroke patients had been published at the time. The first 
was a study of eleven participants, using a verbal cognitive task (i.e. a pre-
determined verbal response to verbal cues) as a secondary task whilst walking 
(Bowen et al., 2001). Gait speed decreased with task, and double support time 
increased; performance of the cognitive task was not reported. The second study 
involved ten participants and compared stride duration whilst performing a word 
generation task, measured initially after their stroke and then 1-9 months later 
(Cockburn et al., 2003). Stride duration improved with recovery more so than 
cognitive performance.  
 
At this time there were also a small number of studies that had addressed the issue 
of whether devices to assist walking may impact on the attentional demands during 
gait. For instance, a dual-task methodology was applied to examine the attentional 
demands of use of standard and rolling walkers by healthy young adults (Wright and 
Kemp, 1992). The task required a vocal response to an auditory tone and the time 
elapsed before the response was measured. Secondary task was significantly 
affected in the dual-task condition with a standard pick-up walker. In a study of 
unilateral transfemoral amputees the cognitive demand of two prostheses was 
compared (Heller et al., 2000). A simple task of reading a number that appeared on a 
monitor and a more demanding distracting task of the Stroop test (i.e. naming the 
colour in which a word is printed) were both used as secondary tasks. Body sway 
was compared between the conditions, finding no significant difference and thus, 
neither prosthesis created a greater cognitive demand. However, the Stroop test 
created significantly larger body sway than the simple task. 
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The emerging literature suggested that a dual-task based experimental study would 
allow for investigation of the effects reported by FES users. Specifically, it would 
allow for a study of the effects that FES users described from the available literature 
(Taylor et al., 1999b, Taylor, 2004, Malone, 2002). As there was very limited 
evidence to support the hypothesis that FES may have an effect on motor-cognitive 
performance during walking, the decision was made to use a questionnaire study to 
explore user reported effects amongst a group of people who had been using FES 
for foot drop as a result of stroke. Furthermore, the secondary cognitive tasks used in 
dual-task studies were various and the reasoning for choice of task was not routinely 
reported in the literature. Again, due to the limited evidence, it was also decided that 
the questionnaire study could contribute to identification of an appropriate dual-task 
for a group of FES users. The questionnaire study aims were to substantiate or refute 
the suggestion in the literature that FES for foot drop is perceived to impact on the 
higher level cognitive functions during gait and, if confirmed, to inform the design of 
subsequent experimental studies that would allow for the testing of this hypothesis.  
 
This chapter begins by detailing the aims of the questionnaire study. The process by 
which the questionnaire design was formulated is then described, including pilot work 
and the use of expert opinion to inform questionnaire structure and content. The 
process by which the questionnaire was implemented is then described, followed by 
results. Finally, the study is discussed, including its limitations, and conclusions 
drawn.    
 
3.2 Aims of the questionnaire study 
 
The questionnaire study had three main aims: 
a) To investigate FES users’ perceptions of the effects of FES on walking. 
b) To investigate FES users’ perceptions of the effect FES may have on 
concentration required when walking. 
c) To investigate FES users’ perceptions of the specific areas in which use of 
FES may contribute to a change in the effort of walking. 
 
The secondary aim of the questionnaire study was to inform choice of a dual-task 
methodology for a possible subsequent gait laboratory study. 
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3.3 Development and design 
 
3.3.1 Choice of questionnaire study design 
 
A questionnaire was chosen to address the primarily exploratory aims of the study. 
Whilst the first aim of investigating the effects of FES on walking had already been 
addressed by the Taylor et al (1999, 2004) studies, the current study planned to 
explore this concept again in a new group of FES users. The other two aims to 
investigate the effect of FES on the concentration and effort of walking had not been 
extensively explored by any previous study. The exploratory nature of this study 
suggested that a questionnaire-based approach would be appropriate (Wood, 2001). 
Furthermore, a questionnaire had been successfully used to explore the effects of 
FES by Taylor et al (1999, 2004).  
 
At the time of the study in 2005 there were two large FES clinical services in the UK 
and only a handful of much smaller services. The nature of service provision meant 
that services operated as regional or tertiary centres servicing the local population as 
well as a scattered population of users from a large area of the UK. As such, the 
choice of a postal questionnaire would give the sample group an equal opportunity to 
respond, rather than reliance upon face-to-face methods of data collection. This 
approach is also less susceptible to interviewer bias and is obviously an economically 
pragmatic approach (Polgar and Thomas, 2000). 
 
Access to the largest group of FES users (in Salisbury (UK)) was arranged. The FES 
group was recruited from a clinical service, which collected information from their 
patients on an on-going basis and had, in the past, used questionnaires for specific 
research questions. Previous response rates of 55% and 74% (Taylor et al., 1999b, 
Taylor, 2004) were seen as indicative of a potentially similar return rate for this study. 
 
3.3.2 Formulation of questionnaire structure, design and content 
 
The questionnaire structure, design and content was developed according to 
recognised strategies (Chesson, 1993, Stone, 1993, Bradburn et al., 2004, Bowling, 
2005). The focus of the questionnaire was clearly defined by the aims and there was 
a clear relationship with the subsequent content (Bowling, 2005). Relevant literature 
52 
 
on user perceptions of FES and related devices was reviewed, and questions used in 
these studies were analysed for inclusion in the questionnaire.  
 
FES users were directly engaged to review perceived effects from the literature and 
to ascertain any other outcomes of device use. Effects of FES as previously 
described in the two studies by Taylor et al (1999, 2004) were reiterated by users, 
thus confirming the effects already reported i.e. improved confidence, increased 
independence. FES users also described other effects of FES when walking such as 
‘I don’t need to look at my feet as much’, ‘I can think about something and not my 
walking’ and ‘I can carry on a conversation’. Furthermore, these effects were 
expressed as very positive effects of FES that seemed to be in addition to improved 
walking and also seemed to be important to users. These effects independently 
expressed by FES users supported concepts noted in the small study by Malone 
(2002) and seem to indicate that FES gave them an ability to perform other non-
motor, cognitive functions more easily whilst walking. The outcomes of these 
discussions were used to inform construction of questions included in the 
questionnaire (see sections b and c that follow). 
 
Questions were devised that were simple, unambiguous and not too long (Stone, 
1993, Bowling, 2005). The order in which the questions were asked was devised 
taking into consideration the filtering of respondents who may no longer be using 
their device, achievement of a natural flow to the topics covered and difficulty of the 
questions asked (Chesson, 1993). It is often recommended that demographic 
questions should be asked at the end of a questionnaire (Bradburn et al., 2004). In 
this study it was felt appropriate to ask these questions at the beginning as they were 
felt to be non-threatening and easy relative to the subsequent questions that 
addressed the aims of the questionnaire (Chesson, 1993, Bowling, 2005). The 
question about date of stroke, at the beginning of the questionnaire, also served to 
screen respondents thus excluding those who had not suffered from a stroke, and 
may have inadvertently received a questionnaire, from analysis of results (Peterson, 
2000). 
 
The content, design and layout of the questionnaire were reviewed, with advice 
sought from an experienced researcher, a psychologist and a statistician. The 
psychologist with expertise in dual-task methodology and the researcher, who had 
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previously designed and published results from questionnaires applied to FES 
groups, gave advice about the construction of the questions and the design and 
layout of the questionnaire. The statistician offered advice concerning planned 
analysis of data and the appropriate choice of question response structures (e.g. 
open vs. closed questions, scaled responses) to facilitate analysis.  
 
Once the content was finalised, the questionnaire was piloted with people from the 
target population. Issues concerning language used and clarity of meaning of the 
questions were highlighted during this process, identifying the importance of using 
language and terms that would be used in everyday conversations. In particular, it 
was important to describe the effects of FES in the questionnaire using the same 
wording as FES users e.g. ‘I don’t have to think so much about my walking when I 
have the stimulator switched on’. The structure of responses to questions was also 
tested to ensure that users could follow the directions given about how to answer 
correctly. Users felt that the inclusion of a response indicating that some questions 
would not apply to their circumstances was important, and this concurred with advice 
from the statistician, as this option would potentially ensure a response rather than 
questions remaining unanswered. Furthermore, FES users were able to identify an 
appropriate response, from those questions using scaled responses, which reflected 
the effect of FES. Overall the content of the questionnaire seemed to capture 
perceived effects of FES for those who participated in the pilot. Following piloting, the 
questionnaire was finalised. 
 
The questionnaire addressed three aims and Figure 3.1 illustrates the process via 
which each aim was developed into content. Following is a description of each of 
these areas and of the remaining sections of the questionnaire. It should be noted 
that the questionnaire was implemented in July 2005, and as such the content and 
design was informed by literature available at that time. 
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Figure 3.1: Process of development of questionnaire content 
 
a) The effect of the device 
 
To address the first aim of the questionnaire, the investigation of users’ perceptions 
of the effects of their device, the relevant literature was reviewed. 
 
FES and AFOs when used in foot drop gait both have the primary aim of enhancing 
dorsiflexion. AFOs apply an external brace to achieve this rather than promoting 
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active dorsiflexion, as is the approach applied by FES. AFOs are an alternative 
device to FES, thus effects perceived by AFO users may be similar to those noted in 
FES studies. Furthermore, as very few studies capturing FES user views were 
available at the time of developing the questionnaire, the decision was taken to 
review the closely related literature on AFO user views to inform the questionnaire 
design. 
 
A systematic review (Leung et al 2003), performed to evaluate the effects of AFOs on 
adult hemiplegic gait, suggested that AFOs may lead to an immediate kinematic and 
temporal improvement in gait in selected hemiplegic patients. Only one study was 
included in this review that reported on the energy expenditure of AFO use, noting 
that oxygen consumption was lowered by the use of an AFO. Studies that included 
AFO user opinion as an outcome (Tyson, 1998, Tyson and Thornton, 2001, de Wit et 
al., 2004), canvassed a total of 49 users, seeking opinion as a secondary outcome. 
In the first Tyson study (1998), AFO users described being able to walk further and 
faster and with greater confidence and safety. More AFO users, in the Tyson et al 
study of 2001, agreed that the AFO improved safety and confidence when walking 
than those who agreed it increased speed, despite a measured statistically significant 
increase in speed. Furthermore, 70% of the participants in the study by de Wit et al 
(2004) felt their self-confidence was improved even though the measured changes in 
walking speed were not clinically relevant. 
 
A review of both FES and AFO studies was used to formulate a list of possible 
perceived effects of devices for foot drop. From the two studies by Taylor et al (1999, 
2004) the list of positive effects of FES, as perceived by users, was as follows: 
- Reduction in effort 
- Reduced risk of tripping 
- Increased walking distance 
- Increased confidence 
- Increased walking speed 
- Increased independence 
- Improved ability to walk on uneven ground 
- No longer need an AFO 
- Improved fitness with exercise 
- No longer need assistance to walk 
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- Improved walking without FES 
- No longer need to use stick 
- Carryover effect 
- Corrects inversion of the foot 
 
The majority of these effects were re-iterated by participants in the study by Malone 
et al (2002). Furthermore, 80% of patients reported an increase in confidence with 
FES, although this was from a mixed group of patients including those with Multiple 
Sclerosis (Singleton, 2004).   
 
From the two AFO studies performed by Tyson et al (1998, 2001) the following 
positive effects were identified by users: 
- Able to walk further 
- Able to walk faster 
- Increased confidence 
- Increased safety 
- Able to swing leg forward more easily 
- Lifting toes improved 
- Taking weight through foot improved 
 
In broad agreement with these, de Wit et al (2004) asked participants to consider the 
difficulty and self-confidence involved in the ‘timed up and go test’ and using stairs, 
with and without an AFO. Less difficulties and greater self-confidence were reported 
when wearing the AFO. Although FES users highly rate a reduction in effort as an 
outcome, this effect was only noted in one AFO study (Geboers et al., 2002) in which 
a questionnaire collated user opinion of 16 AFO users with foot drop as a result of 
peroneal nerve lesion or L5 radiculopathy. Results indicated that AFOs had a positive 
effect on walking performance and walking effort in 75% of the participants. 
 
Each possible outcome regarding the effect of FES, as derived from the FES and 
AFO literature as discussed above, was considered for applicability. The focus of this 
process was to reflect outcomes reported by users, to date reported in few studies, 
but potentially of importance to them in the context of this thesis. Another key point 
was to minimise the length of the list of included outcomes to minimise the burden to 
the respondents. Therefore, questions which did not clearly relate to the focus of the 
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thesis, or had previously been shown to be of little relevance to users were excluded. 
The following lists the reasoning for inclusion of outcomes in Section C (1) of the 
questionnaire (see Appendix A.1): 
- Increased confidence, ability to walk further and faster - Common to both FES 
and AFO studies therefore respondents may perceive this as an effect. 
- Reduction in effort - Highly rated by FES users and also in one non-stroke 
AFO study (Geboers et al., 2002). 
- Increased independence - Highly rated by FES users. 
- Reduced risk of tripping, improved ability on uneven ground, increased safety - 
Identified by both FES and AFO users as positive outcomes of device use. 
- No longer need assistance to walk - Rated by over 30% of FES users (Taylor 
et al., 1999b, Taylor, 2004) as a positive effect and could be related to feeling 
of independence. 
- Improved fitness with exercise, no longer need to use stick - Rated by the 
fewest number of FES users as an effect (Taylor et al., 1999b, Taylor, 2004) 
however potentially important effects for some users. 
 
Two further effects were included in the questionnaire, Section C (1) (see Appendix 
A.1) that were derived from discussions with FES users as well as from the Malone et 
al (2002) study. Users noted that their posture improved with device use and that 
their walking became more balanced and even. 
 
To encourage a response to each potential effect of the device and to be confident 
that each effect was considered by the respondents, the effects were framed as 
statements that required a response. Respondents were given a choice of responses 
and were directed to the need for a response (see Section C (1), Appendix A.1). The 
choice of response was related to the statement and was designed to gain 
agreement by using endorsement stimuli; ‘agree’, ‘disagree’ (Peterson, 2000). A third 
choice was also available - ‘doesn’t apply’ – thus accounting for those respondents 
for whom the statement was not a perceived effect. Designing the response in this 
way addressed issues of sensitivity and specificity (Bowling, 2005) by allowing for 
those not affected by the questions asked. This response structure also aided 
statistical analysis of data, by encouraging respondents to record an answer to each 
of the statements.  
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To obtain the most highly rated effects of FES, the Taylor et al (1999, 2004) studies 
asked the participants to identify, from the effects that they had noted as applicable 
to them, the most important effect. The questionnaire used in this current study also 
asked this question to collate data on the most highly rated effects of FES, in order to 
establish the primary reason for FES use and compare these results with the 
previous studies.  
b) Concentration during walking 
 
To investigate users’ perceptions of the effect the device may have on concentration 
required when walking a single question was posed. 
 
The Malone et al (2002) study used narrative interviews to collate data on the effect 
of FES. Results noted that ‘participants described feeling that their walking was more 
normal and required less effort, as they did not have to concentrate so much on their 
walking.’ Thus, these participants had linked the concept of effort with concentration 
required for walking. This recorded effect of FES from this study was re-iterated 
during informal discussions with FES users who indicated that they didn’t have to 
think so much about walking with FES and that their level of concentration on or 
thought about walking was reduced when walking with FES. As FES users highly 
rated the effect of a reduction in effort in the two Taylor et al studies (1999, 2004), 
and this may include a mental component, a question asking specifically about 
concentration was clearly warranted. 
 
In Section C (4) a single question about the concentration required to walk with and 
without the device was posed. A scaled response was sought rather than a yes/no 
response, to provide a more sensitive and precise response (Bowling, 2005). A 
simple verbal scale of three responses was chosen and the language and format of 
the scale was tested during pilot work and found to be appropriate. 
 
The scale was a simple graded choice between ‘none’, ‘some’ and ‘a lot’, thus 
allowing respondents who did not perceive any effect on their concentration to 
choose ‘none’. Respondents were asked to consider the amount of perceived 
concentration required to walk with and without their device, providing data about the 
change in concentration perceived to be as a result of use of the device. 
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c) Effort of walking 
 
The third aim of the questionnaire was to investigate users’ perceptions of the 
specific areas in which use of their device may contribute to a change in the effort of 
walking. Outcomes as a result of addressing this aim would firstly provide evidence to 
justify the subsequent application of a dual-task methodology in a gait laboratory to 
assess the effort of walking and secondly, to inform the choice of an appropriate 
secondary task. 
 
Development of this section of the questionnaire (Section C (5) – see Appendix A.1) 
was initially driven by informal discussions with FES users. The users described 
effects when using the device such as; being able to think about something else, 
being able to talk to someone else and not having to look at the ground when 
walking. These descriptions of other effects seem to indicate that FES gave them an 
ability to perform other non-motor, cognitive functions more easily whilst walking and 
were supported by narratives from the Malone et al (2002) study, where participants 
indicated that FES use had an effect on other actions pursued whilst walking. 
Secondly, discussions took place with an expert on cognitive processes (Bowen, 
2004, 2005) to discuss possible cognitive tasks that would be part of everyday life 
that device users would do whilst walking. The relevant dual-task literature that was 
available at the time was reviewed as part of these discussions and also as part of 
the questionnaire development process. The aim of the literature review was to 
identify the secondary tasks (i.e. walking being the primary task) used in previous 
studies. Studies of healthy and gait-impaired participants were included; the principle 
search criteria were a dual-task approach to assess gait and/or secondary task 
performance. 
 
The secondary tasks used in dual-task studies were analysed for their relationship to 
everyday tasks and broadly grouped and mapped against statements, in everyday 
language, that reflected how users would potentially describe the effects of the 
device. Table 3.1 shows the results of this process. The largest number of studies 
required the participants to verbally respond to questions whilst walking e.g. 
answering autobiographical questions (Rochester et al., 2004) and hence mapped 
well against the users perception of an effect of FES on an ability to talk to someone 
else whilst walking. Further studies required participants to generate word lists 
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(Cockburn et al., 2003) or memorise digits (Ebersbach et al., 1995) thus requiring an 
ability to think about something else whilst walking. Finally, a handful of studies 
employed tasks that required participants to visually pay attention to a stimulus and 
respond (Heller et al., 2000), a behaviour that some users reported finding easier 
with FES.  
 
The literature reviewed also highlighted studies where physical obstacles had been 
used as a secondary task (Said et al., 1999, van Hedel and Dietz, 2004, Schrodt et 
al., 2004). These secondary motor tasks involved stepping or a change in normal 
walking pattern, which would have created a challenge to a foot drop gait; already 
both physically and mentally demanding and at a higher risk of trips and falls. 
Informal discussions with users had also highlighted secondary physical effects of 
device use, concerned with an ability to avoid trips and falls. It was thus felt 
appropriate to include statements reflective of a secondary motor task that would 
occur during walking. 
 
Finally, during clinical practice some stroke survivors described difficulty maintaining 
their gait when walking in a noisy environment, as the noise acted as a source of 
distraction. For example, one person described emergency vehicle sirens or noisy 
car engines as a creating a need to either stop or reduce their speed when walking in 
the street to be sure of maintaining a balanced, safe gait. Whilst, there were not a 
number of dual-task studies at the time employing secondary tasks that could be 
mapped against this, it was felt appropriate, due to its clinical relevance, to include 
this as a potential effect noted by users whilst walking. 
 
Table 3.1 shows the effects of the device, expressed as a positive statement in 
everyday language, mapped against secondary cognitive and motor tasks used in 
reported dual-task studies. These everyday expressions of tasks were then used to 
devise the dual-task statements in the questionnaire (Section C (5), see Appendix 
A.1). The statements were also devised with the aim of informing the choice of a 
dual-task, appropriate for use in the gait laboratory study that followed. As such, it 
was important to clarify that the relationship of each statement to a potential dual-task 
intervention was established in the literature.  
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Statement Secondary cognitive or motor task and study reference 
I can think about 
something else whilst 
I walk. 
 
Male or female name generation (Camicioli et al., 1997)   
Categorised word generation (Haggard et al., 2000, Cockburn et 
al., 2003) 
Memorisation of digits (Ebersbach et al., 1995) 
Memorisation of words (Lindenberger et al., 2000) 
I can walk without 
thinking about it. 
 
As above. 
I can walk onto a 
kerb. 
 
Obstacles of various heights (Said et al., 1999) 
Treadmill with obstacle (van Hedel and Dietz, 2004) 
Obstacle + arithmetic task (Schrodt et al., 2004) 
I can walk on uneven 
ground. 
 
As above. 
I can avoid a trip or 
fall when I walk. 
 
As above. 
I can look at the 
things around me 
when I walk. 
Stroop test (Heller et al., 2000) 
Physical response to visual stimulus (Sparrow et al., 2002) 
 
I can walk without 
looking at the 
ground. 
 
As above. 
I can walk in a noisy 
environment. 
 
Clinical observation 
I can answer 
questions whilst I 
walk. 
 
Arithmetic task (Haggard, 1998, O'Shea et al., 2002, Hausdorff et 
al., 2003, Sheridan et al., 2003, Schrodt et al., 2004) 
Stops walking while talking test (de Hoon et al., 2003) 
Clock hands on clock face (Haggard, 1998, Haggard et al., 2000) 
Targeting paired words (Haggard et al., 2000) 
Answering questions (Rochester et al., 2004) 
Verbal response to tone (Lajoie et al., 1993, Wright and Kemp, 
1992, Gage et al., 2003) 
I can talk to someone 
when I walk. 
 
Verbal response to verbal stimulus (Bowen et al., 2001, de Visser 
et al., 2003) 
Plus as above. 
 
Table 3.1: Device effect statements mapped against secondary task. 
 
The statements asked if using FES when walking made a difference to the secondary 
task e.g. talking to someone. The statements were framed to elicit a response that 
completed the statement using comparison stimuli (Peterson, 2000) in a scaled 
response; ‘easier’, ‘same’ or ‘harder’. As in the questionnaire section about the 
effects of the devices, statements were used to increase responses and respondents 
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were directed to the need for a response. Respondents for whom the statement was 
not a perceived effect were able to choose ‘the same’ as their response. Again, by 
accounting for those respondents who were not affected, issues of sensitivity and 
specificity were addressed (Bowling, 2005). As in the previous questions about the 
effect of the device, this structure also aided statistical analysis of data. 
 
Finally, to assist with narrowing down the choice of task, respondents were asked to 
identify, from the statements in the questionnaire, the one task that was most 
important to them. 
d) Characteristics of respondents 
 
The questionnaire included questions to establish the characteristics of the 
respondents. Section A (see Appendix A.1) requested the sex, date of birth, date of 
stroke, side affected by the stroke and any health problems or disabilities.  
 
There was potential for the questionnaires to be sent to people who no longer used 
their FES device. As such, in Section B (see Appendix A.1) respondents who no 
longer used their device were not required to answer any of the questions in the 
following Section C; these were concerned with the effects of the device and thus the 
opinion of current users was felt to be more appropriate. Non-users of FES were 
directed to the end of the questionnaire, and no further questions were asked.  
 
Thus, users of FES were asked in Section B of the questionnaire (see Appendix A.1) 
about the use of their device. The questions were broadly based on those used by 
Taylor et al (1999, 2004) for FES users. Therefore, data about the amount of device 
use and the activities pursued whilst using the device was collected. In Section C (3) 
of the questionnaire (see Appendix A.1) respondents were asked about their use of 
any other walking aids, both with and without their device. This information would 
allow the current study’s group to be compared with previous FES groups from Taylor 
et al (1999, 2004) studies. 
 
FES users were asked in Section D (see Appendix A.1) to state when they first 
started using the device. Furthermore, it was possible that some current FES users 
may also have been using an AFO device. They were asked to identify, from a series 
of photos, the type of AFO that they were currently using. To capture a comparison of 
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the two devices respondents were asked which of the FES or AFO device, if they 
were using the latter also, helped them walk with the least effort. 
 
3.4  Ethical approval 
 
Ethical approval was granted by Salford and Trafford Local Research Ethics 
Committee in June 2005 (Appendix A.2) and by The University of Salford Research 
Governance and Ethics Sub-Committee (Appendix A.2). Approval was also granted 
by Salford Royal Hospitals Research and Development Directorate (Appendix A.2). 
 
3.5  Application of questionnaire 
 
The questionnaire was posted to patients attending the Department of Medical 
Physics at Salisbury District Hospital, UK, identified from a database as 18 years and 
over, who had received their device, between and including July 2002 and June 
2004, as a result of foot drop following a stroke. This group had not been involved in 
a questionnaire study of this nature before. 
 
An introductory letter (Appendix A.3) and a participant information leaflet (Appendix 
A.4) were sent with each questionnaire. In addition, the group received a letter 
(Appendix A.5) from the local collaborator at Salisbury District Hospital, explaining 
that confidential information would not be released to the chief investigator, during 
the study. 
 
The questionnaires were coded before being posted enabling non-respondents to be 
identified. Non-respondents were sent a second copy of the questionnaire, four 
weeks after the initial post, to encourage completion and return. 
 
The questionnaires were sent to potential respondents in July 2005. 
 
3.6 Results 
 
3.6.1 Questionnaire response rates 
 
A description of the number of questionnaires sent, and the number and nature of the 
respondents is shown by Figure 3.2. The response rate was 65%. The number of 
responses from respondents who were currently using their FES was 30.  
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Figure 3.2: Responses to questionnaires. 
3.6.2 FES users 
 
The self-reported characteristics of respondents who were using their FES device at 
the time of data collection is summarised in Table 3.2. The mean age of the 
respondents was 64.6 years (± 13.7) and the time since stroke was 74.9 months (± 
42.9). 
Sex male : female (%) 
n = 30 
19 : 11 
(63 : 37) 
 
Mean age years ± SD 64.6 ± 13.7 
 
Mean time since CVA months ± SD 
 
74.9 ± 42.9 
Side of body affected left : right (%)                                             13 : 17
(43 : 57) 
 
Self-reported health problems (%) 
Upper limb affected 
Speech affected 
Sight problems 
Diabetes 
Pulmonary disease 
Heart problems/High BP 
Back problems 
Arthritis 
 
15 (50) 
 5 (17) 
            1 (3) 
4 (13) 
            1 (3) 
6 (20) 
            2 (7) 
3 (10) 
 
Table 3.2: Self-reported characteristics of FES users at time of data collection (n=30). 
FES questionnaires sent = 85 
Responses received = 10 
(Not satisfying inclusion criteria, moved, deceased) 
Responses from 
past FES  
users = 18 
Responses from 
current FES users = 
30 
Corrected total of FES questionnaires sent = 75 
Incomplete response 
= 1 
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Table 3.3: Self-reported usage of FES by respondents (n=30). 
 
The usage of the devices reported by the respondents is shown in Table 3.3. The 
mean time since FES users had received their device was 31.0 months (± 19.8). 70% 
of the respondents used their device for 5 days a week or more. On the days when 
respondents used their device it was used for an average of 7.5 hours (± 4.2).  
 
The activities undertaken by the respondents, either with or without FES, are 
illustrated by Figure 3.3. The top five activities performed with FES were longer 
walks, shopping, walking outdoors, day trips and social events. The top three 
activities performed without FES were exercising, walking indoors and walking 
around the home.  
 
The use of walking aids by the FES users is shown by Figure 3.4. Each respondent 
could use any of the walking aids both with and without their FES, thus results for two 
of the aids (i.e. walking stick and assistance from another person) are in excess of 
100%. A walking stick was the most frequently used aid both with (70%) and without 
(50%) FES, followed by assistance from another person (33%). 43% of users did not 
require assistance from another person when walking.  
Mean time since began use months ± SD 
 
31.0 ± 19.8 
No. of days used per week (%)  
1 
2 
3 
4 
5 
6 
7 
No answer 
 
7 
7 
3 
13 
17 
3 
50 
0 
 
Mean use per day hours ± SD 7.5 ± 4.2 
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Figure 3.3: Activities undertaken by FES users, both with and without FES. 
 
 
Figure 3.4: Use of walking aids by FES users, both with and without FES. 
 
The response by FES users to statements about the effect of their device is shown 
by Figure 3.5. Over 60% of respondents agreed with 10 of the 13 statements. 90% 
agreed that it was less effort to walk with their FES device. 80% and over of 
respondents agreed that they were able to walk further, that their walking was more 
balanced and even, that they were less likely to trip or fall, that they were able to walk 
more safely and felt more confident when they walked. 70% and over felt that they 
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were more able to walk on uneven ground and that they could walk faster with FES. 
More than 60% felt more independent and that their posture was better. 
 
Only 20% of FES users agreed that they could use their walking aid less often whilst 
50% disagreed with this statement and for 20% of respondents this statement did not 
apply. 36% were able to exercise more whereas 27% were not able to and a further 
27% noted that this statement did not apply to them. 53% felt they could walk more 
often without the assistance of another person, over 27% disagreed with this 
statement and 20% did not feel this statement applied to them. 
 
When respondents were asked which of these effects was the most important, the 
three most highly rated, each by 17%, were increased confidence when walking, 
increased independence and less likely to trip or fall (Figure 3.6). Less effort when 
walking was chosen by 13% of users as the most important effect. 
 
 
Figure 3.5: Frequency of response to effects statements by FES users. 
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Figure 3.6: The frequency (%) of most important effect chosen by FES users. 
 
Fourteen of the FES users also used an AFO. The AFOs used were foot-ups, Aircast 
ankle braces, Speed braces, Supralite AFOs, posterior leaf spring AFO and other 
AFOs. Twelve of these FES users felt that their FES helped them to walk with the 
least effort, when compared with their AFO. 
 
When respondents were asked to rate on a three-point verbal scale, the amount of 
perceived concentration required to walk both with and without FES, their responses 
produced a significant difference between the two conditions. Figure 3.7 illustrates 
the frequency of responses for each condition. With FES, the amount of 
concentration rated as ‘some’ increased and conversely, the amount of concentration 
rated as ‘a lot’ decreased, when compared with walking without FES. Thus, there 
was a reduction in the perceived level of concentration required when walking with 
FES which, when statistically analysed, was significant (McNemar x2 = 13.06, df=1, 
p<0.001, 2-tailed). 
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Figure 3.7: Rating by users of concentration needed to walk with and without FES. 
 
 
The frequency with which respondents felt their device affected dual-tasks is detailed 
in Figure 3.8. Five of the ten conditions were made easier with FES for over 50% of 
users. In particular 70% of FES users found it easier to avoid a trip or fall and 60% 
found stepping up onto a kerb and walking without thinking about walking easier with 
FES. 57% of users found walking on uneven ground easier with FES. 54% found it 
easier to look around whilst walking with FES. 17% of users felt using FES made two 
dual-task conditions harder; walking on uneven ground and walking without thinking 
about walking. 
 
When respondents were asked to identify the most important task that was easier 
with FES, 40% of FES users identified avoiding a trip or fall (Figure 3.9). 14% of 
users identified walking on uneven ground, whilst 10% chose stepping onto a kerb 
and looking around whilst walking.  
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Figure 3.8: Effect of FES during dual-task conditions. 
 
 
 
Figure 3.9: The frequency (%) of most important dual-task effect chosen by FES 
users. 
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3.7 Discussion 
 
Interpretation of the results from this questionnaire study should be approached with 
some cautions. As with all self-administered questionnaires there is no guarantee 
that the questions were answered as requested. It is also possible that the person for 
whom the questionnaire was intended did not actually answer the questions. The 
careful ordering of the questions could have been negated by the respondents 
answering the questions in any order that they wished (Bowling, 2005). Even though 
the questions were structured to encourage completion and to allow for those 
respondents for whom each question did not apply, some questions were still omitted 
by some respondents. The results include rates of non-completion for individual 
items. 
 
The questionnaires were sent from an organisation independent of the clinical service 
from which the respondents had received their devices. This is in contrast to the two 
previous FES studies by Taylor et al (1999, 2004) and it could be assumed that the 
possibility of positively biased responses from respondents may have been reduced. 
 
3.7.1 Response rate 
 
The response rate for this FES group was 65%, similar to those from the previous 
two postal questionnaire studies of FES groups; 55% and 74% (Taylor et al., 1999b, 
Taylor, 2004) but lower than reported response rates in stroke populations prior to 
implementation of this study; 73% (Bussin et al., 1999), 83% (O'Mahony et al., 1998), 
78% (Glader et al., 2001) and 81% (Vestling et al., 2003).  
 
There are recognised factors that experts in the field of questionnaire application cite 
as contributing to improved response rates (Fink, 2006). The majority of these factors 
were applied in this study. Potential respondents were advised that their responses 
would be kept confidential and anonymised and were advised how their responses 
would be used. Reminders were sent to non-responders. The questionnaire was 
piloted, checking for clarity and understanding. Broad inclusion criteria were devised 
resulting in a large group of over 80 FES users being identified as potential 
respondents. It was clear from previous studies that an FES group would probably be 
interested in the nature of questions asked. Other factors to improve participation 
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were not feasible, such as alternative options for completion of the questionnaire 
(e.g. web-based) and gift or cash incentives for completion.   
 
The number of respondents who were continuing to use their FES device was 30; 
representing 40% of the corrected total of questionnaires sent. The number of 
respondents who completed the questionnaire, who no longer used their FES device 
was 16 (21%). These figures can only be compared with those from the two previous 
FES studies, which reported on data from 78 users vs. 45 non-users (Taylor et al., 
1999b) and 69 users vs. 9 non-users (Taylor, 2004). As these figures do not exhibit a 
particular pattern it is again difficult to ascertain if the ratio of users to non-user in the 
current study is typical. In reality the ratios for the current and previous studies may 
be more a reflection of service provision and clinical practice, as well as the inherent 
difficulties of reliance upon the motivation of the individuals in the target population to 
return the questionnaire. It is not possible to speculate on the demographics or other 
characteristics of the non-responders. 
 
3.7.2 FES users 
 
The mean age of the FES group was 64.6 years (± 13.7) with 63% males and 37% 
females. This is reflective of a lower rate of stroke in the UK amongst women 
compared with men (Bhatnagar et al., 2010). The mean time since stroke was 74.9 
months (± 42.9) and the amount of time since respondents began using their FES 
device was 31.0 months (± 19.8).  
a) Usage 
 
 
Respondents used their devices in a similar manner to those from previous FES 
studies. 70% of respondents in the current study reported using their device for 5 
days or more a week (Table 3.4) which agrees well with Taylor et al (1999) where 
53% of a mixed group of FES users, used their device every day, and 48% of the 
CVA participants from their 2004 study used their device for 7 days a week.  
 
On the days when respondents used their device, it was used for an average by the 
group of 7.5 (±4.2) hours. Figure 3.10 reports the results for this question in the same 
categories as three other studies that have reported the daily usage of FES; the 
questionnaire allowed respondents to identify the amount of time FES was used 
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rather than providing pre-determined categories. Two of the studies are results for a 
mixed group of participants, including those with stroke, (Taylor et al., 1999b, 
Jenkins, 2012) whilst the other set of results are only for stroke participants (Taylor, 
2004). Over 40% of respondents used their device for 9 hours or more, which 
concurred with the recent service audit by Jenkins (2012). In both studies by Taylor 
this amount of usage was higher at over 50%. The majority of respondents used their 
FES device for between 9 – 12 hours, in contrast to the other studies in which the 
largest percentage of participants used their FES all day. The difference in usage 
patterns may reflect differences in the type of service users, in terms of the severity 
of walking disability for example, or could be as result of the different method used to 
collect this data.  
 
 
Figure 3.10: Usage of FES for current study and three published studies, as a 
percentage of each study group, 
 
Respondents were quite clear about their use of FES in relation to the activities that 
they pursued, particularly evidenced by the high number of respondents who 
answered the question (Figure 3.3). Over 50% of the group reported always using 
their device for activities outside the home (walking outdoors, longer walks, day trips 
and shopping) (Figure 3.3). By contrast, less than 30% reported always using their 
device walking indoors or at home. From clinical experience, it is quite common for 
patients to discard orthoses and equipment that aids walking once they enter their 
home or a safe indoor environment, preferring to rely upon banisters, handrails and 
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strategically placed furniture to mobilise safely. The results for the FES group appear 
to be consistent with this clinical observation.  
 
Most respondents also clearly felt the need to use some other form of walking 
assistance. By far the most common form of assistance was the use of a walking 
stick both with and without FES (Figure 3.4). Surprisingly, more respondents reported 
using a walking stick with FES (70%) than without FES (50%) and this possibly 
reflects that respondents used their FES more often outdoors (Figure 3.3). Over 40% 
of the respondents did not require assistance from another person, either with or 
without FES, thus indicating independence when walking.  
 
Effect Current study 
(from 13 effects) 
Taylor et al 1999b 
(from 12 effects) 
Taylor et al 2004 
(from 14 effects) 
Less effort to walk 
 
1 (90) 2 (77) 1 (83) 
Able to walk further 
 
2 (87) 3 (70) 6 (58) 
Walking more balanced and 
even 
3 (87) N/A N/A 
Less likely to trip and fall 
 
4 (83) 4 (69) 4 (63) 
Walk more safely 
 
5 (83) N/A N/A 
More confident when walking 
 
6 (80) 1 (79) 3 (70) 
More able to walk on uneven 
ground 
7 (77) 7 (41) 9 (42) 
Able to walk faster 
 
8 (73) 5 (62) 5 (60) 
Walking would improve in the 
long term 
N/A N/A 2 (73) 
 
Table 3.4: Ranking of agreement with effect statements by frequency 
 (% of total group). 
b) Effect of FES 
 
There were high levels of agreement with the statements in the questionnaire about 
the effect of the device as perceived by the FES users with over 60% of respondents 
agreeing with 10 of the 13 statements. The highest agreement, of 90%, was with the 
perceived reduction in effort when walking with their FES device. This is in 
agreement with previous studies, with this effect being in the two highest (Taylor et 
al., 1999b) and the highest most commonly perceived effects (Taylor, 2004). Table 
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3.4 compares the results of the current study against those for the two previous FES 
studies. It is worth noting that the 1999 study by Taylor provides results for a mixed 
group of users that includes patients with Multiple Sclerosis, although the majority of 
users (i.e. 79%) received FES due to stroke. 
 
There is strong agreement with the ranking of the most often identified effects 
between the current study and that of Taylor et al 1999b. It would appear that the 
introduction of the concept of improving gait in the long-term, probably as part of 
clinical practice, for the 2004 group had highlighted this as a highly anticipated hope 
for the future amongst users and thus other effects were not chosen as often. It could 
be argued that this is a prospective effect rather than a currently perceived effect, 
and thus perhaps not appropriate to include in this type of question.  
 
Interestingly, two effects in the current study - improved balance and increased safety 
when walking - which were identified from AFO studies, gained high levels of 
agreement. A high agreement with these statements would be expected as a high 
number of respondents agreed they were less likely to trip or fall. 
 
Even though 73% of respondents in the current study felt that they could walk faster 
with FES, this frequency of response still placed this effect below seven other more 
frequently agreed with effects. In Taylor’s two studies this effect was the fifth most 
often identified effect. Furthermore, in a study of foot drop due to both stroke and 
Multiple Sclerosis, the effect of FES on the effort of walking on uneven surfaces was 
perceived to be more important than an increase in speed (Burridge et al., 2007a). As 
has previously been noted in section 3.1, walking speed has traditionally been 
chosen as an outcome measure to assess effectiveness of FES, but is not reflective 
of the most important of the user-perceived outcomes. It’s ranking below several 
other outcomes by respondents in this study, again indicates that users perceive 
other effects to be more apparent. 
 
When respondents were asked to identify the most important effect of the device, 
again results concurred with those from the two previous studies by Taylor (Table 
3.5). The perceived reduction in effort of walking was in the top two of all three 
studies, and was more highly ranked than an ability to walk faster. 
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Effect Current study 
(from 13 effects) 
Taylor et al 1999b 
(from 12 effects) 
Taylor et al 2004 
(from 14 effects) 
More confident when walking 
 
1 (17) 4 (6) 4 (10) 
More independent 
 
1 (17) 6 (1) 6 (7) 
Less likely to trip and fall 
 
1 (17) 2 (15) 5 (8) 
Less effort to walk 
 
2 (13) 1 (29) 1 (27) 
Able to walk further 
 
4 (3) 3 (9) 0 (0) 
Able to walk faster 
 
4 (3) 5 (3) 7 (3) 
Walking would improve in the 
long term 
N/A N/A 3 (20) 
Carryover effect 
 
N/A N/A 2 (22) 
 
Table 3.5: Ranking of most important effect statements (% of total group). 
 
Some respondents provided comments about the effect of their FES device that 
concurred with the responses to the questionnaire statements. Respondents felt that 
use of the device made them ‘less tired at the end of day’ and that they did not ‘tire 
so quickly’. One participant described completing 5 and 7 mile walks whilst on holiday 
with the use of FES. Some felt that FES use made ‘it much easier to get around’, and 
that it ‘slowly makes foot work’ and ‘helps me flex my ankle when walking’. One 
participant felt that it had ‘certainly improved my mobility the last couple of years and 
I would hope that I will walk normally one day’. Others generally felt the device had 
made a ‘great difference to my life’, ‘big difference to my everyday life’ and was ‘very 
beneficial’ and ‘just fantastic’. Two respondents described some difficulties with use 
of FES, but continued to use the device as the benefits of use outweighed the 
problems they experienced. 
 
The results from the current study indicate that this group of FES users responded 
similarly to the effect of the device, compared with previous groups of users. This 
may come as no surprise as the group was obtained from the same clinical service 
as the two previous FES studies (Taylor et al., 1999b, Taylor, 2004) and thus it could 
be argued that the concurrence in results are reflective of local clinical practice. 
However, each study targeted different groups of users, distinguished by the date on 
which they began use of FES, covering over 7 years of service provision. Over this 
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time period the service and clinical personnel would have altered, and the service 
attracted patients from across the UK, rather than exclusively treating the local 
population. 
 
There is now evidence from three studies of 173 FES users that clearly highlights the 
effects of FES that users identify most often and also as most important. Whilst 
results from this study cannot be generalised to all FES users, it is obvious that the 
FES users participating in the three studies thus far, place a high importance on 
effects such as a reduction in effort, the quality of their gait (i.e. less trips, improved 
balance, increased safety) and increased confidence and independence. These 
effects were in contrast to measures used in most FES studies, up to 2005, to 
establish the effectiveness of the device i.e. walking speed. In particular, the effect of 
FES on the effort of walking is consistently a highly rated effect. 
 
It has been proposed that the effect on effort is comprised of mental as well as 
physical components. The results from this study support this concept, in this context, 
as respondents identified a statistically significant reduction in concentration required 
when walking with FES compared with walking without the device. This adds weight 
to results from Malone et al (2002) where subjective descriptions of this effect had 
been noted. Furthermore, since the questionnaire study was completed, in a study by 
Bulley et al (2011), participants described a requirement for less conscious thought 
when walking with FES. 
 
When FES users, who also used an AFO, were asked to directly compare the two 
devices, the majority felt that their FES device allowed them to walk with less effort. 
This result is in agreement with a subsequent study in which participants expressed a 
preference for FES over their previous AFO due to a perceived improvement in the 
effort of walking (van Swigchem et al., 2010) as well as improved comfort, 
appearance, quality of gait, walking distance and stability during gait. In fact studies 
comparing the efficacy of AFOs and FES have consistently shown a clear preference 
for FES (Sheffler et al., 2006, Ring et al., 2009, Bulley et al., 2011) even though 
measures of gait speed (Ring et al., 2009, van Swigchem et al., 2010), activity levels 
(van Swigchem et al., 2010) and functional ambulation (Sheffler et al., 2006) have 
failed to show any significant advantage of FES. This suggests that the outcome 
measures used in these studies may not be capturing important information. 
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c) Dual-task effects of FES 
 
 
The results from the dual-task effects show that respondents recognised the effect of 
FES on performance of secondary tasks – both non-motor and motor - whilst walking 
(i.e. the primary task). Interestingly, 60% of respondents found walking without 
thinking about walking easier with FES, in agreement with the statistically significant 
reduction in perceived concentration required by respondents when walking with FES 
and reported studies (Malone, 2002, Bulley et al., 2011). This was the most 
frequently non-motor task noted as easier with FES, whereas other non-motor tasks 
were identified as easier by just over 50% to just over 30%. Clearly thinking about 
walking, with a foot drop following a stroke, is a recognised phenomenon from 
reported studies, anecdotal evidence from FES users and now supported by the 
results of this study. The second most frequently rated non-motor task as easier by 
54% was looking around whilst walking.   
 
Of the five conditions that were identified by over 50% of users as easier with FES, 
three were secondary motor tasks that created a challenge to a foot drop gait, 
including stepping onto a kerb and walking on uneven ground. In fact, 70% found 
avoiding a trip or fall easier with the use of FES. It may be that the physical effects of 
FES are more frequently noted as easier because the device has primarily been 
provided to improve the gait of the recipient, with clinical assessment of effectiveness 
creating this focus as well as patient expectations driving these physical outcomes. 
Thus, it may not be surprising that users would identify complex physical tasks as 
more frequently noted to be made easier by the use of FES, than non-motor 
secondary tasks. 
 
Furthermore when respondents were asked to identify the most important task that 
was easier with FES, the most highly rated was avoiding a trip or fall and the second 
was walking on uneven ground. Whilst this does concur with results in this study 
regarding the effects of FES and previous studies by Taylor et al (1999b, 2004) it 
should also be viewed with some caution. It is possible that because these two 
outcomes appeared in both questions about the effect of FES their importance has 
been highlighted inadvertently, with the earlier question having cued or primed the 
answer to the second question (Peterson, 2000). 
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3.8 Conclusion 
 
The results from the FES group can be viewed with confidence due to a response 
rate and results that were similar to previous studies. Whilst results from this study 
cannot be generalised to all FES users, the results support those previously reported 
by clearly highlighting the effects of FES that users identify most often and also as 
most important. FES users place a high importance on effects such as a reduction in 
effort, the quality of their gait (i.e. fewer trips, improved balance, increased safety) 
and increased confidence and independence. These effects are in contrast to 
measures used in most FES studies to establish the effectiveness of the device such 
as walking speed.  
 
In particular, the effect of FES on the effort of walking is consistently a highly rated 
effect and it has been proposed that the effect on effort is comprised of mental as 
well as physical components. The results from this study support this concept as 
respondents identified a statistically significant reduction in concentration required 
when walking with FES compared with walking without the device. Furthermore, 
users identified the effect of FES on secondary tasks when walking – with the 
majority noting walking without thinking about walking as easier with FES. 
 
This study achieved the primary aims of investigation of users’ perceptions of the 
effect of their device, the effect of the device on concentration required when walking 
and the specific areas in which use of the device contributes to a change in the effort 
of walking. The secondary aim of the questionnaire was to inform the choice of a 
secondary task to use in a dual-task methodology for the subsequent gait laboratory 
study. The group identified that secondary tasks were affected by device use, and 
the results from this FES group can be analysed with some confidence as the group 
responded to the questionnaire in a manner consistent with other FES groups. The 
two most frequently rated non-motor secondary tasks that were easier with FES were 
walking without thinking about walking and looking around when walking. Therefore, 
an appropriate secondary task for the subsequent study would be a non-motor task 
that distracted respondents from the primary task of walking, forcing the respondents 
gaze to be averted from the walking surface and/or focusing attention and 
concentration on the non-motor or cognitive task.  
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Chapter 4 - Dual-task methodology development and longitudinal study 
 
4.1 Introduction 
 
There is growing evidence to support the concept of a complex relationship between 
higher level cognitive function and gait, as discussed in the review of literature in 
Chapter 2 (section 2.2.3c), from emerging brain imaging (Harada et al., 2009, Suzuki 
et al., 2004) and dual-task gait studies (Al-Yahya et al., 2011, Segev-Jacubovski et 
al., 2011). Dual-task gait studies, of participants with neurological disorders, have 
shown that the costs to gait and cognitive task performance increase in comparison 
to healthy controls (Woollacott and Shumway-Cook, 2002, Yogev-Seligmann et al., 
2008, Al-Yahya et al., 2011, Segev-Jacubovski et al., 2011). Studies in post-stroke 
gait using a dual-task design similarly found deterioration in gait speed (Bowen et al., 
2001, Canning et al., 2006, Hyndman et al., 2006, Plummer-D'Amato et al., 2008, 
Dennis et al., 2009, Pohl et al., 2011) and a reduction in performance of the cognitive 
task (Plummer-D'Amato et al., 2008, Dennis et al., 2009, Pohl et al., 2011). This 
suggests that impairments to the brain’s cognitive functions as a result of stroke, 
particularly when paired with physical impairments, may lead to increased 
competition for limited resources to control gait.  
Stroke patients provided with FES consistently highly rate a reduction in the effort of 
walking as the most important reason for using FES. The suggestion, from a number 
of small qualitative studies (Malone, 2002, McAdam, 2006, Bulley et al., 2011), that 
effort in this context may not only relate to the physical effort, but may also include 
the mental effort of gait, was explored in the thesis in Chapter 3 via a questionnaire 
study. There was strong agreement amongst questionnaire respondents that FES 
reduces the concentration required whilst walking. Furthermore, respondents 
identified that FES use had an effect on the performance of concurrent secondary 
non-motor tasks i.e. those diverting their attention from the cognitive demands of 
walking. It was clear that the results of this study supported the suggestion from 
previous studies of a positive effect of FES on the cognitive processes involved in 
walking. These results can be interpreted as an indication of the effect of FES on the 
motor-cognitive interference experienced during post-stroke gait. 
The results of the questionnaire study supported further exploration of the effect of 
FES on motor-cognitive interference. To address this, a dual-task study was 
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developed and implemented. A dual-task methodology is reflective and typical of real 
world situations, requiring participants to ‘walk and talk’, take note of their 
surroundings, and remember and follow directions, and thus requiring a division of 
attention between walking and a cognitive task. Application of this methodology to 
explore the effect of FES was novel and had previously been applied in only a 
handful of studies concerning other assistive devices for walking (section 3.1). As this 
was the first study of its kind the primary research questions to be answered were: 
 Is the chosen cognitive task appropriate? 
 Does FES reduce the effect of a cognitive task on gait speed? 
 Does FES improve performance of a cognitive task whilst walking? 
 Do any observed changes in performance of the walking and/or cognitive task 
change over time? 
 
The secondary research questions were: 
 Can any observed changes in gait and/or cognitive task be explained by 
factors other than the presence or absence of FES? 
 Can observed changes in performance be related to self-reported effects? 
 
This chapter begins by briefly describing the dual-task study. This is then followed by 
a detailed description of key elements of the study design. In order to justify the initial 
task selection a brief literature review of relevant dual-task studies is presented, 
focusing on the type and application of the tasks used and their relationship to 
cognitive processes. A critique of the literature then follows leading to a description of 
the task developed for use in the study. The reasons for inclusion of other secondary 
measures are discussed. 
 
There then follows a description of the piloting processes used to test the suitability 
and feasibility of the proposed dual-task methodology and subsequent effect of these 
on the final study protocol. Results for the study are then presented and analysed. 
Limitations and problems encountered with implementation of the study are 
discussed and further work undertaken to solve these issues is outlined. Finally, 
conclusions from the study are discussed. 
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4.2 Protocol design 
4.2.1 Study design 
 
FES improves gait speed in the chronic stroke population (Kottink et al., 2004, 
Robbins et al., 2006, Roche, 2009). However, it has been noted that average speed 
with FES improves with increasing time since first use (Burridge et al., 1997b, 
Burridge et al., 2007b, Laufer et al., 2009, Stein et al., 2010). In addition, 
improvements in gait speed are maintained without FES indicating a therapeutic 
effect with some evidence to show that this also continues to improve with time 
(Robbins et al., 2006, Burridge et al., 2007b, Stein et al., 2010). It is possible that any 
effects of FES on motor-cognitive interference may also alter with increasing time 
spent using FES. If motor-cognitive interference effects were seen to change with 
time, this information could be used not only to inform future, larger study designs, it 
may also give insight into possible underlying mechanisms for a reduction in motor-
cognitive interference. A longitudinal repeated measures study design was therefore 
chosen. This design allows for exploration of changes in the effects of motor-
cognitive interference over time, with each participant serving as their own control.  
 
The available gait speed data of those studies reporting changes in speed over time, 
both with and without FES, is plotted in Figure 4.1. The time interval between 
collection points varies somewhat between the studies making comparisons difficult. 
However, in the majority of studies the rate of change in speed increase appears to 
be highest within the first 3 months (Burridge et al., 1997b, Burridge et al., 2007b, 
Laufer et al., 2009). In support of these measured effects, a report on clinical 
experience of FES provision (Burridge et al., 1997a) noted that whilst “the rate at 
which patients adapt to a new gait pattern varies” with FES use, “by 3 months, all the 
patients had adapted, and the improved gait pattern was reflected in their walking 
speeds”. This suggests that studying the effects of FES on motor-cognitive 
interference during the period of adaptation and most rapid change in gait speed may 
provide insight into whether changes in interference show the same trend. Thus, the 
study was designed to collect data at 14 weeks, at which point it was hypothesised 
that adaptations to gait had stabilised. An interim assessment was then planned for 
approximately half-way through the study at 6 weeks after baseline. This reflected 
clinical service (Burridge et al., 1997a) and would also capture data during the 
adaptation period.  
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Figure 4.1: Plot of changes in gait speed over time, both with and without FES, from 
published studies. 
 
The primary outcome measures were gait speed and cognitive task performance. In 
order to answer the question “Does FES reduce the effect of a cognitive task on gait 
speed?” speed of walking was measured with and without FES, under two conditions, 
walking with and without a cognitive task. To answer “Does FES improve 
performance of a cognitive task whilst walking?” cognitive task performance was 
measured when walking, both with and without FES. Cognitive task performance was 
also measured whilst seated to provide a baseline measure against which walking 
performance could be compared and subsequently motor-cognitive interference 
could be assessed.  
 
Thus participants were observed under four walking conditions: 
 no FES 
 no FES with a concurrent cognitive task 
 FES assisted 
 FES assisted with a concurrent cognitive task 
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During the dual-task conditions it was expected that participants would differ in the 
prioritisation that they gave to walking or performing the cognitive task, with the result 
that, as a group there would be variation in the change in outcomes between 
conditions. Thus, the secondary question was formulated; “Can any observed 
changes in gait and/or cognitive task be explained by factors other than FES and 
cognitive task?” Prioritisation of task is most likely a product of the integration of 
factors such as the individual’s cognitive state, compensatory capabilities and 
personality (Yogev-Seligmann et al., 2012). As such, a number of other outcome 
measures were collected via validated tools to obtain data to explore potential 
variation of outcomes. As stroke can affect both cognitive and physical abilities (see 
Section 2.3.3 and 2.3.4) which can both have an effect on the ability to adjust to 
motor-cognitive interference, measures of cognitive ability, independence, falls and 
sensory neuropathy were collected. 
 
In addition, the self-reported effects of FES were collected via a shortened version of 
the questionnaire (Appendix B.1) used in the study reported in Chapter 3. This 
allowed for a comparison between perceived and directly measured effects of FES 
on motor-cognitive interference. 
 
The key elements of the design of the gait laboratory study – choice of cognitive task, 
gait speed and other outcome measures – are discussed in the following sections. 
 
4.2.2 Previously used dual-task tests 
 
To explore the cognitive control of gait for FES users, a task placing a ‘load’ on the 
cognitive processes during gait was required. Conclusions reached from the dual-
task question of the questionnaire study (Section 3.8) indicated that users reported 
finding that FES made it easier to walk under certain conditions in which an additional 
attentional load was placed on them and reduced the amount of concentration 
needed to walk. The two most frequently rated non-motor secondary tasks that were 
easier with FES were walking without thinking about walking and looking around 
when walking. Therefore, an appropriate secondary task for the subsequent study 
would be a non-motor task that distracted participants from the primary task of 
walking and/or forced the participants gaze to be averted from the walking surface, 
and focusing attention and concentration on the non-motor or cognitive task.  
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Available literature at the time of designing the study was consulted and the 
possibility of using an existing neuropsychological test was explored. The following 
discusses this process, reviewing literature available at the time and published since, 
critiquing the tasks discussed and finally describing the tasks chosen for piloting. 
a) Dual-task approaches 
 
Development of the content of the questionnaire had included a process of mapping 
available dual-task studies of both healthy and gait-impaired participants (see Section 
3.3.2c). The results of this process are summarised in Table 3.1 which also shows 
the variety of secondary tasks used.  
 
Tasks chosen in previous studies can be broadly categorised as those involving a 
secondary motor task, including obstacle avoidance, and those involving a cognitive 
process. A review paper by Al–Yahya et al (2011) provides a classification system by 
which cognitive tasks can be clustered, which is applied in the following review. 
There are a large number of dual-task studies of which a selection, with a focus on 
those applied to elderly and neurologically impaired groups, including stroke, are 
reviewed here. 
i) Motor task 
 
Whilst several studies have included a motor task as one of a series of tasks, 
including cognitive tasks, only a limited number of studies have employed purely a 
motor task as secondary to the primary task of walking.  
 
Involving upper limb 
There are only a handful of studies using motor tasks that involve the upper limb. 
Apart from the obvious concurrent performance of a secondary motor task during the 
primary task of walking, these tasks would potentially require the participants to focus 
their gaze and attention on the functioning of the upper limb, and thus divert their 
gaze from the walking surface and surrounding environment. 
 
In a study aimed at analysing ability to perform secondary motor tasks whilst walking 
both stroke and age-matched healthy participants were required to perform two 
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secondary tasks. The first involved correctly buttoning four shirt buttons; the second 
required the participant to carry a tray of glasses without dropping any glasses (Yang 
et al., 2007a). Gait parameter results indicated that stroke participants had more 
difficulty performing two concurrent tasks than the controls. The authors then went on 
to use the tray carrying task to assess the effectiveness of a dual-task based (i.e. 
holding and bouncing a ball whilst walking) exercise program for chronic stroke (Yang 
et al., 2007b). They concluded that improvement in gait parameters under dual-task 
conditions indicated the beneficial effects of the therapy. 
 
Several studies have included a motor task as part of a series of secondary tasks. 
Carrying a glass of water has been used in several of these studies with participants 
instructed to avoid spilling any of the water whilst walking. In a recent study this task 
was used in an attempt to discriminate fallers from non-fallers in cognitively impaired 
older people (Taylor et al., 2013), finding no added benefit of the dual-task 
assessment in this group in identifying fallers. A study of a stroke group by Canning 
et al (2006) used the same task, as well as a cognitive task, comparing gait speed 
with healthy older and young adults. Whilst gait speed deteriorated with this motor 
task for the stroke group, gait was not slower than the group of older people, 
indicating that the task did not interfere with walking in the stroke group.  
 
A cognitive task and motor task was used in a study of a group with Parkinson’s 
Disease to identify which approach produced the greater interference with gait 
(O'Shea et al., 2002). Participants were asked to transfer coins, one at a time using 
their dominant hand, from the pocket on their dominant side to the opposite pocket. 
Gait was compromised by simultaneously performing this task, but no more than the 
cognitive task (serial subtraction) also performed in this study. The rate of coin 
transfer slowed whilst walking.  
 
Walking over obstacles 
Walking along pathways with obstacles has been used as a dual-task approach in 
several studies, comparing performance to walking over a smooth surface. The 
approach here is based on the assumption that the task of stepping over an obstacle 
is more attention-demanding (Plummer-D'Amato et al., 2012). In common with the 
tasks involving the upper limb, there is also an obvious additional motor component 
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to this secondary task and hence it is difficult to attribute outcomes to the influence of 
purely cognitive factors. 
 
A study of older adults used an obstacle designed to simulate a door threshold, with 
an aim of determining how a concurrent cognitive task affected stepping over an 
obstacle (Schrodt et al., 2004). Changes in toe and heel clearance of the obstacle 
were noted during performance of the cognitive task (i.e. the ‘1-back’ task which is 
described later). In another study of older adults, Plummer-D’Amato et al (2012) used 
an obstacle to increase the difficulty of the gait task whist participants walked 
performing a cognitive task also. Results indicated that gait task difficulty influences 
dual-task effects on gait speed in older adults. 
 
Upper limb tasks would potentially divert gaze away from the walking surface, but the 
confounding factor of upper limb hemiplegia would affect the ability to perform the 
task, and thus reduce the possibility of measuring secondary task performance. 
Further, both upper limb tasks and, obstacle avoidance tasks, while diverting 
attention from the task of walking, would also greatly increase the risk of falling in the 
target group. These points are discussed further in the section critiquing all the dual-
task approaches that follows. 
ii) Cognitive tasks 
 
Reaction time tasks 
There are several versions of reaction time (RT) tasks used in the dual-task literature. 
The task requires the participant to respond (e.g. by pressing a button), without the 
need for any discriminatory decision-making, to a sensory stimulus and the elapsed 
time of response is measured. The task is used to measure neural processing speed 
and thus a slowing in RT may be an indication of an underlying attentional deficit 
(Lezak et al., 2004).  
 
Both auditory and visual stimulus can be used in reaction time tasks. Both forms of 
stimulus were used in a study comparing the reaction time of older adults to healthy 
young adults (Sparrow et al., 2002), requiring the participants to press a hand-held 
button to acknowledge the stimulus. Walking trials used auditory (i.e. a chime) and 
visual (i.e. projection of an ‘R’ on a screen) stimulus individually and then in some 
trials both were used randomly. Walking trials were either along a flat unmarked 
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walkway (“untargeted walking”), or required the participant to walk along the same 
walkway, but to also target one step inside a marked area (“targeted walking”). Older 
group RTs were longer in visual stimuli trials, especially during targeted walking. 
Another study by the researcher (Sparrow et al., 2008) used only a visual stimulus, 
possibly as a result of the outcomes of the previous study, to assess the effect of age 
on gait control. During the dual-task step time increased in the older group compared 
with matched controls. 
 
Other studies using RT tasks require a verbal response to an auditory stimulus (e.g. 
a tone), assessing verbal RT, collected via the use of a microphone headset. Using 
this task in a group of younger and older adults, Gage et al (2003) tested walking on 
walkways altered in width and height from the ground, to create walking conditions 
requiring differing attentional demands. RT increased for both groups when postural 
threat was increased. This version of a RT task was also used in a study of a group 
of elderly people using a variety of walking devices, reporting that changes in 
reaction time between conditions indicated that the devices assessed required 
increased attention (Wellmon et al., 2006). 
 
Finally, a study applying a RT approach in a stroke group required participants to 
respond to a stimulation delivered by an electrode at the back of the neck, by 
pressing on a pressure-sensitive pad in the mouth (Regnaux et al., 2005). A marked 
increase in RT was noted amongst the stroke group when compared with healthy 
controls. 
 
Discrimination and decision-making tasks 
Discrimination and decision-making tasks require selective attention and an 
appropriate response, thus are usually used to measure attention and response 
inhibition (MacLeod, 1991). The Stroop test is an example of such a task. In this test 
the name of a colour is displayed printed in a colour that is not the colour named (e.g. 
‘RED’ displayed in blue). The participant is required to successfully enunciate the 
colour in which the word is printed whilst suppressing the tendency to read the word. 
This popular neuropsychological test has been used in the dual-task paradigm. For 
example, it was used in a dual-task study of unilateral amputees (Heller et al., 2000) 
to compare two prosthetic limbs. Using the ratio of sway of the forehead during 
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walking in dual and single task conditions (“Automation index”) as an outcome, there 
was no difference between the devices.  
 
An auditory stimulus can be used as an alternative to a visual stimulus in the Stroop 
test, thereby avoiding the need for sight of a screen or monitor during walking trials. 
An auditory Stroop test has been used in two studies; participants were required to 
respond to ‘high’ or ‘low’, spoken in either a high or low pitch, naming the pitch it was 
spoken in whilst repressing the tendency to repeat the spoken word. The first study 
investigated balance impaired older adults, combining the Stroop test with an 
obstacle crossing task (Siu et al., 2009). Conclusions reached indicated that this 
group, when compared with an older group, lacked the ability to allocate attention 
between a postural and cognitive task, as they were unable to adjust performance 
when instructed to do so for different single and dual-task conditions. The second 
study, of a group of people recovering from operative removal of lower limb tumours 
(de Visser et al., 2003), also found that gait was hindered by the dual-task condition 
during recovery.  
 
Other stroke studies have used an audio-discrimination task (Al-Yahya et al., 2011). 
The example used by three studies required participants to respond ‘yes’ or ‘no’ to a 
verbal cue of either ‘red’ or blue’ respectively. In the first study by Bowen et al (2001) 
performance of this task whilst walking adversely affected gait speed and balance, 
measured via double support time, in a stroke group. In another study, once again 
gait speed was reduced when performing this task, amongst a stroke group and this 
time in comparison with elderly and young groups (Canning et al., 2006). Finally, 
people identified as having unilateral spastic paresis of the lower leg, following a 
stroke, were studied to assess the effectiveness of a bespoke high orthopaedic boot 
(Eckhardt et al., 2011). Functional ability, using the ‘Timed Up and Go Test’, under 
dual-task conditions using this audio-discrimination task, was improved by use of the 
boot. 
 
Several stroke dual-task studies have used the ‘clock task’ which is a visuospatial 
decision-making task. The task requires participants to respond yes or no to a given 
time (e.g. 1:25) based on whether the hands of the clock would both be in the target 
half of the clock face. Plummer-D’Amato et al (2008, 2010, 2012) used this task in a 
series of studies as one of several tests to analyse the interaction between different 
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cognitive processes and specific aspects of gait, finding that this task affected the 
single limb support phase and that very few errors were made in the cognitive task. In 
a study by Dennis et al (2009) two tasks, one of which was the clock task, were used 
in a stroke group and age-matched healthy group. The stroke group appeared to 
favour maintaining gait speed over task performance. This decision-making task was 
adapted from a study of a mixed group of neurologically impaired people, including 
those post-stroke (Haggard et al., 2000).  
 
Discrimination and decision-making tasks have been used in several stroke studies 
and seem to provide sufficient motor-cognitive interference as to create reduction in 
measured outcomes. The performance of the task could be measured, in conjunction 
with gait parameter outcomes, to quantify the extent of the interference.  
 
Verbal fluency tasks 
Tasks that require the participant to spontaneously produce words on pre-specified 
topics are examples of verbal fluency tasks. For example, the participant may be 
asked to list ‘things to eat’. This group of tests examine executive functions (Lezak et 
al., 2004) and are widely used in the dual-task literature, perhaps as the closest 
approximation of real-world ability to ‘walk and talk’. The following discusses some of 
these studies to illustrate the variety of approaches employed.  
 
A large number of studies have required participants to generate lists of words whilst 
walking, assessing verbal fluency and the effect of this task on gait. This approach 
has been used in groups assessing the effect of interference of the task on walking in 
healthy older people (Dubost et al., 2006, van Iersel et al., 2007), frail elderly 
(Beauchet et al., 2005), early Alzheimer’s Disease (AD) (Camicioli et al., 1997), 
acquired brain injury of mixed cause (Haggard et al., 2000), essential tremor (Rao et 
al., 2013), and stroke (Cockburn et al., 2003).  
 
Generation of animal names has been used in many of these studies. Dubost et al 
(2006) found that the older people in their study exhibited increased stride time 
variability with this task performance. Amongst a group of frail elderly (Beauchet et 
al., 2005) this same task did not affect lateral gait instability, however an alternative 
task of counting backwards did alter this, indicating that the choice of task is 
important in this group. In the study by Rao et al (2013) participants with essential 
91 
 
tremor were asked to generate lists of animal names beginning with a letter given to 
them by the researcher (e.g. B). Interference with gait parameters was greatest in 
those with lower cognitive scores. Directing generation of word lists by the supply of a 
starting letter was used as task by van Iersel et al (2007) amongst a group of healthy 
older adults. As in the Dubost study, stride time variability increased with task, as did 
stride length and body sway.  
 
Other topics have been used to generate word lists whilst walking. Female or male 
names was used as the secondary task in a study of groups of healthy elderly 
compared with people with early AD (Camicioli et al., 1997) noting that AD 
participants slowed significantly during dual-task. In studies by Haggard et al (2000) 
of an acquired brain injury group and Cockburn et al (2003) of a post-stroke group, 
participants were given a category about which to generate a list of words (e.g. things 
in the house) with both studies noting increased stride duration and poorer task 
performance during dual-task.  
 
Another approach in dual-task study designs have required participants to respond to 
questions whilst walking, resulting in spontaneous speech. Studies of patients groups 
have used this approach. In a group of people with Parkinson’s Disease (PD), 
participants were required to respond to questions about their past whilst walking and 
then whilst carrying a tray with cups on it (Rochester et al., 2004). The multi-task 
condition resulted in significantly slower gait speed and reduced step length. Several 
studies of stroke groups have used spontaneous speech as a task, in particular using 
the approach defined by Kempner et al (2006). In this study, speech was elicited by 
using a variety of questions requiring participants to describe, for example, people or 
events influencing their lives, recent vacations, significant inventions of the 20 th 
century or individuals they admire. Healthy older adults and those with stroke were 
compared using this dual-task in the study by Kempner et al (2006), finding that both 
gait and speech deteriorated in those with stroke. Subsequent studies of stroke 
groups using this task found that gait speed was reduced during the dual-task 
condition (Plummer-D'Amato et al., 2008, Pohl et al., 2011, Plummer-D'Amato and 
Altmann, 2012). 
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Mental tracking tasks 
This group of tasks require the participant to hold information in their mind for 
manipulation or while performing a mental process, and are usually used to examine 
sustained attention and information processing speed (Lezak et al., 2004).  
 
Serial subtraction is an example of this type of task, requiring participants to perform 
consecutive subtractions by a given amount from a given starting number, 
subtracting aloud whilst walking. This task is frequently used in dual-task designs. In 
a study of older adults two serial subtraction tasks were used (Srygley et al., 2009). 
Performance of both tasks and gait speed reduced during the dual-task condition, 
with subtraction of ‘7’ resulting in slower gait. 
 
In the study by van Iersel et al (2007), which also used a word generation task, again 
two serial subtraction tasks were used to assess walking balance in a group of 
healthy older people, finding that under dual-task balance measure deteriorated. In a 
study that included several dual-tasks, a serial subtraction task was also used to 
assess the effect of dual-tasking on gait variability in older adults and idiopathic 
elderly fallers (Springer et al., 2006). The authors concluded that dual-tasks 
destabilised the gait of idiopathic, elderly fallers. 
 
This task has been used in several studies of patient groups. Walking stability and 
variability of unilateral transfemoral amputees was compared with healthy controls 
under a dual-task requiring serial subtraction (Lamoth et al., 2010). There were no 
effects of task on gait parameters measured. In studies of PD groups this task has 
been used to assess the effectiveness of spatiotemporal parameters and the Gait 
Deviation Index in quantifying gait deviations in dual-task (Speciali et al., 2013) and 
as a comparison with a motor task (O'Shea et al., 2002). In a study by Dennis et al 
(2009) two tasks were used in a stroke group and age-matched healthy group. The 
clock task, as previously discussed, was one of these and the other required the 
participants to serially subtract three, beginning at 100. Results from this study 
indicated that the stroke group appeared to prioritise the cognitive task over 
maintenance of walking speed. 
 
Counting backwards is another example of a mental tracking task used in dual-task 
studies. This task requires participants to count backwards by 1 aloud from a pre-
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determined starting number. This task was used in a study of frail older adults finding 
that slower walking speeds whilst performing the task were associated with recurrent 
falls in this group (Beauchet et al., 2008). Backwards counting was used in a study 
comparing people with dementia and healthy controls showing that stride time 
increased in the dementia group under the dual-task (Allali et al., 2008).  
 
Working memory tasks 
Tasks that require holding information in the mind that is then available for 
processing are referred to as working memory tasks, which involves short-term 
explicit memory (Lezak et al., 2004) (see Chapter 2, section 2.2.3a). Measures of 
recall of information, after completion of walking trials, and provided to participants 
whilst walking, have been used in several dual-task gait studies.  
 
Examples of working memory tasks are those that require the participant to listen to a 
text whilst walking, followed by answering multiple choice questions about the text 
when the walking trial was completed. In a study by Springer et al (2006) that has 
previously been discussed, this approach was used as one of several tasks. The 
same approach was used in a PD group (Yogev et al., 2005) finding that gait 
variability was increased with dual-task compared with matched healthy controls. In 
both of these studies, another dual-task required participants to listen to text taking 
note of the number of times a particular word was used, and to then report this at the 
end of the trials. In a similar approach, PD participants were asked to listen to the 
number of tones sounded whilst completing a walking task, reporting their result at 
the end of the trial (Lord et al., 2010). Results indicated that participants adopted a 
strategy to maintain gait speed rather than be concerned about the accuracy of their 
response 
 
The use of recall was also used in a study of a stroke group and healthy controls 
(Hyndman et al., 2006). Participants were required to remember a 7-item shopping 
list that was recited to them whilst walking, which they were then asked to recall after 
they had finished walking. People with stroke had reduced cognitive recall and those 
identified as fallers, exhibited a reduction in stride length during the dual-task 
condition.  
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In contrast to this type of list recall test, participants in another study were trained in a 
mnemonic memory technique prior to data collection (Lindenberger et al., 2000). The 
task involved recall in correct order of 16-item lists of highly imaginable and highly 
concrete nouns after walking on two narrow tracks of differing complexity. Results 
indicated that increased age resulted in a greater reduction in memory task 
performance and walking speed and accuracy of walking on defined pathways. This 
research group applied the same task again in a study introducing obstacles as a 
further source of difficulty to the walking task concluding that older adults prioritised 
walking at the expense of memory performance (Li et al., 2001).  
 
The ‘1-back’ task is an example of a working memory test. In contrast to those 
described above where the memorisation aspect of the test occurs whilst walking and 
the testing element of the memory takes place when walking is completed, during the 
‘1-back’ test both aspects of memorisation and testing take place whilst walking. The 
‘1-back’ test requires the participant to listen to numbers pronounced and to then 
respond to each presented by stating the previously presented number. This test was 
used in a group of older adults who were required to also walk over an obstacle 
whilst performing the task (Schrodt et al., 2004). Results indicated that maintenance 
of gait performance was given a higher priority than task performance. This test was 
also used in a series of studies by Plummer-D’Amato (2008, 2010, 2011) that used 
several cognitive tasks. The 1-back test produced less gait interference than 
spontaneous speech, affecting paretic single limb support. 
b) Critique of dual-task methodologies 
 
The number and variety of tasks found in the dual-task literature reviewed is 
indicative of a lack of standardisation and clarity about appropriate task choice. A 
similar picture of varied task choice is also found in studies involving people with 
stroke; each of the cognitive task categories discussed above included a stroke 
study. The following section critiques task choice in the context of the literature and 
review articles, leading to an argument for the development of a task as a novel 
approach for assessing the effect of FES on cognitive processes. 
 
Firstly, a secondary motor task has been applied in various dual-task methodologies 
either requiring involvement of the upper limbs (e.g. carrying a tray of glasses) or 
requiring negotiation of obstacles. Results from the questionnaire study, discussed in 
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section 3.8, support the potential for the use of obstacles as a secondary task, as 
participants placed a high importance on the quality of their gait, recognising the 
effect of FES on complex physical tasks such as stepping up onto a kerb. The 
difficulty with use of a motor task, secondary to the primary task of walking, is the 
potential for interference between similar motor-driven cognitive processes, rather 
than creating a clear distinction between the cognitive processes involved in gait and 
those involved in other neurally-modulated behaviour. Thus, use of a secondary 
motor task alone would not allow for the proposed study to verify or refute FES-user 
reports that indicate it is easier to think and concentrate while walking with FES. 
There are also important safety and pragmatic considerations with the use of an 
obstacle avoidance task in a group of people post-stroke. The high risk of falls when 
testing obstacle avoidance would create a need to use a harness system to ensure 
safety during walking trials. This would have introduced additional practical 
constraints on testing (Salford has a single ceiling-mounted harness system in the 
most heavily used of the motion analysis laboratories). This approach was 
discounted and the focus was on a secondary cognitive task. 
 
One of the most striking similarities of the majority of cognitive tasks reviewed, 
including those used on stroke groups, was a need for the participant to respond to 
the stimulus or input verbally whilst walking (Canning et al., 2006, Kemper et al., 
2006, Plummer-D'Amato et al., 2008). The motor component of articulation has the 
potential to create an interference effect, and may explain some of the motor-
cognitive interference measured in some dual-task studies. This point was made in 
the study by Dennis et al (2009) in discussing the limitations of their choice of serial 
subtraction task. The authors noted that their choice of task required continuous 
vocalisation and a self-generated response sequence. Hence participants may have 
adopted the same rhythm for walking and talking, plus the motor component of 
articulation may have had an interference effect. Prior to this study, this point was 
also made by Hyndman et al (2006) who made the choice to avoid vocalisation whilst 
walking by applying a working memory task, requiring the participants to recall a list, 
delivered verbally whilst walking, after walking was complete. This task choice 
elegantly removed the confounding effect of motor interference due to talking, 
drawing upon sustained attention to encode and maintain material in short-term 
memory and replicated the type of cognitive interference encountered in everyday 
memory. 
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Thus, a memory task that avoided a verbal response whilst walking would also avoid 
a ‘second’ motor task whilst walking, and was a valid and important point to consider 
when selecting a task. Furthermore, in the context of no clear indication of task 
choice from previous studies, including those of stroke groups, the results from the 
questionnaire study provided an initial focus to drive task choice. The following 
describes how this and several other factors were addressed during the process of 
task development. 
4.2.3  Development of new task 
 
The process of identification of a suitable secondary cognitive task for the dual-task 
protocol was driven by the following points, which are each discussed: 
 Questionnaire results from Chapter 3 
 Task that was measurable and a primary outcome 
 Avoidance of interference from a secondary motor task 
 Feasibility of the task application whilst walking 
 
Importantly the focus was driven by the outcome of the questionnaire study (see 
section 3.8) which concluded that an appropriate task would require FES users in the 
planned study to walk without thinking about walking and/or look around whilst 
walking.  
 
Secondly, an important point adopted for this thesis was the identification of a 
secondary task that could be measured and used as an outcome. The potential in 
adopting this approach would be to quantify the effect of FES on motor-cognitive 
interference, under dual-task conditions. Furthermore, from the literature reviewed 
there was a noted inconsistency in the outcomes of dual-task studies reported. Whilst 
gait parameters were reported by all studies, the performance of task was not always 
included as an outcome (Eckhardt et al., 2011, Canning et al., 2006). In some cases 
the tasks were purely utilised to create divided attention and hence there was a focus 
on ensuring that the task was completed correctly. In a recent review of dual-task 
studies of older people (Beurskens and Bock, 2012) this point was raised as a 
methodological issue noting that by ignoring outcomes related to either the task or 
gait, changes in dual-task performance cannot be distinguished from those due to 
task prioritisation.  
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Thirdly, the focus was also driven by avoidance of tasks that would require a verbal 
response whilst walking. Adopting this type of task would remove the potential 
interference of articulation on motor-cognitive processes. Thus the task could be 
described as ‘purely’ involving cognitive processes, without the inclusion of a 
secondary motor task to interfere with the primary motor task of walking. This type of 
task would require a response once walking finished, thus reliant upon neural 
processes involved in memory in order to execute them. This important point 
regarding task selection directed the choice to those tasks reliant upon memory. 
 
Finally, as in dual-task studies, the feasibility of application of the task during walking 
was an important factor. This also included taking account of the environment in 
which the study could take place e.g. the available space within a gait laboratory. 
Furthermore, it was important to ensure that the creation of a cognitive load did not 
make the task so difficult that participants were unable to complete the task or that 
their walking ability was put under excessive duress as to make walking unsafe. The 
task also needed to be appropriate for a stroke population. These final points were 
addressed during piloting of the task chosen and the study protocol which is 
discussed later in the chapter. 
 
These important points were taken into the process of task choice. The initial driver 
(i.e. questionnaire study outcomes) indicated that FES users would respond to a task 
that required them to look around whilst walking. By default this would avert their 
gaze from the walking surface and require a visual stimulus or input. From the review 
of the tasks used in the dual-task literature, those using visual stimulus tested 
reaction time (Sparrow et al., 2008) and discrimination (Heller et al., 2000) rather 
than memory. Thus, the decision was made to consider using an existing 
neuropsychological test as a task. The following describes the process by which 
neuropsychological tests were explored and considered, and the task was chosen. 
  a) Visual task 
 
Existing visual memory tests required a visuomotor response which is typically 
drawing e.g. Complex Figure Test or Rey-Osterrieth Test (Lezak et al., 2004). In 
these tests the requirement is to replicate the figure after it is shown. Whilst this may 
have been appropriate to incorporate into a dual-task study, by projection of the 
figure onto a screen whilst walking, in a stroke group this type of testing would be 
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more difficult for those with upper limb effects of stroke and potentially create further 
participant exclusion criteria. As an alternative, visual recognition tests, which test 
short-term memory, negated the need for the participant to draw and also allowed 
figures to be projected on a screen whilst the participant walked. There are several 
examples of these in the literature, using variations on a format which shows the 
participant target figures at the beginning of the test and subsequently requires the 
participant to identify these from amongst a series of foils as the test progresses and 
further figures are shown e.g. Recurring Figures Test (Kimura, 1963), Continuous 
Recognition Memory Test (Hannay et al., 1979), Continuous Visual Memory Test 
(Trahan and Larrabee, 1988), Wechsler Memory Scale – III Faces (Wechsler, 1997). 
b) Verbal task 
 
The outcome of the questionnaire study also indicated that FES users would respond 
to a task that required them to walk without thinking about walking. Thus a cognitive 
task that diverted their attention from the task of walking would create a cognitive 
load suitable for a dual-task protocol. This would be achieved by a visual recognition 
task. But with tasks used in dual-task studies employing visual input in the minority, a 
decision was made to take forward two memory tasks to piloting. As the majority of 
tasks reviewed in the literature used a verbal input or stimulus, inclusion of a ‘verbal’ 
task was identified as appropriate in this context. Either a verbal or visual task would 
divert attention away from walking and thus potentially provide a measure of the 
degree to which participants need to think about walking. A ‘common sense’ 
assessment of both approaches indicates that tasks derived from this dual-focus 
would potentially be reflective of real life situations occurring whilst walking. 
 
There were some examples from the dual-task literature of tasks requiring a 
response after walking was complete, drawing upon the cognitive processes involved 
in memory, and reliant upon verbal stimulus or input (Yogev et al., 2005, Springer et 
al., 2006, Hyndman et al., 2006). Alternatively, a verbal recognition test, to mirror the 
format of the visual task, offered a potentially more easily applied and measured 
verbal task. Amongst available verbal neuropsychological tests there are several 
recognition tests that expose the participant to target words and then require the 
participant to identify them when they are paired with another word e.g. Memory Test 
for Older Adults (Hubley and Tombaugh, 2002), Recognition Memory Test 
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(Warrington, 1984). Both of these examples of tests also include a visual recognition 
component that follows the same format of testing.  
c) Task development 
 
The format of the Memory Test for Older Adults and the Recognition Memory Test 
(RMT) were the most appropriate choice for the purposes of creating a cognitive load 
that tested short-term recognition and could be adjusted for difficulty to avoid 
excessive cognitive load. In fact Warrington’s Recognition Memory Test (RMT) had 
been incorporated into The Camden Memory Tests (Warrington, 1986) as a 
shortened version, indicating that it was possible to develop tests of differing lengths 
and thus tailor the task to the time spent walking.   
 
Thus two tests were devised, based on the format of the RMT, which tested visual 
and verbal recognition and taken forward to piloting. The format required participants 
to walk whilst listening to words spoken (verbal) or looking at figures shown (visual) 
at two second intervals; this frequency is taken from the Continuous Visual Memory 
Test. Then, when seated, the participants heard the word paired with another word or 
saw the figure paired with another figure, in a different order to that in which they 
were previously heard or shown. They were asked to identify the word or figure that 
they had heard or seen previously. 
 
In order to be able to score the results in a consistent manner across participants it 
was important to ensure that similar cognitive processes were involved for all 
participants when committing the target word or figure to their short-term memory. 
Words can introduce a number of dimensions into a memory task that can affect test 
performance e.g. imagery, familiarity, emotion (Lezak et al., 2004). Thus, words of 
low imagery and of three syllables or less were chosen using a database of words 
(Wilson, 1988) which could be searched based on these criteria. Similarly, figures 
that are of familiar objects, flora or fauna would affect test performance. Participants 
could potentially translate the image into its verbal form, rather than remember it in its 
image form, resulting in a test of verbal rather than visual memory. Thus, figures 
were chosen that were abstract and indeterminable using those from the Continuous 
Visual Memory Test (Trahan and Larrabee, 1988) supplemented by abstract figures 
drawn by the researcher.  
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For the piloting process several visual and verbal tests were produced. The words 
and figures were not repeated during the course of a single gait laboratory session, 
neither as targets nor as paired foils. Appendices B.2 and B.3 provides examples of 
the word lists that were played as pre-recorded lists and the figures that were 
projected on a screen, both at two second intervals. Examples of the paired words 
and figures, that tested the participants’ memory, are also included. 
4.2.4 Other measures 
 
It was expected that, when participants are asked to walk and perform the concurrent 
cognitive task, they would differ in the weighting they gave to walking or task 
performance. For example, stroke participants have been noted to adopt a strategy of 
altering the grammatical content of speech and adopting a slower gait speed during 
dual-task in order to maintain performance in both tasks (Pohl et al 2011). In contrast, 
when stroke participants were required to cross obstacles whilst walking and 
performing a cognitive task (Smulders et al 2012) results suggested that maintaining 
gait was prioritised. Yogev-Seligmann et al (2012) have proposed a model that 
explains the integration of factors such as the individual’s cognitive state, 
compensatory capabilities and personality that may be involved in task prioritisation. 
 
The study design therefore included collection of other measures that were chosen to 
describe the participants and to allow investigation of whether observed changes in 
gait and/or cognitive task could be explained by factors other than the presence or 
absence of FES. The following discusses the measures chosen. 
 a) Falls measures 
 
One possible explanation for participants’ choice of priorities could have been their 
falls history, and perceived risk and attitudes about the safety of walking and the 
possibility of falling. Advice was sought from the lead clinician of the local NHS falls 
service (Greene 2008) in the choice of measures appropriate to capture these 
potentially influential factors.  
 
A widely used validated tool, at the time of designing this study, was the Falls 
Efficacy Scale (FES) (Appendix B.4) (Tinetti et al., 1990). This scale was designed to 
measure self-perceived fear of falling (Hellstrom and Lindmark, 1999) by assessing 
confidence in performing ten activities of daily living without falling (Yardley et al., 
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2005) on a scale of one (most confident) to ten (least confident). A score out of 100 
was obtained when the scale was applied, with higher scores indicating lower 
confidence. The scale had been used in several stroke studies (Michael et al., 2006, 
Fritz et al., 2007, Michael et al., 2009). Participants completed the scale at baseline 
and both subsequent data collection visits to examine change in confidence over 
time with use of their FES device and subsequent relationship to primary outcome 
measures. 
 
As recommended in a study exploring fear of falling (Delbaere et al., 2010a) this 
measure of perceived falls risk was matched by a measure of falls risk based on 
external factors. A large variety of measures are cited in the research literature to 
assess this risk. To reduce the burden of the study on participants a quick and simple 
tool was chosen that was used locally in Salford by the falls team (Greene, 2008) and 
was designed for use in primary care. The Falls Risk Assessment Tool (FRAT) 
(Nandy et al., 2004) has five items (Appendix B.5). Three or more risk factors 
positively predict a fall within the next six months. Again, this was collected at 
baseline and both subsequent data collection visits, in particular to note any change 
in risk with time. 
 
Finally, the participant’s fall history was recorded, to match perceived risk with actual 
risk in this instance, via discussing fall or near fall events, using a proforma to record 
details of each event (Lord et al., 2007)(Appendix B.6). At the initial visit participants 
were asked to recall events during the previous 12 months, whilst at subsequent data 
collections they were asked to recall any events during the intervening period. Whilst 
one of the highly rated reasons for use of FES, by users, is a reduction in the risk of 
falling and tripping (Section 2.4.3e) only one study to date has assessed the effect of 
FES on the occurrence of falls (Hausdorff and Ring, 2008) noting a decrease in 
incidence. Results from the data from this study will potentially add to knowledge in 
this area. 
b) Cognitive abilities 
 
The participants were also assessed in terms of their general cognitive abilities as 
this would influence their performance on a cognitive task whilst walking. Thus 
outcomes of a cognitive assessment could be used in analysis of primary results to 
explain the contribution of this variable to the outcomes. The opinions of two 
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psychologists experienced in the field of stroke rehabilitation and research (Bowen 
2007 and 2008, Kitching 2008) were sought to establish the most appropriate tests to 
quantify and describe this factor. Two tests were chosen to quantify this factor, both 
of which are well established in the field of neuropsychological assessment, and are 
relatively brief, in keeping with minimising the burden of the study on the participant. 
Both tests were applied once at the beginning of data collection. 
 
Firstly, to estimate the participants’ pre-morbid (i.e. pre-stroke) state of mental ability 
the National Adult Reading Test (NART) (Nelson, 1991) was used. This test is often 
used to estimate this ability in adults as vocabulary correlates best with overall ability 
level (Lezak et al., 2004). The NART is comprised of fifty words printed in order of 
increasing difficulty (Appendix B.7). The words are ‘irregular’ and thus can only be 
read correctly if the participant recognises them, rather than phonetically decode the 
word if it is unfamiliar. The test requires the participant to read aloud the list of words. 
The number of errors made are recorded and this is used to obtain an estimation of 
their predicted pre-morbid general intellectual ability (Bright et al., 2002). The score is 
converted to Predicted WAIS-R Full Scale IQ using the conversion scale devised by 
Nelson and Willison (Nelson, 1991) following re-standardisation of the NART. 
 
Secondly, the Digit Span test from the Wechsler Memory Test (Wechsler, 1981) was 
used to assess the participants’ level of attention (forward span) and working memory 
(backwards span) (Lezak et al., 2004). A series of increasingly longer digit 
sequences are spoken by the researcher, and the participant is requested to repeat 
each sequence exactly. In the case of the backwards span, the participant is required 
to repeat them in an exactly reversed order (Appendix B.8). For both forwards and 
backwards spans, the participant repeats increasingly longer series until they are no 
longer able to do so correctly, and each span is scored out of 14. The raw 
unconverted scores for both forward and backwards spans can be evaluated against 
a scale indicating the range of performance abilities (Lezak et al., 2004). Scores of 6 
and above for the forward test are within normal limits, and scores of 4 and above are 
within normal limits for the latter (Lezak et al., 2004).  
c) Overall independence 
 
An overall measure of daily functioning was determined at each data collection visit 
to describe the cohort and to identify any changes that may have occurred over time. 
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The Barthel Index (Mahoney and Barthel, 1965) was used to provide an overall 
measure of independence in activities of daily living (ADL) (Loewen and Anderson, 
1990)(Appendix B.9). This is a well-established and widely used (van der Putten et 
al., 1999) global measure of functional status (Loewen and Anderson, 1990) that has 
been included in the ‘Stroke: Transfer of Care Summary’ produced by the Royal 
College of Physicians (RCP, 2008b). 
 d) Sensory neuropathy 
 
Finally, participants were assessed for peripheral neuropathy of the feet and lower 
legs, using a 10 gram monofilament to apply a standardised assessment (NICE, 
2004). Neuropathy can affect balance when walking and contributes to a greater risk 
of falls (Richardson et al., 1992, DeMott et al., 2007) and hence may influence task 
prioritisation. As with other measures in this study, neuropathy was assessed at each 
data collection to assess any changes over the duration of the study. 
 
4.3 Pilot work to finalise protocol 
 
The use of a dual-task methodology and the decision to use cognitive tasks that were 
developed for this study necessitated piloting of the protocol. Feasibility and 
suitability of application of the protocol to a group of FES users post-stroke was 
assessed by piloting procedures outlined in the following sections. The specific aims 
of the piloting were to: 
a) Selection of the most appropriate task 
b) Identify the best mode of delivery for the secondary memory task 
c) Establish if the protocol was feasible 
d) Establish if the protocol was safe 
 
The following describes the key issues addressed during piloting work. 
4.3.1 Measuring cognitive task performance 
 
Success in cognitive task performance was a primary outcome measure, along with 
gait speed, for this study. The ability to score the memory task and hence compare 
results across conditions was therefore important.  
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Due to anticipated gait speed differences, between participants, between walking 
conditions (i.e. with and without FES) and also over the course of the study, the time 
taken to walk a fixed distance would vary. The average speed at which new FES 
users walk, prior to provision of FES, ranges from 0.19 m/s (Bogataj et al., 1995) to 
0.94 m/s (Granat et al., 1996). Furthermore, an average improvement in gait speed 
with FES use has been reported to be 0.13 m/s (Kottink et al., 2004). Consequently, 
if the slowest speed of 0.19m/s and the fastest of 1.07 m/s (i.e. 0.94 + 0.13 m/s) are 
used to calculate the time it would take for a range of study participants to cover a 
typical 10m length walkway, the range could be 9 to 53 seconds.   
 
Assuming that gait and cognitive task performance were both to be measured in a 
laboratory of fixed length, the following possible design options were considered: 
a) Fix the number of target words/images and vary the length of each walking 
trial to accommodate different walking speeds. 
b) Vary the number of target words/images presented over a fixed length walking 
trial to accommodate different walking speeds.  
c) Vary the frequency with which target words/images appear over a fixed length 
walking trial to accommodate different walking speeds. 
d) Use a fixed number of targets or words/images for all participants and all 
conditions. 
 
Solution a): To ensure the same degree of recall difficulty, each memory task should 
have the same number of items to be recognised either verbally or visually; leading to 
the use of a memory task of a fixed duration.  
 
The restrictions of using a gait laboratory of fixed length would create a situation 
where faster participants would need to turn around to continue walking, whilst 
performing the memory task, potentially more than once. Turning, with the inherent 
need to decelerate and then accelerate, is considered more cognitively demanding 
than walking in one direction at a steady state (Herman et al., 2011) and presents 
significant practical challenges if using a visual task. It was agreed that turning during 
dual-tasking was not an acceptable option as this would contaminate the task 
performance results and hence varying the length of each walking trial was rejected.  
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An alternative was to use the largest of the University of Salford’s gait laboratories in 
which participants could walk in a straight line over a distance of up to 25m, 
potentially avoiding the need for participants to turn whilst walking. Application of a 
visual task in this environment however, would create challenges of delivery. From a 
practical perspective, the lab is heavily used for teaching, and is not ideally suited for 
people with stroke, being rather crowded with equipment and having tripod-mounted 
cameras. Additionally, faster walkers (i.e. 1.07 m/s) potentially would require a 20m 
length walkway to see ten figures, for example, delivered at 2 second intervals. Thus 
the size of the projected figures would need to be sufficiently large to be viewed at 
the beginning of a walk, for the fastest walkers starting the furthest distance away 
from the screen. To ensure consistency of task difficulty, between conditions and 
participants, the size of figures would need to have been the same for each test. At 
the end of the walk, in the case of a fast walker, the figures may then be overly large, 
creating difficulties for those participants with hemi-neglect, who would potentially not 
pay attention to the entire figure, thus increasing the difficulty of the memory task. As 
such, the use of the walkway lengths tailored to gait speed was rejected. 
 
Solution b): An alternative potential solution to the problem of speed variation 
between participants and across conditions would be to vary the number of targets, 
according to the time spent walking.  However, it was not clear whether it would be 
possible to model the effects of altering the number of items to be recalled on 
cognitive task difficulty. If this proved impossible, this would mean analysing the 
results for memory task performance across conditions, as speed changed with 
condition and across participants, would not be possible. 
 
Solution c): A further alternative approach was to deliver a fixed number of targets 
and alter the frequency with which they were delivered. This could accommodate 
differing gait speeds and thus ensure that the targets were seen wholly during 
walking. Hyndman’s study (2006) had used this approach to deliver a 7-item list, 
closely matching the time taken to walk 5m with the time taken to deliver the entire 
list by altering the frequency of item delivery. Lists were prepared over durations of 5, 
10, 15 and 20 seconds, thus the range in interval between items was 0.7 to 2.9 
seconds. Task performance was analysed with no apparent allowance for differences 
within the group nor between the seated condition, presumably delivered over a 
standard time period, and the walking condition. The speed of the group is reported 
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in the dual-task condition as 0.5 ± 0.3m/s, thus the range of time spent walking 5m 
was approximately 5 to 50 seconds. This indicates that each of the 5 to 20 second 
lists were probably used in the group study, creating a variation in the task applied, 
and potentially confounding outcomes comparing task performance when seated with 
walking.  
 
This approach would result in the gap between each target differing between walking 
conditions, and between participants. This inconsistency in the task would be difficult 
to account for when analysing the results. 
 
Solution d): Having rejected potential options (a-c), due to the difficulty in taking 
account of variations in task length/frequency and consequences of varying walking 
length on task performance, it was decided to fix the number and frequency of targets 
and length of walkway. This approach would fix the difficulty of cognitive task 
performance across conditions and between participants and allow for comparison. 
As a consequence during some trials, when walking speeds were faster, some of the 
target items would be heard or seen whilst the participant stood still after walking the 
length of the walkway; during the slower trials, participants would potentially complete 
viewing the targets before reaching the end of the walk. This is further justified below. 
 
The memory tasks require the participant to pay attention to the task during the 
acquisition phase, committing the target words and figures to short term memory, and 
retain the targets in short term memory between the end of the acquisition phase and 
testing. This is a continuous process as the memory task continues and more items 
are committed to and retained in memory, including whilst standing still if this were to 
occur (in the faster participants) and while walking, after the end of the task (in slower 
participants). 
 
The number of targets chosen for the memory tasks was based on the length of 
walkway, the average walking speed for new FES users and the frequency at which 
targets would be delivered. With a 10 metre walkway and an average walking speed 
for FES users, as calculated from the studies included in Kottink’s review (2004), of 
0.5 m/s, the duration of walking was calculated as 20 seconds. Thus, with a 2 second 
interval for target delivery (as described in section 4.2.3c), the number of targets was 
defined as 10 per memory task. The length of test in the context of placing a 
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sufficient cognitive load was tested during piloting, with a plan to assess the scores 
on memory task performance as indicative of appropriate difficulty under all 
conditions.  
4.3.2 Measuring dual-task performance  
 
Piloting was performed firstly with healthy participants and then one post-stroke 
participant to establish a suitable study protocol in terms of timings of each data 
collection aspect and appropriate use of study apparatus. Further piloting was then 
performed with a group of three people – one post-stroke subject who did not use 
FES and two post-stroke established FES users – who all agreed to take part to 
assist development of the study protocol. They represented a range of people post-
stroke, exhibiting variety in gait speed and cognitive ability.  
 
Gait speed data was collected using kinematic data from waist markers, collected via 
a 3D video motion capture system (Qualysis). The method of analysis of this data 
followed published methodology (Carter et al., 2009) and utilised code written by Dr 
Thies, University of Salford, in Matlab software. A more detailed description of this 
approach is given in the study protocol that follows in this chapter. 
 
The FES non-user participant was asked to follow the planned study protocol to 
assess feasibility of the dual-task protocol, with a focus of application of the memory 
tasks. Thus, two trials were collected for each memory task, in the absence of the 
two FES walking conditions i.e. with and without FES. Performance on task was 
recorded, but speed was not (Table 4.1). For the subsequent piloting with the two 
FES users, the planned protocol was followed, involving execution of both memory 
tasks whilst seated, collection of gait speed and task performance whilst walking and 
collection of other measures (e.g. Barthel score) between walking trials. Both 
memory tasks were piloted using ten items presented at 2 second intervals. Each 
FES user performed one walking trial under each condition. Tables 4.2 and 4.3 show 
the results for task and speed. 
 
 Verbal task Visual task 
Seated Walking (2 repeats) Seated Walking (2 repeats) 
FES non-
user 
10 10, 7  10 6, 9 
 
Table 4.1: Task performance success (out of 10) for FES non-user pilot participant. 
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 Verbal task Visual task 
Seated FES No FES Seated FES No FES 
FES user 
(1) 
5 7 7 8 8 9 
FES user 
(2) 
8 8 8 9 8 7 
 
Table 4:2: Task performance success (out of 10) for FES user pilot participants. 
 
 
 Walking condition 
FES No FES FES + 
verbal task 
FES + 
visual task 
No FES + 
verbal task 
No FES + 
visual task 
FES user 
(1) 
1.04 0.96 0.87 0.88 0.90 1.05 
FES user 
(2) 
1.39 1.12 Not 
collected 
1.14 1.09 1.09 
 
Table 4.3: Speed (m/s) of FES user pilot participants. 
 
As the test of memory task performance involved distinguishing a series of targets 
seen or heard during walking from paired foils, a score of 5 out of 10 could be 
attributed to pure chance. Analysis of the scores achieved by the pilot participants 
were all, with the exception of one score, over 5 out of 10. This suggests that 
attention was paid to the two memory tasks. Memory task performance results also 
showed a drop in performance of the memory tasks for the FES non-user on 3 out of 
4 trials, when compared with their performance during sitting (Table 4.1). However, 
FES users showed little consistent change in task performance across conditions 
(Table 4.2). As expected, speed increased with FES for both participants compared 
with no FES. Introducing either task led to a decrease in speed when walking with 
FES, but less clear effects when walking without FES (Table 4.3).  
 
One further FES user participant piloted the final protocol using the visual task 
exclusively, before the study proceeded to recruitment, to confirm that the protocol 
would run correctly and smoothly. Task performance results were collected for three 
walking trials, both with and without FES (Table 4.4). 
 
Seated FES 
 
No FES 
10 
 
9 10 10 9 10 10 
 
Table 4:4: Visual task performance success (out of 10) for FES user pilot participant. 
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4.3.3 Discussion of results of piloting 
 
The ability of the pilot participants to understand and follow the cognitive tasks both 
whilst seated and whilst walking was assessed. Both memory tasks were generally 
easily understood and followed. Subjective assessment of the perceived impact of 
the memory tasks whilst walking, by pilot participants, described them as sufficiently 
difficult to require their attention and concentration, and that whilst walking successful 
completion of the memory tasks seemed more difficult. However, the three pilot 
participants each found the verbal task hard to hear whilst walking on one occasion 
during the piloting procedure. Each time this necessitated the verbal walking trial to 
be repeated, thereby compounding fatigue. 
 
It also became clear that completion of the memory tasks required some familiarity 
with the testing procedure and created a small amount of initial anxiety due to 
concerns about memory ability. This anxiety soon reduced after completion of one 
test. It was therefore decided to deliver this planned measure of performance of the 
memory tasks while seated in the screening battery, rather than as part of the main 
protocol. This would firstly, ensure that all participants who entered the study 
understood and could complete the memory tasks and secondly, potentially address 
any anxiety felt due to lack of familiarity with the memory task.  
 
During walking trials whilst performing both of the memory tasks, pilot participants 
walked safely. No stumbles, toe catching, near misses or falls occurred and the pilot 
participants felt safe during the dual-task conditions, including without their FES 
device switched on. Pilot participants did not need to stop walking whilst concurrently 
performing either memory task. 
 
The visual task was chosen to take forward to the final protocol for the following 
reasons. Firstly, it satisfied the effects of FES as identified by the questionnaire 
outcomes i.e. a task that created a distraction from the perceived thinking associated 
with walking and from looking at the walking surface whilst walking. Secondly, during 
piloting there were no problems experienced with application of the visual task whilst 
walking, in contrast to the verbal task. 
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4.3.4 Visual task 
 
Piloting identified that the visual task was the most appropriate and hence taken 
forward. Secondly, piloting showed that the protocol was feasible to deliver; the 
results of piloting suggested that motor-cognitive interference was achieved by use of 
the visual task, and that this task was able to be executed. Finally, piloting 
established that the protocol was safe.  
 
The visual task was finalised for the study protocol to show ten abstract figures at 2 
second intervals whilst the participant was walking. The target figures, paired with 
foils, were then shown to the participant whilst seated after walking was completed. 
The participant was required to identify the target figures and a score of success was 
obtained. The target figures and the foils were not repeated during a testing session, 
allowing for six walking trials with task (i.e. three each with and without FES). The 
target figures were not repeated as target figures during the entire study, thus 21 
different visual tests were required; 1 seated test and 6 walking trial tests for each of 
the three data collection visits. Furthermore, extra visual tests were devised to allow 
for the possibility of aborted walking trials. The order in which the target figures were 
shown, when paired with the foils, was different to the order in which they were 
shown when walking. Targets were either ‘A’ or ‘B’ when paired with the foils and this 
was also randomised (see Appendix B.3). The order in which the different visual tests 
(i.e. 21 in total) were used was randomised between participants. 
 
4.4 Final protocol and Ethical and R&D approval 
 
Ethical approval was granted by Stockport Research Ethics Committee (Appendix 
B.10) and by The University of Salford Research Governance and Ethics Sub-
Committee. Approval was also granted by Greater Manchester Primary Care 
Research Governance Partnership (Appendix B.10) for Salford Primary Care Trust 
and Heywood, Middleton and Rochdale Primary Care Trust. 
 
Difficulty recruiting to the study resulted in submission of an amendment to ethical 
and research and development committees, requesting a change in recruitment to a 
proactive approach, which had been initially proposed but was unfortunately rejected 
in the initial ethics applications. Furthermore, the amendment also proposed that the 
researcher be able to provide an FES device to participants, under the care of a 
practitioner, for the duration of the study. Ethical approval of the amendment was 
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granted by North West 8 Research Ethics Committee – Greater Manchester East 
(Appendix B.11), the University of Salford Research Governance and Ethics Sub-
Committee and the Greater Manchester Primary Care Research Governance 
Partnership (Appendix B.11). Approval was also granted by Lancashire Care NHS 
Foundation Trust Research and Development.  
 
Participants recruited to this study entered into the study after approval and 
implementation of the amendment 
4.4.1 Recruitment and screening  
 
Physiotherapists, experienced in the assessment of suitability for FES and provision 
of FES, based in Greater Manchester, were asked to identify potential participants 
from their caseload. Inclusion criteria were as follows:- 
 adults 18 years and over 
 hemiplegic foot drop gait resultant from stroke 
 no previous use of FES 
 able to understand spoken and written English 
 suitable for FES following physiotherapy assessment. 
 
Those physiotherapists able to provide an FES device, both via the NHS and 
privately, were asked to give potential participants an invitation letter (Appendix B.12) 
and participant information sheet (Appendix B.13). If their patient agreed, the 
practitioner forwarded the name and contact details of the potential participant to the 
researcher. 
 
Some FES services in Greater Manchester provided FES on a private basis to 
patients. Other physiotherapy services could assess patients as suitable for FES but 
relied upon provision of the device via a case-by-case NHS commissioned service 
with neighbouring FES services. In both of these situations potential study 
participants were offered the opportunity to use an FES device provided by the 
researcher for the duration of the study. Thus, physiotherapists were asked to give 
these potential participants an invitation letter (Appendix B.14) and participant 
information sheet (Appendix B.15). If their patient agreed, the practitioner forwarded 
the name and contact details of the potential participant to the researcher. 
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Participants recruited via this process only received the FES device if they were 
suitable for inclusion in the study after successful completion of the screening 
process (described below). Further use of FES was facilitated by the researcher and 
the participant’s physiotherapist after completion of the study. The participant 
accessed either private or NHS provision and the study device remained in situ until 
this was achieved, to enable seamless care. 
 
Once details of potential participants were received, the researcher made contact to 
discuss their willingness to be considered for inclusion, to answer any questions, to 
establish availability for all data collections and to rule out exclusion criteria e.g. 
planned surgery, involvement in other studies. An appointment was then arranged to 
meet the potential participant. 
 
At the first meeting informed consent was obtained (Appendix B.16), after the study 
was discussed with the participant to ensure that the nature of their involvement was 
understood. The participant was then screened for suitability by establishing past and 
current medical status, including medication and ongoing treatment or planned 
investigations. Each participant was assessed to establish that they were medically 
stable and had no co-morbidities that would confound the data collected in the study. 
If necessary, the participant’s GP or named consultant was contacted, with the 
agreed consent of the participant, to clarify past and/or current medical history. 
 
The participant was then asked to complete, whilst seated, the visual memory test to 
assess their ability to understand and follow instructions, and thus be able to 
participate in the study. Those participants found to be unsuitable to proceed with 
involvement in the study at this stage, were returned to their referring clinician for 
ongoing care. 
 
If agreed via completion of the appropriate section on the consent form, the 
participant’s GP and other appropriate health professionals were then informed of 
their inclusion in the study via letter (Appendix B.17).  
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4.4.2 Study protocol 
 a) Visit 1 
 
Following successful screening, further data was collected at the initial meeting with 
the participant as follows: 
 Participant descriptives – age, sex, height, weight, dominant foot/leg 
 Stroke history – date of stroke, side affected, other effects of stroke, 
treatments and interventions received 
 Use of walking aids/orthoses 
 NART  
 Digit Span – Forwards and Backwards 
 Barthel Index 
 Fall and near fall history – questions via proforma  
 FRAT 
 Falls Efficacy Scale (FES) 
 Assessment of neuropathy  
 
The participants then attended the gait laboratory for the collection of baseline gait 
parameter data, approximately 7-10 days after provision of their FES device. Before 
this collection of data, each participant completed a final screening procedure to 
ensure that they were able to walk safely during the test procedures. The reasoning 
behind this procedure was that, despite the positive results from the piloting, there 
would potentially be an increased risk of falling during walking without FES, whilst 
performing the memory task, potentially the most demanding condition. Whilst the 
researcher walked with the participant, they were asked to perform an example of the 
visual memory task. If the participant tripped, nearly fell or felt particularly unsafe 
during this test they were not asked to continue with their participation in the study. 
b) Visits 2 and 3 
 
Each participant attended the gait laboratory on two more occasions; 6 weeks after 
this initial visit and then a further 8 weeks later. At each of these subsequent visits to 
the gait laboratory the participant’s medical status was checked to ensure continued 
suitability for inclusion in the study and to note any confounding conditions that may 
have affected study results. The following measures were taken at each of these 
subsequent visits, including those repeated from baseline:  
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 Approximate use of FES, since the last visit 
 Falls or near falls since the last visit – questions via proforma 
 Barthel Index 
 FES questionnaire  
 Falls Efficacy Scale (FES) 
 Assessment of neuropathy 
 Visual memory task whilst seated 
c) Walking trial protocol and data analysis 
 
The gait laboratory set-up is illustrated by Figure 4.2. The participants walked in one 
direction only for all trials; towards the screen upon which the figures for the task 
were projected. The length of walkway was approximately 10m. 
 
 
Figure 4.2: Photo of gait laboratory set-up for dual-task protocol. 
 
A wall-mounted, 12 camera 3D motion capture system (Qualysis) collected kinematic 
data at 100Hz.  During walking trials, a cluster of four 9 mm reflective markers, 
mounted on a fixed plate, were attached to the participant on a flexible wide belt, and 
were placed to sit over the posterior aspect of the sacrum. Marker data were filtered 
with a fourth-order Butterworth filter with a cut off frequency of 7Hz and analysed 
using Matlab software. The first derivative of one of the waist marker’s position data, 
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recorded along the direction of forward progression, was used to obtain gait speed, 
during the ‘comfortable gait speed’ interval. This interval was found by excluding the 
data taken when the waist velocity was less than 85% of the maximum velocity for 
the trial (Carter et al., 2009). 
 
Participants were instructed to walk at a comfortable pace for each walking trial. 
During dual-task trials no instructions were given regarding prioritising either walking 
or task completion. Participants were made aware, at the beginning of the study, that 
they would be required to watch a series of abstract figures projected onto a screen 
that was positioned at the end of the walkway, whilst they walked. They also were 
instructed that they would be asked to recognise these figures, when paired with 
another figure, after they had finished walking and were seated. They were 
familiarised with the test format via the screening procedure.  
 
They were instructed to begin walking from outside the data capture area and to 
continue walking along the entire length of the laboratory, coming to a stop in front of 
the screen. They were also instructed to continue watching the figures on the screen 
whilst walking until a blank screen appeared, and to continue looking at the screen 
until they stopped walking. They were also instructed, if necessary, to continue 
watching the screen if the figures were still being projected after coming to the end of 
their walk.  
 
The order in which walking trials for the four conditions were collected was 
randomised between participants and between data collection visits. Furthermore, 
the order in which visual tests were shown was randomised between participants. 
 
4.5 Results 
4.5.1 Recruitment 
Two participants were recruited to this study. The intention was to recruit up to twelve 
however this proved impossible primarily due to a lack of local FES service provision 
in Manchester. Several attempts were made to address this during the recruitment 
period. Firstly an amendment to the recruitment procedure, which included provision 
of the FES device by the researcher, was arranged. Secondly, R&D approval for 
several NHS services across Greater Manchester to act as patient identification 
centres was gained following assurances from the service clinicians that they would 
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be able to refer potential participants. A total of four services gave a commitment to 
recruit participants to the study, referring two people to the study who were 
subsequently recruited. Unfortunately, the study was stopped due to lack of 
participants. As discussed in more detail in the Discussion section of this chapter, the 
results from this study were used to inform a further study, which is presented in 
Chapter 5.  
 
As only two participants completed the study the results are presented as two case 
studies. 
 
4.5.2 Participant descriptors 
 
Table 4.5 summarises descriptors of both participants. 
 
 
 
Participant A B 
Age (years) 75 46 
Sex Female Female 
Height (m) 1.52 1.72 
Weight (kg) 65 102 
Hemisphere affected by stroke Left Right 
Time since stroke at study commencement (mths) 27 41 
Barthel score
#
 (max of 20) 14 19 
NART raw score (errors of possible 50) 11 19 
Predicted premorbid general intellectual ability from NART 
score 
117
* 
107
* 
WAIS-R Digit Span forwards (max of 14) 10
† 
6
† 
WAIS-R Digit Span backwards (max of 14) 5
† 
3
¥ 
NOTE: 
# 
Barthel score remained constant over data collection period 
*
Median IQ = 100±15 SD 
†
Scores 
are within normal limits 
¥
Score borderline of cognitive defecit  
Abbreviations: NART, National Adult Reading Test (Nelson, 1991); WAIS-R, Wechsler Adult 
Intelligence Scale – Revised (Wechsler, 1981). 
Table 4.5: Participant descriptors. 
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4.5.3 Gait speed, task performance and other outcomes  
a) Participant A 
 
Participant A had no other health issues and there was no evidence of peripheral 
neuropathy. The participant reported that the stroke had resulted in a reduction in 
right hand function, occasional poor memory and some difficulty finding the correct 
words to use. During the course of the study she was actively involved in regular 
physiotherapy and guided cardiovascular exercise. She had previously been supplied 
with a double caliper to address her foot drop, which she no longer used as it did not 
lift the foot sufficiently to enhance gait. This participant used a tripod walking stick to 
aid walking. 
i) Gait speed 
 
The results for speed, measured during each condition, are summarised in Table 4.6. 
The participant was able to complete two walking trials for each condition at each 
data collection visit. 
 
                             Weeks since FES provision 
0 6 14 
No FES 
 
0.21 (0.20, 0.21) 0.20 (0.19, 0.20) 0.22 (0.22, 0.22) 
FES 
 
0.20 (0.20, 0.20) 0.21 (0.21, 0.22) 0.22 (0.22, 0.23) 
No FES + task 
 
0.21 (0.20, 0.21) 0.19 (0.19, 0.20) 0.20 (0.20, 0.20) 
FES + task 
 
0.21 (0.21, 0.21) 0.19 (0.19, 0.19) 0.20 (0.20, 0.20) 
 
Table 4.6: Mean speed (min, max) for each condition, over two walking trials, 
collected at each visit (Participant A). 
 
 
Changes in average gait speed over time for each condition are illustrated by Figure 
4.3. Speed increased over 14 weeks by 5% without FES and by 10% with FES. At 6 
and 14 weeks concurrent performance of the visual task reduced walking speed, both 
with and without FES, as expected. At week 0, dual-tasking resulted in an increase in 
speed of 5% with FES. At 6 weeks dual-tasking resulted in reduction of speed by 
10% with FES and 5% without FES. At 14 weeks dual-task performance reduced 
speed by 10% when walking with FES and without FES.  
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Figure 4.3: Walking speed at each visit, averaged over two trials, for each walking 
condition (Participant A). 
ii) Visual task performance 
 
Figure 4.4 illustrates the success with which the visual task was performed during 
walking trials. Success in visual task performance was reduced when walking with 
and without FES. At weeks 0 and 14 visual task performance was lower without FES, 
when compared to with FES, as was expected. At week 6 with FES resulted in lower 
visual task performance than without FES.  
 
 
 
 
Figure 4.4: Score on visual task at each visit, averaged for two walking trials for each  
condition and from one seated trial (Participant A). 
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iii) Falls 
 
At initial data collection the participant was assessed, using the Falls Risk 
Assessment Tool (FRAT), as not at high risk of a fall in the future. At this point the 
participant could not recall experiencing a fall or near fall in the preceding year. 
During the interim between first and second data collection this remained the same. 
At week 14 the participant described one near miss in the last 8 weeks whilst 
outdoors negotiating steps, suffering a loss of balance and no injuries. 
 
Results for the Falls Efficacy Scale (FES) changed over the course of the 
participant’s study involvement; baseline at 42, 6 weeks at 31 and 14 weeks at 48 
(scores out of 100). In particular at 6 weeks there is a drop of 11 points on the scale, 
but then a rise above the baseline at 14 weeks despite a near miss during the 
interim. 
iv) Questionnaire results 
 
Over the course of involvement in the study the participant completed the 
questionnaire twice; at 6 and 14 weeks. Responses to the questions were 
predominately positive but did alter between the two collections.  
 
Of the 13 statements about what the participant was able to do when using FES, she 
agreed with 9 at 6 weeks and 10 at 14 weeks, indicating an overall positive effect of 
FES use. The specific changes in response are as follows:  
-  A positive shift at 14 weeks to agreement with the three statements ‘I am less 
likely to trip and fall’, ‘I am able to exercise more’ and ‘I am able to walk 
without assistance from another person more often’. 
- A negative shift at 14 weeks to disagreement with the two statements ‘I am 
more able to walk on uneven ground’ and ‘My posture is better’. 
Her most important reason for using FES was at 6 weeks was ‘I am able to walk 
faster’ and at 14 weeks this changed to ‘I am able to walk more safely’. 
 
In the second section of the questionnaire, the participant identified the amount of 
perceived concentration when walking with FES as ‘none’ and without FES as ‘some’ 
at both data collections. 
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In the third and final section, from 10 statements about the difference that FES made 
when walking under different conditions, the participant identified 8 at 6 weeks and 6 
at 14 weeks as ‘easier than without the stimulator. The specific changes in response 
are as follows: 
- A positive shift at 14 weeks to agree that ‘thinking about something else whilst 
I walk’ was easier with FES 
- A negative shift at 14 weeks to indicate that ‘talking whilst walking’, ‘walking on 
uneven ground’ and ‘answering questions whilst walking’ were the same with 
FES as without FES. 
The most important activity that was easier with FES remained the same at both data 
collections as ‘stepping up onto a kerb’.  
 
Between data collections the participant increased the number of activities pursued 
using FES, which concurred with increasing use of the device, as familiarity with its 
use improved and the amount of time worn increased to approximately 10 hours a 
day. At 6 weeks the participant had used the device minimally, predominately to 
stimulate muscle contraction rather than as an aid to walking. This was due to a 
misunderstanding between the treating clinician and the participant. Despite this, the 
participant was very positive about the device describing it as ‘smashing’ at 6 weeks 
and then at 14 weeks describing the positive effect of FES as ‘getting around quicker 
and easier’ and ‘able to go places I haven’t been before’.  
b) Participant B 
 
Participant B had several other health issues; Diabetes secondary to Polycystic ovary 
syndrome, Asthma, mild Angina and Hypothyroidism. There was evidence of 
unilateral peripheral neuropathy of the left foot. The participant reported that the 
stroke had resulted in a minor loss of spatial awareness which was most apparent 
when fatigued, and of being easily distracted in noisy environments. She had used a 
fixed ankle AFO until being provided with FES and occasionally used a walking stick. 
i) Gait speed 
 
The results for speed over time, measured during each condition, are summarised in 
Table 4.7. The participant was able to complete three walking trials for each condition 
at each data collection visit. 
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 Weeks since FES provision 
0 6 14 
No FES 
 
0.79 (0.78, 0.79) 0.81 (0.77, 0.86) 0.86 (0.85, 0.90) 
FES 
 
0.79 (0.79, 0.80) 0.89 (0.86, 0.93) 0.94 (0.91, 0.98) 
No FES + task 
 
0.74 (0.72, 0.75) 0.76 (0.75, 0.79) 0.79 (0.76, 0.77) 
FES + task 
 
0.75 (0.74, 0.77) 0.84 (0.82, 0.87) 0.84 (0.82. 0.86) 
 
Table 4.7: Mean speed (min, max) for each condition, over three walking trials, 
collected at each visit (Participant B). 
 
Changes in speed over time for each condition are illustrated by Figure 4.5. Speed 
increased over 14 weeks by 9% without FES and by 19% with FES. At each visit 
concurrent performance of the visual task reduced walking speed, both with and 
without FES, as expected. At week 0, dual-tasking resulted in a reduction of speed by 
5% with FES and 6% without FES. Similar percentage reductions in speed were seen 
at 6 weeks. At 14 weeks dual-task performance reduced speed by 10% when walking 
with and by 8% without FES.  
 
 
 
 
Figure 4.5: Walking speed at each visit, averaged over three trials, for each walking 
condition (Participant B). 
 
ii) Visual task performance 
 
Figure 4.6 illustrates the success with which the visual task was performed during 
walking trials. Success in visual task performance was consistently the lowest at 
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each data collection, when walking without FES. When walking with FES visual task 
performance varied little from seated results. At week 14 seated performance was 
lower than when walking with FES.  
 
 
 
 
Figure 4.6: Score on visual task at each visit, averaged for three walking trials for 
each condition and from one seated trial (Participant B). 
 
iii) Falls 
 
At initial data collection the participant was assessed, using the Falls Risk 
Assessment Tool (FRAT), as at high risk of a fall in the future. At this point the 
participant could recall experiencing one fall in the preceding year whilst in the 
garden, due to a loss of balance, resulting in a bruised hand. She also described 
nearly falling as a weekly occurrence, due a loss of balance usually when multi-
tasking. During the interim between first and second data collection the participant 
recalled one fall whilst walking up stairs at home, resulting in no harm, and two trips 
whilst indoors. At week 14 the participant did not report any near misses or trips 
during the interim, and only one fall when not using FES, which did not result in harm 
and was due to catching her dropped-foot on a dress. 
 
Results for the Falls Efficacy Scale (FES) change over the course of the participant’s 
study involvement; baseline at 26, 6 weeks at 50 and 14 weeks at 45 (scores out of 
100). In particular there is a rise in scores associated with FES use at 6 weeks which 
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is slightly reduced at 14 weeks, perhaps due to a fall during the interim, but 
essentially maintained at 14 weeks. 
iv) Questionnaire results 
 
Of the 13 statements about what the participant was able to do when using FES, she 
agreed with 11 at 6 weeks and with 12 at 14 weeks. There were only a few changes 
in effects of FES over the two data collections. The specific changes in response are 
as follows:  
- A positive shift at 14 weeks to agreement with the two statements ‘I am able to 
walk further’ and ‘I am able to exercise more’. 
- A negative shift at 14 weeks to disagreement with one statement ‘I am able to 
walk faster’. 
Her most important reason for using FES was consistent at both data collections as ‘I 
am more independent’. 
 
In the second section of the questionnaire, the participant identified the amount of 
perceived concentration at 6 weeks when walking with FES as ‘some’ and without 
FES as ‘none’. At 14 weeks this changed, when walking without FES to ‘a lot’.  
 
In the third and final section, the participant identified, at 6 weeks, 9 of the 10 
statements about the difference that FES made when walking under different 
conditions as ‘easier than without the stimulator’. At 14 weeks the participant 
identified all 10 statements as easier. The specific change in response was as 
follows: 
- A positive shift at 14 weeks to agree that ‘walking in a noisy environment’ was 
easier with FES. 
The most important activity that was easier with FES remained the same at both data 
collections as ‘avoiding a trip or fall’. 
 
Between data collections there was a small increase in the number of activities 
pursued by the participant using FES. The participant used the device daily after a 
short initial familiarisation period, indicating at both 6 and 14 week data collection that 
she used it consistently for 8 hours a day, both whilst working and when at home. It is 
worth noting that this participant ran her own business. The participant also received 
Botox therapy as required to address inversion spasm of the foot due to stroke. 
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During the course of the study the participant noted that the Botox injection received 
approximately one month prior to FES provision seemed to be more effective and last 
longer. She especially noted that she had not needed to return for a further injection, 
which would have normally occurred within the timespan of her involvement in the 
study. 
 
This participant had used an AFO prior to FES provision. She felt that FES allowed 
her to walk with least effort in direct comparison to the AFO. The participant noted 
that FES allowed her to ‘do other things whilst walking’ and ‘to look around’. 
 
4.6 Discussion 
 
Prior to the provision of FES, Participant A walked without FES at a mean speed that 
placed her at the lower end of reported gait speeds for participants in other FES 
studies (Kottink et al., 2004, Robbins et al., 2006) and the walking speed for 
Participant B placed her at the higher end. Gait speed then increased for both 
participants with the use of FES over the study period, in a manner consistent with 
previous findings (Taylor et al., 1999c, Burridge et al., 1997b). Gait speed at weeks 6 
and 14 was faster with FES than without FES. This, as well as an increase in speed 
without FES relative to baseline at 14 weeks, is in agreement with previous work 
(Burridge et al., 1997b, Taylor et al., 1999a) noting the evidence of a therapeutic or 
‘carryover’ effect.  
 
Under dual-task conditions, gait speed dropped both with and without FES, 
compared with the single task condition. Gait speeds with FES, under dual-task were 
largely faster than without FES and task. For Participant B the drop in speed during 
the dual-task conditions with and without FES, as compared to walking without the 
visual task, was the same for each condition at each visit, rising from 5% to just over 
10% at 14 weeks. Thus, the reduction in gait speed due to the effect of cognitive task 
performance increased over time (perhaps because gait speed itself increased over 
time), but was no greater whether the participant walked with or without FES. 
Interestingly, when walking with FES and performing the cognitive task very similar 
walking speeds to the single walking task without FES were measured.  
 
For Participant A at week 14, under dual-task conditions, walking with FES reduced 
speed by 9% and without FES was slower with a 10% reduction, when compared the 
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single task conditions. These percentage changes represent small reductions in 
speed relative to an already slow walking speed. The results at 6 weeks are 
confusing and are probably more likely to be a representation of a lack of FES use, 
as a result of a misunderstanding between the participant and her clinician. 
Interestingly, results for visual task performance also appear to be affected by this. 
 
The slowing of gait with the introduction of a concurrent cognitive task is consistent 
with previous stroke research (Bowen et al., 2001, Canning et al., 2006, Hyndman et 
al., 2006, Plummer-D'Amato et al., 2008, Dennis et al., 2009, Pohl et al., 2011). The 
fact that a non-motor cognitive task was used in this study also supports the general 
theory of motor-cognitive interference (Dennis et al., 2009) and argues against this 
simply occurring when two motor tasks (talking and walking) draw on similar 
resources. 
 
The results for visual task performance during walking were largely as expected; 
performance when walking without FES produced the lowest scores. Results suggest 
that when walking with FES, the participants were able to devote a similar degree of 
attention to the cognitive task, as when seated, and this did not change over time. 
This suggests that potential cognitive gains from FES use may cancel out cognitive 
costs of performing everyday dual tasks such as walking and cognitive activity. In 
contrast, when walking without FES, cognitive task performance dropped by up to 
20% (Participant A) and 40% (Participant B) compared to when seated. Whilst not 
consistently the same amount this drop in performance was maintained over time. 
This result for Participant B indicates that without FES there was a marked motor-
cognitive interference effect. The questionnaire results support this interpretation of 
the cognitive task results; both participants found that less concentration needed to 
be allocated to walking with FES at 14 weeks and that concurrent tasks became 
easier when walking with FES. 
Participant A was very positive about the effect that FES had on improving her ability 
to do things and go places that, up until using FES, she had not been able to do. 
Participant B was able to make a direct comparison with an AFO device used, stating 
that FES allowed her to walk with less effort. She also was able to clearly identify that 
FES use had a positive effect on increasing the amount of time that Botox therapy 
remained effective. Furthermore, Participant B clearly felt that FES had a positive 
126 
 
effect on her ability to perform concurrent tasks and to avoid looking at the ground 
whilst walking. 
 
The changes in the primary outcomes over time for both participants show some 
variation. At baseline gait speed differed very little between the four walking 
conditions. This then changed with increased time of use of FES, with change in gait 
speed between conditions increasing at both 6 and 14 weeks. Under dual-task, both 
with and without FES, speed was slower than single task and this was consistent at 
both 6 and 14 weeks. The absolute size of the reduction in speed with addition of 
visual task became larger with time. Visual task performance also showed some 
variation with time, between the two participants. At 14 weeks Participant A’s 
performance without FES was the lowest in comparison to seated scores over the 
three visits. Participant B however exhibited a consistently large difference between 
seated scores and those without FES, across the three data collections. 
 
4.7 Conclusion 
 
This novel approach, applying a dual-task methodology to assess the effect of FES 
on motor-cognitive interference, necessitated consideration of choice of secondary 
task and subsequent piloting to establish appropriateness for an FES user group. 
Piloting clearly established that a dual–task using a visual task, which was developed 
for the study, was feasible. Piloting also established that the protocol was safe. Most 
importantly piloting confirmed that the task would impose a cognitive load and create 
sufficient interference to affect gait speed and some evidence that it may affect task 
performance under dual-task conditions. Furthermore, the other measures collected 
were appropriate and feasible in the context of the study, and did not create an 
unnecessary burden upon the participants during piloting.   
 
The results of the piloting process were then re-iterated by the outcomes from the 
participants recruited to the longitudinal study. These participants showed evidence 
of motor-cognitive interference in a reduction in gait speed and in visual task 
performance under dual-task conditions. Furthermore, FES reduced the effect of this 
interference. In addition, responses to the questionnaire supported these primary 
outcome measures. 
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Difficulties with recruiting further participants to the study, despite several attempts to 
solve unforeseen issues, unfortunately resulted in a halt to further work. However, 
confidence in the protocol and the results obtained were the drivers to seek an 
alternative group of FES users, upon which to apply this novel and now tested 
methodology. Changes in the primary outcome measures over time indicated that, in 
the context of measuring the effects of a dual-task, it was more probable that 
consistent and clearly measurable effects occur after longer use of FES. Thus, the 
protocol was adopted for application in a group of FES users based in a well-
established clinical service in Sheffield, UK. The overall aim remained the same – to 
explore the effect of FES on motor-cognitive interference - but in a larger group of 
established users using a cross-sectional study design. Chapter 5 describes this 
study. 
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Chapter 5 – Cross-sectional dual-task study 
 
5.1.  Introduction 
 
At the beginning of the thesis there was very little information on how FES may 
impact on motor-cognitive interference. One small qualitative study had reported that 
FES users described use of their device being associated with a reduction in the 
concentration required to walk (Malone, 2002). In questionnaire studies users had 
consistently highly rated the effect on effort reduction as important (Taylor et al., 
1999b, Taylor, 2004). These effects of FES were first explored in detail in the 
questionnaire study, described in Chapter 3. Respondents reported a reduction in the 
concentration required to walk with FES compared to walking without. Further, they 
supported statements suggesting performance of specific secondary tasks during 
walking as easier with FES than without. These results supported the first study of 
FES for foot drop that used a dual-task methodology to study the effects of FES on 
motor-cognitive interference during gait. Chapter 4 described the development of this 
methodology, with particular focus on development of an appropriate task and testing 
of feasibility of the protocol.   
Whilst results varied between participants, there was some evidence to support FES 
user reported outcomes from the questionnaire study in Chapter 3. Visual task 
performance was poorer without FES, dropping by up to 20% and 40%, compared 
with seated performance. With FES, particularly for one participant (B), levels of 
visual task performance were close to those when seated, suggestive of a positive 
effect of FES on motor-cognitive interference. This supports a perceived reduction of 
concentration required to walk with FES and the positive effect of FES on secondary 
tasks; both reported from the questionnaire study. Gait speed results were firstly, 
indicative of the effect of the visual task, in that speed reduced both with and without 
FES with the addition of the task. Secondly, the drop in speed under dual-task 
changed with time; in particular rising for one participant (B) from 5% to 10% for both 
with and without FES. Speed with FES and task was faster than without FES and 
task at 14 weeks. Thus, application of the protocol with two new FES-users showed 
that FES appears to have a positive effect on motor cognitive interference during 
walking. However, participant numbers were too low to allow firm conclusions to be 
drawn. 
129 
 
Chapter 4 demonstrated the feasibility of the dual-task protocol in that reductions in 
both gait speed and visual task performance could be successfully measured during 
the dual-task condition. The protocol was effective at delivering and measuring 
motor-cognitive interference and the novel visual task created a sufficient cognitive 
load. The protocol was also shown to be safe for a group of post-stroke FES-users 
and achievable; the task was not overly burdensome to perform whilst walking. The 
practicalities of recruiting new users to this study proved difficult to overcome, and 
therefore recruitment was stopped. However, application of the protocol and results 
obtained from the longitudinal study suggested there was merit in studying a larger 
group to further explore the effect of FES on motor-cognitive interference. 
The results from Chapter 4 showed greater and more consistent differences between 
conditions in gait speed and task performance at 14 weeks than at the previous data 
collection visits. This indicated that established users of FES may be more likely to 
exhibit clearly measurable effects during dual-task conditions. In addition, studying a 
group of established FES users would be representative both of the general FES 
user population and of the respondents to the questionnaire study, described in 
Chapter 3, who had clearly identified a positive effect of FES on concentration and 
dual-tasks. Finally, and most importantly, several well-established clinical services 
could be accessed in the UK, from which to recruit an appropriate sample of 
established FES-users. Thus, the dual-task protocol was applied to a group of 
established users of FES. 
The study reported in Chapter 4 focused only on speed as the measure of motor 
performance. However, Chapter 3 results showed that FES-users reported other 
effects of FES on gait stability which are measurable in the laboratory setting e.g. 
over 80% agreed that walking was more balanced and even. In this study the 
analysis of gait is therefore extended to investigate how gait parameters that are 
reflective of gait stability and balance may be affected by FES and motor-cognitive 
interference. Stroke gait was reviewed in Chapter 2, section 2.3.4a, noting the lack of 
data defining the characteristics of foot drop gait, resulting in largely a description of 
hemiparetic gait. Post-stroke gait is typically slow as well as being characterised by 
abnormal temporal and spatial parameters. Of these abnormal parameters, there are 
those that are more closely associated with maintenance of balance and may be 
associated with falls risk. Due to the increased risk of falls in post-stroke populations, 
also discussed in Chapter 2 (section2.3.4b), the importance of these measures is 
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elevated when assessing the effectiveness of FES. The literature associated with the 
gait parameters measured in this study is discussed in the following paragraphs, in 
the context of the aspects of gait that have been identified by FES users as of high 
importance. 
As previously mentioned, respondents to the questionnaire study in Chapter 3, 
identified that FES use had a positive effect on various aspects of walking. Over 80% 
of respondents agreed that FES made their walking more balanced and even. In 
addition, over 70% agreed that FES increased their ability to walk on uneven ground. 
This latter outcome is in agreement with several studies that have identified an 
improved ability with FES to walk on uneven ground, walk on carpet and avoid 
obstacles (Burridge et al., 2007a, Laufer et al., 2009). The indication from both 
qualitative and quantitative outcomes is that FES has an effect on improving balance 
during gait and on improving the ability to negotiate non-smooth walking surfaces.  
The maintenance of balance whilst walking is closely linked to maintaining postural 
stability; the ability to maintain the position of the body’s centre of mass within 
specific boundaries (Lord et al., 2007). For example, during double support the 
boundary is defined by the area of both feet, whereas during single support this is 
reduced to the area bounded by a single foot – an inherently more challenging task. 
Thus perturbations of the centre of mass outside the boundaries, defined by the base 
of support, challenges balance and heightens the risk of falling (Winter, 1995). 
Maintenance of balance during walking is a particular challenge in post-stroke gait 
due to the presence of weakness, cognitive impairments and often maladapted 
reflexes (Lord et al., 2007, Carr and Shepherd, 2011).   
A balanced gait would be characterised by a normal representation of the phases of 
the gait cycle, both per leg but also between legs, with stance accounting for 60% 
and swing phase for the remaining 40% of cycle time. In post-stroke gait, the swing 
phase of the paretic leg is typically longer than the non-paretic leg, being measured 
as 39.8 ± 4.6% vs 21.5 ± 4.5% in a study by Chen et al (2005). To date there have 
been a few FES studies that measured gait phases to assess device effectiveness. In 
a study of an implantable FES device (Kottink et al., 2012) gait cycle phases were 
analysed reporting normalised stance phase of 60% and first double support phase 
of 11% of the paretic limb and  single support of the non-paretic limb of 41% after 26 
weeks use. 
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In addition, comparison of the time spent by each leg, in the phases of gait, are a 
measure of the symmetry of gait. A high asymmetry indicates an uneven distribution 
of weight-bearing; a situation that is inherently more likely to be susceptible to loss of 
balance via gait perturbations due to uneven walking surfaces, for example. Thus, 
gait asymmetry may lead to an increased risk of falls (Woolley, 2001, Yogev et al., 
2007, Oken and Yavuzer, 2008). Hemiparetic gait can exhibit greater swing time 
asymmetry (Chen et al., 2005, Morris et al., 2010). This measure was adopted as an 
outcome in several studies to assess the effect of FES on balance and fall risk, 
reporting an improvement of up to 45% (Hausdorff and Ring, 2008, Laufer et al., 
2009, Ring et al., 2009). 
Respondents to the questionnaire study also indicated that FES had a positive effect 
on reducing the likelihood of tripping or falling. Over 80% agreed that FES had this 
effect, plus this was identified as one of three of the most highly rated important 
reasons for using FES, and 70% felt that FES made it easier to avoid a fall. Whilst 
there are some limitations associated with this result (see section 3.7.2c) this is an 
important effect of FES for users and is reflective of the effect of FES on the quality of 
their gait. The importance of this effect to FES users concurred with outcomes from 
both previous studies by Taylor et al (1999, 2004). Despite the importance of 
avoiding a fall, only one study has reported on the incidence of falls with FES, finding 
a 92% reduction with FES use over a two month period (Hausdorff and Ring, 2008). 
This paper also assessed change in stride time variability with FES use as an 
indicator of improvement in gait rhythmicity, but also due to a strong link with this gait 
parameter and falls risk in the literature (Hausdorff et al., 1997, Hausdorff et al., 
2001). After 8 weeks use stride time variability was reduced by 33% which indicated 
improved stability (Montero-Odasso et al., 2012). Lower stride time variability, which 
is the stride-to-stride fluctuations in gait, is thought to reflect less higher cognitive 
control of gait and more efficient gait patterns (Hausdorff, 2005).  
These FES studies suggest that some of the typical temporal abnormalities seen in 
post-stroke gait, affecting gait cycle phases, gait asymmetry and stride time 
variability, can be improved by the use of FES. By improving them the assumption is 
that gait is more balanced, even and rhythmical, and subsequently less susceptible to 
perturbation. The effect of FES on these parameters may in some part be due to a 
reduction in motor-cognitive interference during walking facilitated by FES. 
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A small number of dual-task stroke studies have reported on gait parameters that 
have been affected by the addition of a cognitive task. Double support time has been 
shown to be susceptible to dual-task interference in stroke groups by an increase in 
the amount of time spent in this phase of gait (Bowen et al., 2001, Plummer-D'Amato 
et al., 2010). Both studies note that this increase may be indicative of a disruption to 
balance during walking. In fact, an increase in this parameter is suggested to be an 
attempt to stabilise gait (Maki, 1997). 
Furthermore, paretic single limb support time (i.e. non-paretic swing time), has been 
shown to be especially susceptible to dual-task interferences in stroke groups 
(Plummer-D'Amato et al., 2008, Plummer-D'Amato and Altmann, 2012). Single 
support in the paretic limb is a particularly vulnerable aspect of stroke gait, firstly due 
to the inherent challenges to balance during single support, and secondly in stroke 
due to loss of muscle control and power, reducing the ability to bear weight whilst in 
single support. Both of these studies noted a reduction in the time spent in single 
support on the paretic limb under dual-task conditions, suggesting adoption of a 
cautious gait.  
Abnormal spatial gait parameters also characterise post-stroke gait. Step length can 
be altered, with either limb exhibiting a shorter step length (Chen et al., 2005). In a 
dual-task study the difference in step length between single and dual-task 
distinguished fallers and non-fallers in a stroke group. Fallers exhibited a larger 
decrement between the single and dual-task conditions in non-paretic leg step length 
(Baetens et al., 2012). Stride length is also typically reduced in hemiparetic gait 
(Morris et al., 2010). Differences in stride length, under dual-task conditions, in a 
post-stroke group have been found to distinguish fallers from non-fallers, with the 
latter exhibiting longer strides (Hyndman et al., 2006). Therefore, the small number of 
studies investigating the effects of cognitive tasks on post-stroke gait, indicate that in 
response to motor-cognitive interference, people revert to a more stable base of gait 
in which more time is spent with two feet in contact with ground (i.e. double support) 
and less time is spent on the weaker leg. Furthermore, the perceived risk to balance 
and the potential to fall is presumably translated into an approach that shortens stride 
and step length. Measuring these gait parameters, which are susceptible to dual-task 
interference in post-stroke gait, in the current study, may provide evidence of the 
effect of FES on gait that relate to user perceptions such as improved safety and 
increased avoidance of falls. 
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The primary research questions for this dual-task study of established FES users 
were: 
- Does FES reduce the effect of a cognitive task on speed and gait parameters 
associated with balance and stability? 
- Does FES improve performance of cognitive task whilst walking? 
 
The secondary research question was: 
- Can changes in gait and/or cognitive task be explained by factors other than 
the presence of absence of FES i.e. confidence of avoiding a fall, cognitive 
ability, overall independence or sensory neuropathy? 
- Can observed changes in performance be related to self-reported effects? 
 
This chapter begins by briefly describing the protocol used in this study, with 
reference to the previous study and highlighting key differences. The results are then 
presented and analysed, followed by discussion of results, including analysis of the 
results in the context of questionnaire results for this group of FES users. Finally, the 
chapter concludes with a discussion of limitations and conclusions drawn.  
 
5.2  Protocol 
 
This study recruited participants from a well-established NHS FES service based at 
the Northern General Hospital in Sheffield, UK. The patients from this service 
attended for review of their FES device, following initial set-up and issue, at 3 months 
then again at 6 months and continued to be seen every 12 months for review. The 
clinicians offered to assist in recruitment from their patient caseload of established 
users and also offered use of their clinical and gait laboratory facilities to collect data.  
The needs of the clinical service were balanced against the requirements of the 
study. Thus, patients who were due for clinical review, during the period of participant 
recruitment, were invited to take part in the study. Those who agreed to take part and 
fulfilled the inclusion criteria were seen at the Sheffield clinic by the researcher for 
data collection and were also seen by the clinicians, on the same day, for their 
clinical review. Thus, participants were not required to attend the clinic for a separate 
data collection appointment. 
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The clinical service accommodated the extra appointment time required for data 
collection. This was restricted to a minimum to avoid a significant disruption to 
service provision. A maximum of three trials per walking condition was 
accommodated, however the number of markers used to derive kinematic data was 
minimised to ensure good marker visibility per trial and thus avoid poor trials and the 
need for replication of trials. The minimum marker set facilitated identification of gait 
events i.e. heel strike and toe off, allowing for subsequent calculation of spatio-
temporal gait parameters. Gait speed was collected as part of the clinical review via 
use of light gates; this data was shared between the clinicians and the researcher. 
The following describes details of the protocol, referring to similarities and differences 
with the protocol followed in the previous study, described in Chapter 4, as 
necessary. 
5.2.1 Sheffield protocol 
 
Participants’ progression through the study is illustrated by Figure 5.1. 
 
a) Participant selection criteria 
 
Participants included in this study fulfilled all of the following inclusion criteria: 
 18 years and older 
 3 months or more use of single channel FES 
 Unilateral foot drop due to CVA 
 Able to understand spoken and written English 
Participants included in this study had been using their FES for three months or 
more. As discussed in the context of the design of the previous longitudinal study 
(see section 4.2.1), there is a general trend of improvement in gait speed with time 
and an indication that this can continue for many months after first use of FES. Some 
studies have shown continuing improvement in gait speed at 26 weeks or more 
(Kottink et al., 2007, Laufer et al., 2009, Stein et al., 2010). However there is 
evidence to suggest that by 3 months of FES use any further changes in speed and 
gait patterns would be slowed (Burridge et al., 1997a, Burridge et al., 1997b). In 
addition, the clinicians who ran the FES service in Sheffield concluded from their own 
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clinical observations that by 3 months of FES use the gait of the majority of their 
caseload had stabilised. 
 
Figure 5.1: Flowchart of participant progression through the trial. 
 
Potential participants were excluded if any of the following exclusion criteria were 
fulfilled: 
 Past medical history or current medical status, including medication and 
ongoing treatment or planned investigations that contra-indicated 
participation e.g. Parkinson’s disease, investigations for possible cancer. 
 Involvement in another research study that would have confounded study 
results. 
 Inability to follow and participate in the Visual Memory Test. 
 Trip or near fall when walking without their FES whilst performing the 
memory test (i.e. test trial for risk of falling as part of screening process). 
 
b) Recruitment process 
 
Clinicians at the FES clinic at the Northern General Hospital in Sheffield identified 
potential participants from their patient database, who satisfied the inclusion criteria 
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and were due for their clinical review as part of their routine care. Participant 
invitation letters and information sheets were sent (Appendix C.1 and C.2) which 
included a reply slip (Appendix C.3) and stamped addressed envelope. In the letter, 
the potential participants were asked to either telephone the researcher or return the 
response slip, indicating either that they would like to be considered for the study, or 
that they would not. Those who were interested in being involved in the study 
voluntarily provided the researcher with their preferred contact details by contacting 
the researcher either by phone or by using the reply slip. Potential participants were 
asked to contact the researcher, rather than the clinicians at Sheffield, to reduce the 
time spent by the clinicians supporting this study.  
 
Those who advised that they did not wish to be contacted by the researcher had their 
name forwarded to the Sheffield clinicians to be appointed for their review. Those 
who indicated that they were interested in becoming involved were contacted by the 
researcher and screened for suitability. Their names were then forwarded to the 
clinicians to be appointed either to the data collection sessions or for a normal review 
if they were screened as not suitable. 
 
After 14 days the clinicians followed-up by phone those patients who had not been in 
touch with the researcher, to address the appointment scheduling issue. Those who 
expressed an interest in participating in the study (and hence who required a longer 
appointment slot) were asked if they agreed to the researcher contacting them and 
for their contact details being forwarded to the researcher. If they agreed, the 
researcher then contacted these remaining potential participants to screen them for 
suitability and the outcome of this was forwarded to the clinicians. 
c) Screening  
 
The participants attended the FES clinic at the Northern General Hospital in 
Sheffield. Their partner, family member or friend was present during data collection at 
their request. An initial discussion occurred during which the inclusion criteria were 
checked as fulfilled and the exclusion criteria were ruled out. Informed consent was 
obtained and the consent form was signed by the participant (Appendix C.4). The 
participant then completed, whilst seated, the memory test that was used i.e. visual 
recognition memory test. This assessed their ability to understand and follow 
instructions, and thus their ability to participate in the study. Those participants found 
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to be unsuitable to proceed with involvement in the study at this stage, were then 
seen by the clinical staff for their normal clinical review, and no further study data was 
collected. 
 
Those participants assessed as suitable to proceed with their involvement at this 
point were then assessed for risk of falling during their participation. As in the 
previous study, they performed the visual memory test whilst walking without FES, 
whilst a member of the research team walked with them. If the participant tripped, 
nearly fell or felt unsafe during this test trial they did not continue with their 
participation in the study, and were seen by the clinical staff for their normal clinical 
review. 
 
Those participants assessed as suitable to proceed with their involvement were then 
asked further questions and also asked to complete further tests. These are 
described in the following sections. 
 
If agreed via completion of the appropriate section on the consent form, the 
participant’s GP and other appropriate health professionals were informed of their 
inclusion in the study via letter (Appendix C.5). 
d) Gait parameter and task performance collection 
 
Measures of gait and task performance were collected following the protocol 
described in Section 4.4.2c. Thus, gait parameters were collected under the same 
four walking conditions and a baseline measure of task was collected whilst seated. 
The gait laboratory set-up is illustrated by Figure 5.2. The participants walked in one 
direction only for all trials; towards the monitor upon which the figures for the task 
were projected. The total length of walkway was approximately 10m; 7.9 m of which 
was defined by light gates at each end, with approximately 1m at either end to allow 
acceleration before passing the gate and deceleration of gait after passing the other 
gate.  The light gates were used to calculate gait speed. 
A wall-mounted 8 camera Vicon MX motion analysis system, collected kinematic data 
at 100Hz. During walking trials, 9mm reflective markers were placed on the shoes 
and lateral malleolus as illustrated by Figure 5.3. One marker was placed on the heel 
at the most posterior point of the midline of the shoe (labelled ‘heel marker’ in 
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subsequent sections), and this was used to identify heel strike in analysis. Three 
markers were placed across the metatarsophalangeal joints; dorso-medially on the 
first, dorsally between the second and third and dorso-laterally on the fifth. The 
marker placed between the second and third metatarsophalangeal joints was used to 
identify toe-off during analysis (labelled ‘toe marker’ in subsequent sections). The 
other two markers were used to identify last point of foot contact if the participant’s 
foot did not leave the ground through the most distal part of the foot, but alternatively 
through the medial or lateral part of the foot. Similarly, the medial and lateral toe 
markers were also used to identify the first point of foot contact in those participants 
who did not initially strike with the heel; striking with midfoot or forefoot. A final 
marker was placed on the lateral malleolus, to facilitate construction of a foot model 
to aid analysis in Visual 3D. Video cameras, synchronised with the Vicon motion 
analysis system, were placed at the far end and midway along the walkway and 
captured video footage of each gait trial.  
 
Figure 5.2: Gait laboratory set-up showing monitor for projection of visual task, Vicon 
cameras and video cameras. 
 
Kinematic data was reconstructed using Nexus 1.5.2 and then analysed using Visual 
3D. No filtering of marker data was performed; plots of marker positions were visually 
assessed finding minimal noise (i.e. randomised digitising errors) (see Figure 5.4 for 
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an example plot). Visual identification of gait events using kinematic data and visual 
inspection of video and model data was used. As explained below, video footage 
also aided identification of gait events in this study, which has been found to be 
reliable in the identification of heel strike and toe-off (Wall, 1996). 
 
Figure 5.3: Reflective marker placement. 
 
 
Figure 5.4: Example plot of marker position; toe marker plot, x-axis time in seconds, 
y-axis vertical displacement in metres. 
Video footage, together with inspection of the foot model created in Visual 3D was 
used to identify the point of initial foot contact in participants who did not strike with 
their heel. In these trials, the first point of foot contact was labelled as heel strike. 
Video footage and inspection of the foot model created in Visual 3D was also used to 
identify lift-off in those trials where participants did not transfer weight through the 
distal foot e.g. lift-off medially through the hallux due to an abducted foot position. In 
the remaining cases, the vertical component of heel and toe marker position data, 
expressed in the global lab coordinate frame, were plotted against time and used to 
visually identify each individual initial contact and lift-off. Heel strike and lift-off 
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(termed toe-off throughout the subsequent parts of the thesis) times were recorded 
and these were subsequently used to calculate spatiotemporal gait parameters via 
the report function of Visual 3D (described in Section f that follows). 
e) Other measures 
 
The other measures collected in this study were included, as in the previous study, 
as measures to describe the population and to address the secondary research 
question. These measures are the same (with the exception of the FES-I) as those 
collected in the previous study, as described in section 4.2.4, and are listed below:  
 NART  
 Digit Span – Forwards and Backwards 
 Barthel Index 
 Fall and near fall history – questions via proforma  
 FRAT 
 Falls Efficacy Scale – International (FES - I) 
 Assessment of neuropathy  
 FES questionnaire  
The only exception was replacement of the FES (Falls Efficacy Scale) with the 
Falls Efficacy Scale – International (FES-I) (Appendix C.6). This scale is a revised 
and updated version - that is also valid and reliable - of the original Falls Efficacy 
Scale developed by Tinetti et al (1990). The FES-I measures confidence for 
avoiding a fall and level of concern about falling (Yardley et al., 2005, Moore et 
al., 2011). The FES-I is successful in detecting concerns about social activities 
and more demanding outdoor activities, and is thus useful in evaluating 
community populations (Yardley et al., 2005). The FES-I has become a widely 
accepted tool for assessing concern about falling (Delbaere et al., 2010b) and has 
been analysed as appropriate for assessment of older adults at risk of falling 
(Helbostad et al., 2010, Greenberg, 2012). Notably the FES-I has been used in an 
assessment of an AFO (Hung et al., 2011). 
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Participant descriptors were also collected as follows: 
 Participant descriptives – age, sex  
 CVA history – date of CVA, hemisphere affected, other effects of CVA 
 Use of walking aids/orthoses 
 Approximate use of FES i.e. on a daily/weekly basis 
f) Data analysis 
 
i) Sample size 
 
Data collected from the previous longitudinal gait laboratory study and pilot work to 
inform development of the study protocol was analysed to estimate a sample size for 
this study. Following statistical advice, changes in speed and performance of 
cognitive task across conditions were compared. Analysis of gait speed results for 
seven trials of each condition from four participants to calculate sample size is 
detailed in Table 5.1. Decrements in gait speeds between conditions were calculated 
to obtain a percentage change in gait speed, from which the standard deviation (SD) 
was calculated. As each participant was measured under all conditions the results 
could be compared using the paired t-test and hence the notation for use of Altman’s 
nomogram (Petrie and Sabin, 2009) of (2 x δ) ÷ σd to obtain the standardised 
difference could be applied to obtain the sample size for each comparison.  
Condition compared to 
without FES, with task 
to obtain decrement 
With FES, without 
task  
With FES, with task Without FES, without 
task 
σd
1 
10.1% 12.3% 9.1% 
δ
2 
7.9% 7.9% 7.9% 
Standardised 
difference 
1.56 1.28 1.74 
Sample size
3 
13 19 10 
1. SD of difference between decrements. 
2. Smallest mean difference. This is the smallest change in gait speed that indicates a clinical 
improvement in hemiparetic gait (Flansbjer et al., 2005). 
3. Calculated at 80% power, 0.05 significance. 
Table 5.1: Calculation of sample size based on gait speed results. 
142 
 
Cognitive task performance results for ten trials from five participants was also 
analysed to calculate sample size in relation to the primary research question of FES 
improving cognitive performance whilst walking. As each participant was measured 
under each condition of seated, walking with FES and walking without FES the 
results could be compared using the paired t-test – i.e. comparison between 
decrements when two walking condition scores are compared with seated score. In 
this calculation the smallest mean difference in cognitive task score between 
conditions was defined as a change in score of 1 (i.e. smallest difference in an 
individual’s score between conditions). Therefore, applying the same notation for use 
of Altman’s nomogram the following was obtained:- 
σd = 1.36 (SD of difference between decrements without and with FES) 
δ  = 1 (smallest mean difference nb. the cognitive task is scored out of 10) 
Standardised difference = (2 x δ) ÷ σd = 1.47 
A sample size of 15 was required to have an 80% chance of detecting a difference in 
means of 1 on the cognitive score (SD of difference = 1.36) at the 5% level of 
significance using the paired t-test. 
Therefore the largest sample size (i.e. 19 for gait speed) from all four calculations 
was sought to ensure that all desired minimal effects are detected. The sample size 
was increased to 21 to allow for the unlikely event of a possible 10% of participants 
withdrawing from the study during data collection. 
ii) Analysis of data 
 
The participants completed up to three walking trials per walking condition dependent 
upon their ability. Gait speed was calculated per trial by calculating time taken to walk 
between light gates placed 7.9 m apart at both ends of the walkway.  
The report function of Visual3D was utilised to calculate temporal and distance 
parameters from heel strike and toe-off events for both feet. Stance time was 
computed using time between heel strike and toe-off and conversely, swing time 
used time between toe-off and heel strike. Stride time was calculated as the time 
between consecutive heel strikes of the same leg. Double support time was 
computed using time between right heel strike to left heel toe off and left heel strike to 
right toe-off. Stride length was calculated using the distance between consecutive 
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heel strikes of the same leg. Step length was calculated using the distance between 
heel strikes of contralateral legs.  
Measures of gait rhythmicity and variability were then calculated using these 
measures. Stride time variability was characterised as the coefficient of variation 
(CV), calculated as SD/Mean x 100 (Lord et al., 2011). The gait asymmetry index 
was calculated using swing time, as follows; 100 x [(swing time paretic – swing time 
nonparetic)/(swing time paretic + swing time nonparetic)] (Hausdorff and Ring, 2008).  
Statistical analysis of differences between the walking and task conditions was 
performed using SPSS 20, applying repeated measures ANOVAs, with Greenhouse-
Geisser correction as appropriate, to gait and task outcome measures. Post hoc 
testing, using the Bonferroni correction, was applied to reveal significant differences 
between conditions.  
5.2.2 Ethical and R&D approval 
 
Ethical approval was granted by NRES Committee South Central - Southampton A 
(Appendix C.7), approving an approach to recruitment that differed from the one 
eventually followed. An application to The University of Salford Research, Innovation 
and Academic Engagement Ethical Approval Panel was not initially accepted due to 
concerns with the proposed recruitment process. The application was subsequently 
approved (Appendix C.8), following a change to the recruitment approach, as 
described in Section 5.2.1b above. This change necessitated submission of an 
amendment to the NRES committee which was subsequently approved (Appendix 
C.9). Approval was also granted by Sheffield Teaching Hospitals NHS Foundation 
Trust Research and Development Department (Appendix C.10). 
 
5.3 Results 
5.3.1 Recruitment 
Forty-three potential participants were identified by the clinicians and sent study 
invitation packs. Of these, 21 expressed an interest in being involved in the study, 
either by sending a reply slip to the researcher, contacting the researcher by phone 
or agreeing to being contacted by the researcher after the clinician had followed them 
up after no response to the initial posting. Of these, 16 attended for data collection 
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and were all screened as suitable on the day for inclusion in the study. The number 
of participants recruited to the study represented 37% of the total number contacted. 
The remaining 5 did not attend for data collection for the following reasons:- 
- 2 people booked appointments but cancelled on the day due to sudden illness 
and were unable to re-appoint 
- 1 person could not attend on the available appointment dates 
- 1 person was suffering from heel ulcerations and was not able to use his FES 
device for the duration of the data collection period 
- 1 person was unwell when initially contacted and was then unable to be 
contacted 
5.3.2 Participant descriptors 
 
The characteristics of participants is summarised in Table 5.2. The mean age of 
participants was 59.6 years (± 17.2) and the time since stroke was 90.7 months (± 
87.6). Participants self-reported a range of both stroke-related and other health 
problems. None of the participants tested positive for sensory neuropathy of the feet. 
The mean Barthel Index score for participants was 18.5 (± 1.3). There was little 
difference in scores between participants and the mean score indicates that they had 
high levels of independence in their activities of daily living.    
The number of errors made during performance of the NART by each participant was 
used to obtain an estimation of their predicted pre-morbid general intellectual ability 
(see Chapter 4, 4.2.2b). The mean predicted premorbid IQ for the group was 114 (± 
11). The mean IQ for UK residents is 100 (± 15) (Lynn and Vanhanen, 2002). 
Therefore the group mean was above that for UK residents and the minimum IQ for 
the group (i.e. 90) was not below the lowest range of the UK average. 
Performance on the digit span tests, both forward and backward, were assessed 
using the raw unconverted scores, against a scale indicating the range of 
performance abilities (see Section 4.2.2b). For both tests, with exception of two 
participants, all participants’ scores were within normal limits. 
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Sex  male : female 
 n = 16                 
9 : 7 
Mean age years ± SD (range) 
 
59.6 ± 17.2 (22, 81) 
Mean time since CVA months ± SD (range) 
 
90.7 ± 87.6 (12, 348) 
Hemisphere affected by CVA  left : right 
n = 16                                               
9 : 7 
Self-reported CVA related problems  
Upper limb affected 
Face affected 
Sight problems 
Speech affected 
Memory problems 
Hearing problems 
Fatigue 
 
Self-reported health problems 
Heart problems/High BP 
Diabetes 
Hypothyroidism 
Lower limb osteoarthritis 
Back problems 
Fibromyalgia 
Osteoporosis 
 
Negative test for sensory neuropathy 
 
 
15 
3 
10 
8 
4 
1 
1 
 
 
5 
1 
1 
2 
2 
1 
2 
 
16 
Barthel Index score out of 20 ± SD (range) 
 
18.5 ± 1.3 (16, 20) 
Mean predicted premorbid full scale IQ ± SD (range) 
  
114 ± 11 (90, 128) 
Digit span scale n = 16 
 
Within normal limits 
Borderline of cognitive deficit 
Indicative of cognitive deficit 
 
Forward 
 
14 
1 
1 
Backward 
 
14 
1 
1 
 
Table 5.2: Characteristics of participants (n= 16) 
a) Use of FES 
 
The usage of FES by the participants is summarised in Table 5.3. The mean time 
since participants began using FES was 30.9 months (± 24.0). Participants reported 
using their device on average for 4.5 days (± 2.0) days a week. On the days when 
participants used their device they reported using it for an average of 6.0 hours (± 
2.4). 
 
 
 
146 
 
Mean time since began use  months ± SD (range) 30.9 ± 24.0 (3, 97) 
 
Mean use per week (self-reported)  days ± SD 
 
4.5 ± 2.0 
Mean use per day (self-reported)  hours ± SD 
 
6.0 ± 2.4 
 
Table 5.3: Usage of FES by participants (n=16). 
b) Falls descriptors 
 
Tables 5.4 and 5.5 summarise the results of measures taken to assess falls risk, 
level of concern about falling and falls history. The FRAT results show that the 
majority of participants were assessed as at risk of falling in the next 6 months. A 
positive response to three of the five items on the tool identified the participant at risk. 
One of the items is a diagnosis of stroke hence it is not surprising that the majority of 
participants were deemed to be at risk. This result is supported by the fall history 
information, based on recall, from 15 of the participants; one participant did not recall 
any fall events.  
The FES-I scores were categorised, using cut-off points determined in a validation 
study of the scale (Delbaere et al., 2010b), as low 16 – 19, moderate 20 – 27, and 
high 28 – 64. Three of the participants had moderate levels of concern, with the 
majority having high levels of concern. This result concurs with that for risk of falls 
and the fall history for the group. 
FRAT 
At risk of a fall 
 
Y:N 
n = 16 
FES-I 
Level of concern 
 
High : Moderate : Low 
n = 16 
12 : 4 13 : 3 :0 
 
Table 5.4: FRAT and FES-I scores for the group. 
 
No. of falls No. of participants No. of near misses No. of participants 
0 11 0 4 
1 3 1 3 
2 1 2 7 
3 1 3 0 
4 0 4 2 
 
Table 5.5: Self-reported falls and near misses by participants (n=16). 
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5.3.3 Gait speed and visual task performance 
a) Gait speed 
 
Results for gait speed for the group, under each condition, are illustrated by Figure 
5.5. The Shapiro-Wilk test of normality was applied to gait speed data, using the ‘FES 
off’ data as a representation of baseline gait speed, assessing the distribution as 
normal (df=16, p=0.14). 
  
 
 
Figure 5.5: Walking speed for the group, for each condition (Mean ± SD).  
 
Fourteen participants completed three walking trials per condition, whilst the 
remaining two participants were unable to achieve this due to fatigue, completing two 
walking trials per condition. 
There was a statistically significant difference between mean gait speed over the four 
walking conditions (F(2.18,45)=15.17,p=0.00001). Post hoc testing revealed three 
statistically significant differences in mean gait speed (Table 5.6). Speed showed a 
statistically significant reduction with addition of task for FES (0.52 ± 0.28 m/s vs 0.47 
± 0.25 m/s, p=0.003) and for no FES (0.50 ± 0.28 m/s vs 0.45 ± 0.26 m/s, p=0.002). 
This change in speed with addition of task, for both FES and no FES, represents 
approximately a 10% reduction in speed. It is interesting to note the similarities in 
differences in speed between these two comparisons and the similar confidence 
intervals calculated.  
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Speed with FES was faster than speed without FES plus task, representing an 
approximate increase in speed of 15%, which was also statistically significant 
(p=0.0002). There was a 4% increase in speed between FES and no FES, but this 
did not show statistical significance at p<0.05. There was no statistically significant 
difference between speed attained with task when walking with or without FES 
(p=0.256).  
 
Speed 
(a) 
Speed 
(b) 
Mean 
difference 
(a-b) 
p value 95% CI for difference 
Lower Bound Upper Bound 
FES FES + task 0.052
* 
0.003 0.017 0.087 
No FES 0.026 0.065 -0.001 0.053 
No FES + task 0.077
* 
0.0002 0.037 0.117 
No FES No FES + task 0.051
* 
0.002 0.017 0.085 
FES + task 0.026 0.633 -0.072 0.020 
FES + task No FES + task 0.025 0.256 -0.009 0.059 
*The mean difference is significant at the 0.05 level. 
Table 5.6: Pairwise comparisons results of repeated measure ANOVA, analysing 
differences between mean speed for each condition. 
b) Visual task performance 
 
Results for success of visual task performance are illustrated in Figure 5.6 and 
shown in Table 5.7. There was a statistically significant difference in task 
performance between the three task conditions (F(2,30)=18.29, p=0.000006). During 
both dual-task conditions, task success statistically significantly reduced, compared 
with the seated measure; FES p=0.0003, no FES p=0.0001. There was no significant 
statistical difference between task performance with and without FES (p=0.405). 
 
Task 
performance 
(a) 
Task 
performance 
(b) 
Mean 
difference 
(a-b) 
p value 95% CI for difference 
Lower Bound Upper Bound 
Seated FES  1.325
* 
0.0003 0.638 2.012 
No FES 1.925
* 
0.0001 1.036 2.814 
FES No FES  0.6 0.405 -0.423 1.623 
*The mean difference is significant at the 0.05 level. 
Table 5.7: Pairwise comparisons results of repeated measure ANOVA, analysing 
differences between task performance for each condition. 
149 
 
 
Figure 5.6:  Visual task performance for each condition (Mean ± SD). 
 
c) Regression of speed and task 
 
Linear regression was performed of speed during task conditions (i.e. with and 
without FES) on task results whilst walking (i.e. with and without FES). Scatterplot of 
values is shown by Figure 5.7. Regression of speed on task found no linear 
relationship (B= 0.038, p=0.285, 95% CI [-0.033, 0.109]).  
 
 
Figure 5.7: Scatterplot of speed vs visual task performance during dual-task 
conditions, with and without FES. 
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5.3.4 Gait parameters 
 
Results for temporal and spatial gait parameters are reported, including statistical 
analysis of differences between results for each condition.  
a) Temporal and spatial gait parameters 
 
i) Stride time  
 
Mean stride time (Figure 5.8) statistically significantly differed between the four 
walking conditions (F(3,45)=9.86, p=0.00004). Differences in stride time agreed with 
those found for gait speed, as would be expected. Stride time statistically significantly 
increased with addition of task for FES (1.83 ± 0.61s vs 1.91 ± 0.65s, p=0.001) and 
for no FES (1.95 ± 0.71s vs 2.05 ± 0.79s, p=0.011). Stride time without FES plus task 
was statistically significantly longer than with FES (1.83 ± 0.61s vs 2.05 ± 0.79s, 
p=0.009).  
 
 
Figure 5.8: Stride time for each condition (Mean ± SD). 
 
ii) Stance time 
 
Stance time under each condition, for both paretic and non-paretic legs is 
represented by Figures 5.9 and 5.10 These measures of mean time represent a 
percentage of stride time (i.e. cycle time) for the paretic leg as follows; 67% FES, 
69% FES with task, 70% no FES and 72% no FES with task. The percentage of 
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stride time that these measures represent for the non-paretic leg are as follows; 79% 
FES, 80% FES with task, 81% no FES, 81% no FES with task.  
 
Stance time, for both paretic and non-paretic legs, statistically significantly differed 
between the four walking conditions; paretic (F(1.39,45)=11.80, p=0.001), non-
paretic (F(1.37,45)=9.59, p=0.003). Post hoc test using the Bonferroni correction 
revealed five statistically significant differences in mean stance time for the paretic 
leg and four for the non-paretic leg. 
 
Stance time for the paretic leg statistically significantly increased when walking 
without FES, compared to with FES (1.23 ± 0.53s vs 1.37 ± 0.64s, p= 0.031). The 
addition of task statistically significantly increased stance time for both FES (1.23 ± 
0.53s vs 1.32 ± 0.59s, p=0.001) and no FES (1.37 ± 0.64s vs 1.47 ± 0.73s, p=0.016). 
FES had the lowest stance time on the paretic leg whilst no FES with task had the 
highest, with a statistically significant difference between the two (p=0.005). The 
difference in stance time between the two task conditions was statistically significant; 
no FES with task had a longer stance time than FES with task (1.32 ± 0.59s vs 1.47 ± 
0.73s, p=0.044). 
 
 
Figure 5.9: Stance time of the paretic leg for all conditions (Mean ± SD). 
 
Stance time for the non-paretic leg statistically significantly increased when walking 
without FES, compared to with FES (1.44 ± 0.58s vs 1.57 ± 0.68s, p= 0.05). The 
addition of task increased stance time for both FES (1.44 ± 0.58s vs 1.52 ± 0.62s, 
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p=0.005) and no FES (1.57 ± 0.68s vs 1.67 ± 0.75s, p=0.02), and both of these were 
statistically significant increases. FES had the lowest stance time on the non-paretic 
leg and no FES with task the highest, with a statistically significant difference 
between the two (p=0.011). The difference in stance time between the two task 
conditions was not statistically significant (p=0.097). 
 
 
Figure 5.10: Stance time of the non-paretic leg for all conditions (Mean ± SD). 
 
iii) Swing time 
 
Mean swing time, for both paretic and non-paretic legs, under each condition is 
represented by Figures 5.11 and 5.12. Swing time did not statistically significantly 
differ between conditions for both paretic leg swing time (F(1.87,45)=1.04,p=0.36) 
and non-paretic leg swing time (F(2.04,45)=0.27,p=0.77). 
These measures of mean swing time represent a percentage of stride time (i.e. cycle 
time) for the paretic leg as follows; 33% FES, 31% FES with task, 30% no FES and 
28% no FES with task. Swing time on the paretic leg is equivalent to single support 
time on the non-paretic leg. The percentage of stride time that these measures of 
swing time represent for the non-paretic leg are as follows; 21% FES, 20% FES with 
task, 19% no FES, 19% no FES with task. Swing time on the non-paretic leg is 
equivalent to single support time on the paretic leg. 
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Figure 5.11:  Swing time of the paretic leg for all conditions (Mean ± SD). 
 
 
Figure 5.12: Swing time of the non-paretic leg for all conditions (Mean ± SD). 
 
iv) Double support time 
 
Double support time under each condition is illustrated by Figure 5.13. These 
represent a percentage of stride time (i.e. cycle time) as follows; 46% FES, 49% FES 
with task, 51% no FES and 53% no FES with task. Mean double support time 
statistically significantly differed between the four conditions (F(1.36,45)=11.76, 
p=0.001). It statistically significantly increased when walking without FES, compared 
to with FES (0.85 ± 0.52s vs 0.99 ± 0.63s, p= 0.025). The addition of task increased 
double support time for both FES (0.85 ± 0.52s vs 0.94 ± 0.58s, p=0.001) and no 
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FES (0.99 ± 0.63s vs 1.09 ± 0.71s, p=0.018); both of these increases being 
statistically significant. FES had the lowest double support time and no FES with task 
the highest, with a statistically significant difference between the two (p=0.006). The 
p value for the difference in double support time between the two task conditions was 
just above the significance level, set at 0.05, at 0.051; with FES and task had a 
smaller double support time than without FES and task. 
 
 
Figure 5.13: Double support time for all conditions (Mean ± SD). 
 
b) Spatial gait parameters 
 
i) Step length 
 
Step lengths for both the paretic and non-paretic legs are illustrated by Figures 5.14 
and 5.15. Mean step length, for both paretic and non-paretic legs, statistically 
significantly differed between the four walking conditions; paretic (F(2.26,45)=8.20, 
p=0.001), non-paretic (F(1.49,45)=5.29, p=0.02). Post hoc test using the Bonferroni 
correction revealed three statistically significant differences in mean step length for 
the paretic leg and the non-paretic leg. 
Step length for the paretic leg statistically significantly decreased with the addition of 
task for both FES (0.44 ± 0.14m vs 0.42 ± 0.14m, p=0.02) and no FES (0.44 ± 0.15m 
vs 0.41 ± 0.1m, p=0.006). There was also a statistically significant difference 
between FES and no FES with task (p=0.03).  
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Figure 5.14: Step length of the paretic leg for all conditions (Mean ± SD). 
 
Step length for the non-paretic leg statistically significantly decreased with the 
addition of task for both FES (0.39 ± 0.18m vs 0.37 ± 0.18m, p=0.004) and no FES 
(0.38 ± 0.18m vs 0.36 ± 0.18m, p=0.013). There was also a statistically significant 
difference between FES and no FES with task (p=0.006).  
 
 
Figure 5.15: Step length of the non-paretic leg for all conditions (Mean ± SD). 
 
ii) Stride length 
 
Mean stride length (Figure 5.16) statistically significantly differed between the four 
conditions (F(3,45)=16.87, p=0.000000). There was a statistically significant 
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decrease in stride length with the addition of task for both FES (0.84 ± 0.31m vs 0.79 
± 0.3m, p=0.001) and no FES (0.81 ± 0.32m vs 0.77 ± 0.3m, p=0.002). FES had the 
longest stride length and no FES with task the shortest, with a statistically significant 
difference between the two (p=0.00003).  
 
 
Figure 5.16: Stride length for all conditions (Mean ± SD). 
 
c) Gait stability and balance 
 
i) Stride time variability 
 
The number of steps for both the paretic and non-paretic leg was collected for 
walking trials. The results for trials with FES for each participant, which produced the 
least number of steps over the capture area, as a result of fastest walking speeds 
were analysed for total number of steps of all the trials. Those trials that collected 
less than 12 steps per leg were removed from the analysis of stride time variability. 
This is in agreement with suggested recommendations from a recent review paper 
(Lord et al., 2011). The average number of steps for the remaining 11 participants, for 
each walking condition was 18.6 ± 4.9. 
Mean stride time variability under each condition is represented by Figure 5.17. 
Repeated measures ANOVA determined that stride time variability did not statistically 
significantly differ between conditions (F(1.8,30)=0.77,p=0.47). 
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The difference between stride time variability measures for FES and no FES 
represents a 29% reduction with FES. There was also a 29% reduction in stride time 
variability with FES when task was removed. 
 
Figure 5.17: Stride time variability for all conditions (n=11, Mean ± SD). 
 
                ii) Gait asymmetry 
 
Gait asymmetry, calculated using swing time, under each condition is represented by 
Figure 5.18. For gait to be symmetrical the index value should be close to 0. The 
results for each walking condition show that gait was not symmetrical for each 
condition for the group. Mean gait asymmetry did not statistically significantly differ 
between the four conditions (F(1.78,45)=0.49, p=0.59).  
 
 
Figure 5.18: Gait asymmetry index for all conditions (Mean ± SD). 
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5.3.5 Questionnaire results 
 
The results for the questionnaire completed by the participants follow. 
 
a) Activities and walking aid use 
 
The activities undertaken by the participants, either with or without FES, are 
illustrated by Figure 5.19. The top five activities performed with FES were longer 
walks, shopping, walking outdoors, day trips and social events. The top three 
activities performed without FES were exercising, walking indoors and walking 
around the home. 
The use of walking aids by the participants is shown by Figure 5.20. Each participant 
could use any of the walking aids both with and without their FES, thus results for the 
aids are in excess of the total number of participants. A walking stick was the most 
frequently used aid both with and without FES. The other aids were used infrequently 
by participants. 
 
 
 
Figure 5.19: Activities undertaken by participants, both with and without FES. 
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Figure 5.20: Use of walking aids by participants, both with and without FES. 
 
b) The effect of FES 
 
The response by participants to statements about the effect of their device is shown 
by Figure 5.21. Over 50% or more of participants agreed with 10 of the 13 
statements. 15 agreed that they were able to walk more safely with their FES device. 
Furthermore, 14 participants agreed that they were less likely to trip or fall and that 
their walking was more balanced and even. 13 felt that they were able to walk further 
and faster, that they were more confident when they walked and that they were more 
independent with FES. 12 participants felt that they were able to walk with less effort 
and 10 felt that they were more able to walk on uneven ground. 9 participants felt that 
their posture was better with FES. 
 
11 participants disagreed with the statement that they could use their walking aid less 
often, with the remaining 5 participants responding that this statement did not apply 
to them. Furthermore, 6 participants disagreed that they were more able to walk on 
uneven ground with FES. 6 participants felt that with FES they were able to walk 
without the assistance of another person, 4 disagreed with this statement and 6 did 
not feel that this statement applied to them. 5 were able to exercise more whereas 4 
were not able to and a further 7 noted that this statement did not apply to them. 
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When participants were asked which of these effects was the most important, the 
most highly rated by 4 participants was increased confidence when walking (Figure 
5.22). The next most highly rated by 3 participants was an ability to walk more safely, 
followed by less effort to walk and less likely to trip or fall, which were both chosen by 
2 participants. 
 
 
 
 
Figure 5.21: Frequency of response to effects statements by participants. 
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Figure 5.22: The frequency of the most important effect chosen by participants. 
 
 
Figure 5.23: Frequency of scaled responses to rating by participants of concentration 
needed to walk with and without FES. 
c) Perceived level of concentration  
 
When participants were asked to rate on a three-point verbal scale, the amount of 
perceived concentration required to walk both with and without FES, their responses 
produced a significant difference between the two conditions. Figure 5.23 illustrates 
the frequency of responses for each condition. With FES, the amount of 
1 
1 
2 
2 
4 
1 
1 
3 
1 
able to walk further
able to walk faster
less effort to walk
less likely to trip and fall
more confident when
walking
more independent
walk without assistance
more
walk more safely
no answer - no agreed
statements
2 
0 
11 
2 
3 
14 
0
2
4
6
8
10
12
14
16
with without
N
o
. o
f 
p
ar
ti
ci
p
an
ts
 
FES 
a lot
some
none
162 
 
concentration rated as ‘some’ increased and conversely, the amount of concentration 
rated as ‘a lot’ decreased, compared with walking without FES. Thus, there was a 
reduction in the perceived level of concentration required when walking with FES 
which, when statistically analysed was significant (McNemar x2 = 7.69, df=1, p<0.01, 
2-tailed). 
d) Dual-task effects 
 
The frequency with which participants felt their device affected dual-tasks is detailed 
in Figure 5.24. Seven of the ten conditions were made easier with FES for 50% and 
over of the participants. In particular 12 participants found it easier to avoid a trip or 
fall and walking without thinking about walking easier with FES. 11 participants found 
it easier to talk whilst walking with FES. 10 found it easier to step up onto a kerb. 
Furthermore, 9 found FES made it easier to look around and answer questions whilst 
walking. 8 found walking without looking at the ground easier with FES. 7 participants 
felt using FES did not make a difference to walking on uneven ground, walking in a 
noisy environment or thinking whilst walking. 
 
 
 
Figure 5.24: Effect of FES during dual-task conditions perceived by participants. 
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Figure 5.25: The frequency of most important dual-task effect chosen by participants. 
 
When participants were asked to identify the most important task that was easier with 
FES, 4 identified walking without thinking about walking and avoiding a trip or fall 
(Figure 5.25). The next most important task was identified by 3 participants as 
walking without looking at the ground. 
e) Participant comments 
 
Participants also provided an interesting insight into how the use of FES affected 
their lives. Several expressed the effect of FES as an overall summation describing 
FES as ‘brilliant’, making a ‘huge difference’ to their life and ‘improving the quality of 
my life’. One participant ‘wouldn’t be without’ their FES device and said that they 
often recommended it to other people who have had a stroke. In the case of one 
participant, they described a shopping trip without their FES device, due to a lost 
wire, during which they found they forgot to buy items and rushed decisions, finding 
the experience a lot harder, more fatiguing and that they were more concerned about 
falling than usual. Another participant felt that using FES gave them the confidence to 
attend university and that without FES they would not have gone.  
Four of the participants had used or were currently using an AFO. When asked which 
device helped them walk with the least effort, three participants chose FES. 
Furthermore, these participants stated that the AFO ‘didn’t work’ and that FES was 
‘more comfortable’. Although the remaining participant chose the AFO, they did feel 
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that FES was a better option as it made their leg actually move, and that an AFO 
would never make their leg improve, however they felt an AFO was easier to use. 
5.4 Discussion 
5.4.1 Participant descriptors 
 
There was almost equal representation of left and right hemisphere affected by 
stroke and sex in the sample of FES users participating in this study. The mean age 
of the group was 56.6 ± 17.2 years. With 75% of stroke cases occurring in people 
over 65 years of age (DOH, 2005), this group were younger than typical for people 
post-stroke, and also represented a wide range of ages – minimum of 22 years and a 
maximum of 81 years. When compared with other FES studies of people post-stroke, 
the age of participants in this study is similar. In the study by Ring et al (2009) the 
mean age was 52.2 ± 3.6 years, in the study by Laufer et al (2009) it was 55.0 ± 14.6 
years and in the study by Hausdorff et al (2008) it was 54.0 ± 13.5 years.  
The mean time since stroke was 90.7 ± 87.6 months. The range of time since stroke 
was large amongst participants; minimum of 12 and a maximum of 348 months. 
There was also a large range of time since commencement of FES use; mean 30.9 ± 
24.0 months, minimum of 3 and maximum of 97 months. The sample also exhibited a 
diverse range of both stroke related problems and other health issues. It is interesting 
to note that ten of the participants self-reported that their sight was affected by their 
stroke, however they were able to clearly see the visual task whilst walking and did 
not identify that their sight impeded their task performance. 
The participants self-reported use of their FES in terms of days per week and also 
hours per day basis. In comparison to previously reported usage, discussed in 
Section 3.7.2a, this group used their device less often during the week at 4.5 ± 2.0 
days per week and less per day at 6.0 ± 2.4 hours per day. 
5.4.2 The effect of FES on gait speed and gait parameters 
 
The effect of FES on gait speed and other gait parameters, when compared with 
walking without FES, is discussed in the context of the FES literature. 
a) Gait speed 
 
Gait speed is routinely used as an outcome measure to assess the effect of FES both 
clinically and in research studies. Mean gait speed with FES in this study was faster 
165 
 
than walking without FES, as expected and evidenced in the FES literature (Kottink 
et al., 2004, Robbins et al., 2006, Roche, 2009). However, in this sample the 
difference was not statistically significant. In fact the change in gait speed with FES 
represents approximately a 4% increase which is much lower than the pooled 
improvement reported by Kottink et al (2004) of 38%.  
 
Speed both with and without FES for each participant is plotted in Figure 5.25. Only 
one participant slowed with the addition of FES and four maintained the same speed 
both with and without FES. Thus, the remaining 11 participants exhibited an increase 
in speed with the addition of FES, although as can be seen from Figure 5.26, this 
was small in some cases. It is possible that the number of walks requested of 
participants, to collect data across all conditions, together with the attentional effort 
required in 2 of the 4 test conditions, led to greater fatigue than in previous, less 
complex studies. This may have resulted in a slowing of gait during data collection. 
 
 
 
 
Figure 5.26: Plot of gait speed of each participant showing change in mean gait 
speed with addition of FES. 
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b) Gait parameters 
i) Stance time 
 
Stance time for the paretic leg reduced with FES, compared to without FES, from 
1.37 ± 0.64s to 1.23 ± 0.53s. This represented a small reduction in the mean 
percentage of the gait cycle spent in stance, reducing from 70% to 67%, which was 
statistically significant (p= 0.031). Stance time for the non-paretic leg also reduced 
when walking with FES, from 1.57 ± 0.68s to 1.44 ± 0.58s. Again this represented a 
small reduction in the mean percentage of the gait cycle, reducing from 81% to 79%, 
which was statistically significant (p= 0.05). 
 
A study of an implantable FES device (Kottink et al., 2012) showed, after 26 weeks 
use, stance phase duration reduced to 60 % on the paretic leg and 71% on the non-
paretic compared to baseline. Thus, the reduction in stance phase of both legs with 
FES in the current study agree with Kottink’s outcomes, including the difference 
between the legs, with the paretic stance time closer to the normal value of 60%, 
than that for the non-paretic leg. 
ii) Double support time 
 
When walking with and without FES were compared, double support time reduced 
with FES; 0.99 ± 0.63s without FES to 0.85 ± 0.52s with FES. This represents a 5% 
reduction in the mean percentage of the gait cycle, reducing from 51% to 46%, and is 
statistically significant (p= 0.025). This is more than double the percentage of the gait 
cycle spent in double support of 20%, reported in healthy walking (Whittle, 2003) and 
agrees again with Kottink’s study (2012), which noted that the double support phase 
was reduced, when compared with baseline after 26 weeks use of FES, on both 
paretic and non-paretic legs to 11% and 19% respectively. Thus, in the current study 
FES improved the time spent in double-support, although the effect was limited and 
did not approach normal. 
iii) Swing time 
 
Swing time, for both paretic and non-paretic legs, increased by a small amount with 
FES which was not statistically significant, when analysed across all conditions using 
ANOVA. When expressed as a percentage of the gait cycle, mean swing time on the 
paretic leg increased with FES to 33% from 30% without FES. For the non-paretic leg 
a similar increase occurred; from 19% without FES to 21% with FES. Thus, FES 
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enhanced the percentage of the gait cycle both legs were in swing, bringing them 
both slightly closer to the normal percentage of cycle time of 40%, with the paretic leg 
closer to normal than the non-paretic leg. 
 
Swing time on the paretic leg is equivalent to single support time on the non-paretic 
leg and swing time on the non-paretic leg is equivalent to single support time on the 
paretic leg. Single support phase was measured in Kottink’s study also. Although this 
was reported as the first single support phase, FES use of 26 weeks increased the 
percentage of the gait cycle spent in single support for both legs; the paretic 
increasing from 25% to 29% and the non-paretic increasing from 36% to 41%. Thus, 
in both Kottink’s and the current study, FES had the effect of increasing the 
percentage of the gait cycle spent in swing phase for both legs, which also increased 
the percentage of the gait cycle each leg spent in single support. Although, the 
percentage of the gait cycle spent in this phase of gait was improved in the current 
study, the difference between the values for each leg and their difference from 
normal show that participants still walked with non-symmetrical gait.   
iv) Stride time variability 
 
Mean stride time variability reduced by 29% with FES, compared to walking without 
FES. Even though this was a large reduction this was not statistically significant when 
the difference between the four walking conditions was analysed with ANOVA. A 
study by Hausdorff et al (2008) reported stride time variability as indicative of the 
effect of FES on gait rhythmicity. Due to the strong links between this measure and 
fall risk, a measure of fall occurrence was also collected. These new FES users 
obtained an immediate 23% reduction when FES was first used, followed by a 33% 
reduction after 8 weeks of FES use, which was maintained after one year of use 
(Laufer et al., 2009). Furthermore, after 8 weeks FES use fall frequency was 
calculated to have reduced by 92%, with 14 of the study’s 24 participants falling in 
the two months prior to the study and only 2 falling during the study. 
 
The findings from the current study show good agreement with Hausdorff’s and 
Laufer’s outcomes at 8 weeks and 12 months. It is interesting that with prolonged use 
of FES, as in the current study group, there is still approximately a 30% difference in 
this measure when compared with walking without FES. Furthermore, 5 participants 
from the current study self-reported falling in the last year, which represents 
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approximately 30% of the group. This can be compared to fall rates of 43-70% 
reported by studies of groups 1 year post-stroke (see section 2.3.4b) as lower than 
perhaps expected. However this group are greater than one year following stroke.  
v) Gait asymmetry 
 
Gait asymmetry, calculated using swing time, did not statistically significantly differ 
between walking with and without FES, when analysed using ANOVA for all 
conditions. In fact, the index increased by a small amount of 4% with addition of FES 
in this group. However, asymmetry with FES of 21 ± 12% was close to outcomes for 
a group of users after 12 months use of 26 ± 13%, also calculated using swing time 
(Laufer et al., 2009). In this reported study, at 12 months asymmetry was 38 ± 20% 
without FES which is higher than 20 ± 13% for the current group of users. It is 
possible that this result represents asymmetry without FES for longer-term users, 
although it should be noted that the range of time of FES use was 3 to 97 months 
amongst the participants in this study. 
5.4.3 The dual-task effect when walking without FES 
 
The dual-task effect on task, gait speed and other gait parameters, when walking 
without FES, is discussed in the context of the dual-task stroke literature. 
a) Task performance 
 
Task performance, when walking without FES, reduced in comparison to baseline 
seated scores from 9.81 ± 0.40 to 7.78 ± 1.34. This was equivalent to a large 
reduction in performance of 20% which was also statistically significant (p = 0.0001).  
 
The task used in this study was novel in design, testing visual recognition short-term 
memory of participants, requiring articulation of response after walking. Hyndman et 
al (2006) used a similar approach, testing short-term memory recall of a shopping list, 
in their dual-task study of people with stroke compared with healthy controls. The 
stroke group recalled fewer items than the controls and their task performance 
deteriorated significantly under the dual-task condition compared to seated measures 
by 17%. Although there are obvious differences in the task used, the difference 
between seated and dual-task performance is similar between Hyndman’s study and 
this study. However, whilst the number of items remained the same for each trial in 
both Hyndman’s and this study, the length of time over which the 7-item list used in 
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the former was delivered, was altered to match the length of time during which each 
participant walked 5 metres. Thus, the gap between each item differed between 
seated and walking conditions, and between walking trials for each participant. In 
contrast, the interval between the projection of each figure was kept constant in the 
current study, lending greater confidence in comparisons between conditions, due to 
consistency in task. Secondly, the dual-task condition in Hyndman’s study was 
measured only once, compared with 2-3 walking trials per condition in the current 
study. Again, this limits comparison of results.  
b) Gait speed 
 
There was a reduction in mean gait speed under the dual-task condition when 
walking without FES, from 0.50 ± 0.28 m/s to 0.45 ± 0.26 m/s, which was statistically 
significant (p = 0.017) and represented a 10% reduction in speed. Previous studies 
suggest this represents a clinically relevant change in gait speed (Flansbjer et al., 
2005). This also suggests that the effect of the task was sufficient to reduce gait 
speed to level that would affect function, when walking without FES, indicating that 
there was significant motor-cognitive interference. 
Other reported dual-task studies of stroke groups, also found reductions in gait speed 
with addition of task (see Chapter 2, section 2.3.5). Direct comparison of gait speed 
reduction with these studies is limited due to the novel design of task used in the 
current study. The exception is Hyndman’s study, as described in the previous 
section, which recorded a reduction in speed of 29%, which is almost three times that 
of the current study, using a task that similarly did not require articulation during 
walking and tested memory. Apart from differences in the task, the stroke group in 
Hyndman’s trial was older at 66.5 ± 11.8 years vs 59.6 ± 17.2 years, and had 
suffered their stroke more recently 16 (7, 56) months vs 90.7 (12, 346) months. 
Secondly, gait speed measures under dual task were taken for only one walking trial. 
The effect of increased age may explain greater motor-cognitive interference (Al-
Yahya et al., 2011) but basing the outcome on one trial suggests caution in 
comparison of results. 
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c) Gait parameters 
i) Double support time 
 
Double support time statistically significantly (p=0.018) increased under the dual-task 
condition when walking without FES, from 0.99 ± 0.63s to 1.09 ± 0.71s. This is 
equivalent to a 10% increase in time spent in double support during the gait cycle.  
 
Two dual-task studies of stroke groups have measured this parameter as an indicator 
of the effect of task on balance when walking. In the study by Bowen et al (2001) the 
first of the two double support phases of gait were measured and a significant 
increase under the dual-task condition was noted. In a study using several tasks, 
Plummer-D’Amato et al (2010) found a significant increase in the amount of time 
spent in double support under dual-task with the ‘1-back’ task and a spontaneous 
speech task, and although there was a measured difference for the clock task, it was 
not statistically significant. Thus, the results from the current study are in agreement 
with outcomes from other stroke groups indicating that balance under dual-task was 
similarly affected when walking without FES. The motor-cognitive interference due to 
addition of task is evident in this disruption to gait cycle phases in an attempt to 
stabilise gait. 
              ii) Swing time 
 
Swing time of the non-paretic leg did not change under the dual-task condition when 
walking without FES (i.e. from 0.38 ± 0.09s to 0.38 ± 0.11s). This measure is 
equivalent to single support time of the paretic leg. Swing time of the paretic leg also 
did not change under the dual-task condition when walking without FES (i.e.0.58 ± 
0.15s for both conditions). This measure is equivalent to single support time of the 
non-paretic leg. 
 
These outcomes are in contrast to a pilot study which used three different tasks to 
explore their effect on different aspects of gait (Plummer-D'Amato and Altmann, 
2012). Their interpretation of results concluded that as task difficulty increased, from 
a memory task (‘1-back’ task) to a visuospatial task (clock face) and finally to a 
spontaneous speech task, discreet components of gait were effected until finally gait 
overall was slowed. Thus, the memory task was associated with a decrement in 
paretic single leg support, the visuospatial task created interference in both the 
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paretic and non-paretic single leg support phases and finally the speech task 
interfered with overall gait speed. Using this interpretation, it could be concluded that 
the visual recognition task used in the current study, which did test memory, was not 
difficult enough to create changes in swing time and hence single support time for 
either leg. However, gait speed did decrease by 10% with task, which is a statistically 
significant and clinically relevant change. Applying the conclusions from Plummer 
D’Amato’s study, the visual memory task could be described as placed at the more 
difficult end of the continuum due to the effect on speed. 
5.4.4 Dual-task effect with FES 
 
The effect of FES on dual-task is discussed by analysis of results for visual task 
performance, gait speed and other gait parameters, compared with dual-task results 
without FES. The analysis is made in the context of the dual-task literature and 
measures associated with gait stability and fall risk. 
a) Visual task performance 
 
The difference between performance of the visual task between walking with and 
without FES was not statistically significant (p=0.405), despite poorer performance 
without FES. However, during both dual-task conditions task success statistically 
significantly reduced, compared with the seated measure; FES p=0.0003, no FES 
p=0.0001. Thus, in this case using this visual task, FES did not have a significant 
effect upon task performance whilst walking. 
b) Gait speed 
 
The difference between gait speed under dual-task between with and without FES 
was not statistically significant (p=0.256), despite a slower speed without FES of 
approximately 4%. However, speed did significantly reduce with addition of task for 
FES (p=0.003) and for no FES (p=0.002). This change in speed with addition of task, 
for both FES and no FES, represents approximately a 10% reduction in speed, which 
is clinically relevant (Flansbjer et al., 2005). Therefore, in this group of FES users, 
FES did not significantly reduce the effect of the visual task on gait speed.  
 
 
 
172 
 
c) Gait parameters 
i) Gait cycle phases 
 
Whilst there was no statistically significant difference between stance time on the 
non-paretic leg between the two dual-task conditions (p=0.097), stance time for the 
paretic leg statistically significantly increased by 3% when walking without FES under 
the dual-task condition from 69% of cycle time to 72% (p=0.044).   
 
Double support time statistically significantly increased with the addition of task both 
with and without FES and represented a percentage of cycle time as follows; 46% 
FES, 49% FES with task, 51% no FES and 53% no FES with task. There was a 4% 
reduction in the percentage of the gait cycle spent in double support time with FES 
and task compared with without FES and task. The p value for the difference 
between these two task conditions was calculated at just above the significance level, 
set at 0.05, at 0.051. 
 
Results indicate that FES was successful at reducing the amount of time spent in 
double support, and stance for the paretic leg, under cognitive load. Whilst both 
phases were longer than normal, FES brought these phases closer to normal values. 
Thus, FES could be described as having a positive effect on normalising this gait 
phase under dual-task conditions, and these measures indicate the positive effect of 
FES on motor-cognitive interference. 
ii) Step length 
 
There was no statistically significant difference between step length for both the 
paretic and non-paretic legs, between the dual-task conditions. The study by Baetens 
et al (2013) identified that fallers amongst a stroke group would exhibit a greater 
decrement in non-paretic step length between single and dual-task conditions than 
non-fallers, suggesting a larger decrement in non-paretic step length may be 
associated with greater instability. Using their formula to calculate dual-task related 
decrement – i.e. (single-task step length – dual-task step length) ÷ single-task step 
length x 100% - the difference between step length, under dual-task, with and without 
FES was analysed, from the results of the current study. Interestingly, the decrement 
between single and dual-task with FES was 10.6 ± 12.9% and without FES the 
decrement was 5.4 ± 11.6%. It is also worth noting that in the study by Chen et al 
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(2005) of post-stroke gait, whilst differences in step length were found, the direction 
was not consistent, as either leg could exhibit a shorter step length. 
iii) Stride length 
 
Stride length statistically significantly decreased with addition of task both with and 
without FES. However, there was no statistical significant difference between stride 
length under both dual-task conditions. Hyndman et al (2006) distinguished fallers in 
a stroke group by a greater reduction in stride length, under dual-task, again 
suggesting a link between risk of falling and robustness of gait parameters to the 
introduction of a secondary task. Thus, assessing the effect of FES on gait under 
dual-task using stride length, did not suggest that walking with FES would reduce the 
likelihood of a fall. 
iv) Gait rhythmicity and symmetry 
 
Repeated measures ANOVAs were used to analyse stride time variability and gait 
asymmetry across the four walking conditions. For both of these gait measures there 
were no statistical significant differences between conditions. Thus, there was no 
statistical significant difference between dual-task conditions with and without FES. 
FES did not affect these measures of gait during task performance. 
5.4.5 Questionnaire 
 
There is agreement between the results from the questionnaire, when compared with 
outcomes of the questionnaire study discussed in Chapter 3. The activities 
undertaken both with and without FES broadly agree with Chapter 3 results; the top 
five activities undertaken with and FES and the top three without FES are the same 
in both groups. Furthermore, a walking stick was most frequently used both with and 
without FES by both groups. 
Amongst the participants, there was a high level of agreement with the statements 
about the effect of FES with over 50% of participants agreeing with 10 of the 13 
statements. The pattern of response to this question agreed with the questionnaire 
study, again supporting the importance of the effects of FES, other than gait speed, 
amongst users. The effects that were most highly rated by participants i.e. increased 
confidence, ability to walk more safely, less effort to walk and less likely to trip or fall, 
are in agreement with those identified in the questionnaire study (Chapter 3) and two 
previous studies by Taylor et al (1999b, 2004). Thus, apart from improving the quality 
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of gait, participants felt that the effect of FES on confidence and effort were 
important. 
The perceived level of concentration required to walk with FES was statistically 
significantly less than that required to walk without FES. This agreed with the results 
from the questionnaire study. Furthermore, agreement with the dual-task statements 
was high, as 50% and over of participants agreed with seven of the ten statements. 
This is higher than in the questionnaire study in which 50 % and over agreed with five 
of the statements. This outcome may have been influenced by asking this question in 
the context of a dual-task study, and thus raising the participants’ awareness of the 
effect of FES on dual-task conditions. This may have also influenced their high rating 
of the most important dual-tasks as ‘walking without thinking about walking’ and 
‘walking without looking at the ground’. Avoiding a trip or fall was also highly rated, as 
in the questionnaire study, again reflecting the importance of the physical effect of 
FES on the quality of gait. 
These questionnaire results generally agree with those reported in Chapter 3, 
indicating that the effect of FES on outcomes other than gait speed are firstly, 
perceived by FES users, including those in this study and, secondly, are important to 
FES users. Despite this, the quantitative outcomes, using this dual-task approach, 
measuring the perceived effect of FES on other aspects of walking, and in particular 
the perceived reduction in concentration required to walk with FES, are in contrast to 
these FES user reported outcomes. That is, the interference in gait performance 
under a dual-task condition is not affected by the use of FES. This contradiction is 
explored in the next section which analyses in more detail the relationship between 
the questionnaire results and the primary outcomes of gait speed and task 
performance. 
5.4.6 Analysis of primary outcomes in the context of questionnaire results 
 
Analysis of questionnaire results for individual participants was performed to explore 
their relationship with the primary outcomes of gait speed and task performance. To 
address this, three sub-groups of participants were defined, based on their response 
to questions 4 and 5 (see Appendix B.1); a) those who did not perceive FES to have 
a positive effect on the concentration required to walk, b) those who identified dual-
tasks as ‘harder’ with FES than without; and c) those who agreed that both 
concentration reduced and dual-tasks were made easier with FES. The results of the 
175 
 
questionnaire and primary outcomes are discussed for each of these groups to 
highlight any individual differences in responses and evidence of outliers. Participant 
descriptors are also included in the analysis to explore individual variances. 
a) Group reporting no effect of FES on concentration whilst walking 
 
Thirteen participants perceived that FES reduced the amount of concentration 
required to walk, returning a statistically significant difference between the amount 
needed whilst walking with and without FES (see question 4, Appendix B.1). Three of 
the participants, labelled A, B and C to aid discussion, responded in a different way. 
Two (A and B) felt that both with and without FES the levels of concentration were 
unchanged and were both ‘a lot’. One participant (C) felt that the concentration 
required increased from ‘some’, without FES, to ’a lot’ with FES. Interestingly, the two 
who felt that FES had no effect, responded in the same manner to the dual-task 
questions as most of the other participants, agreeing that FES made tasks ‘easier’ or 
‘the same’, but nothing was ‘harder’. The participant (C) who perceived FES required 
more concentration to walk also felt that it made every task ‘harder’. 
The task and gait speed results were explored for these three participants. Figure 
5.27 illustrates their task performance over the three conditions. Participant A did not 
perceive that FES reduced the amount of concentration required to walk, however 
their ability to successfully identify correct task responses was better with FES. 
Furthermore their gait speed (see Figure 5.28), under dual-task conditions, was 
better with FES. Both these results indicate that FES had a positive effect on motor-
cognitive interference for this participant. Finally, when reviewing their response to 
the dual-task question they responded that the majority (i.e. 8 out of 10) were easier 
with FES. This participant’s perception that FES did not have an effect on 
concentration required to walk, was not supported by the other results. 
For the other two of the participants (B and C) task performance without FES was 
either the same or higher than with FES (see Figure 5.27). When speed is compared 
between the two task conditions (see Figure 5.28), speed increased when walking 
without FES and task, which is in contrast to group results. Thus, under dual-task 
conditions FES did not have a positive effect on speed or task performance, which 
supports the perception of these two participants i.e. FES does not have a positive  
effect on the level of concentration required to walk. Interestingly these three 
participants all made comments about the positive benefits of FES use.  
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Figure 5.27: Task performance for each          Figure 5.28: Change in gait speed for 
participant for each condition.                          each participant with task for both FES                                                                           
                                                                         and no FES. 
 
 
The other measures collected for these participants do not distinguish them as a 
group from the other participants. Barthel scores indicated that they had attained high 
levels of independence. Predicted pre-morbid IQ and digit span backwards scores 
were within normal limits. Whilst the other two participants had forward digit span 
scores within normal limits, one participant had a score that was indicative of 
cognitive deficit. This was participant B whose speed and task performance under 
dual-task were not improved by FES.  
Scores on the FES-I placed them all as having high levels of concern for falling. 
Participant descriptors and FES usage did not distinguish them from the other 
participants. The only exception being that they had been using FES for less than 10 
months, in contrast to the remaining participants who had been using FES for 14 
months or more. A shorter time of use, in comparison to the rest of the participants 
may be an explanatory factor; the effect of FES when performing concurrent tasks 
may be associated with increased use. 
b) Group reporting some dual-tasks as harder with FES 
 
The members of this sub-group, labelled participants D, E, F and G, were defined by 
their responses to question 5 (see Appendix B.1). The majority of all participants felt 
that FES made performing all dual-tasks either ‘easier’ or ‘the same’. However, the 
four participants of this sub-group felt that FES made some tasks ‘harder’; three each 
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identifying one task as harder, (‘stepping up onto a kerb’, thinking about something 
else’ and ‘ walking in a noisy environment’) and one participant stating that nothing 
was easier with FES, with tasks either being ‘the same’ or ‘harder’ with FES. 
Interestingly, all four participants perceived that FES reduced the amount of 
concentration required to walk. 
The task and gait speed results were also explored for these four participants. Figure 
5.29 illustrates their task performance over the three conditions. For two of these 
participants (D and E) task performance during walking with FES was improved, and 
(see Figure 5.30) gait speed was improved with FES under the dual-task condition. 
Both of these participants identified one dual-task each in the questionnaire as 
harder and, one of these participants only agreed that three of the dual-task 
statements were ‘easier’ with the remainder being ‘the same’. This suggests that for 
these two participants, despite finding some tasks harder their primary outcomes 
indicate that FES had a positive effect on motor-cognitive interference. 
 
Figure 5.29: Task performance for each participant for each condition. 
 
In contrast task performance without FES was less successful than with FES for two 
of these participants (F and G) (see Figure 5.29), one of which was the participant 
who had found that nothing was ‘easier’ with FES and for whom gait speed did not 
change between the two dual-task conditions (i.e. F). For this participant their 
response to this dual-task question agrees with task and gait speed outcomes, 
indicating that FES did not improve performance in the dual-task condition. 
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Fig 5.30: Change in gait speed for each participant with task for both FES and no 
FES. 
 
The other measures collected for these participants do not distinguish them as a 
group from the other participants. Barthel scores indicated that they had attained high 
levels of independence. Predicted pre-morbid IQ scores were within the average 
range. Whilst the others had digit span scores that were within normal limits, 
participant E had a forward digit span that was borderline for cognitive deficit, and a 
backward digit span that was indicative of cognitive deficit. The results for this 
participant exhibited an ‘expected’ dual-task interference of speed and task, with both 
reducing in the dual-task conditions and FES reducing the dual-task effect and hence 
the motor-cognitive interference. As backward digit span is a measure of working 
memory, evidence of interference during dual-tasks could be expected. 
Scores on the FES-I placed three participants as having high levels of concern for 
falling and one as having moderate concern. For this participant (i.e. F), discussed 
previously, FES did not improve dual-task performance and did not make any of the 
dual-tasks ‘easier’. It is possible that this participant’s level of concern influenced their 
approach to the effect of FES, with dual-task measures not perceived or perhaps not 
of high importance. If this were the case then the dual-task measures of speed and 
task agree with the participants perceptions. Interestingly, this participant did 
comment that ‘if I used it more I would get more benefit from it’ which perhaps 
indicates an understanding of the potential benefits of FES, but not necessarily the 
dual-task benefits. This comment may also indicate that the participant is gaining 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
FES + task  no FES + task
M
e
an
 g
a
it
 s
p
e
e
d
 (
m
/s
) 
D
E
F
G
179 
 
some benefit from FES use; in this case the focus of the study (i.e. dual-task) did not 
align with the benefits that this particular participant receives by using FES.  
Participant descriptors and FES usage did not distinguish these participants from the 
other participants. The only exception being that three of this group were male. 
c) Self-reported responders 
 
Nine participants (labelled H to P) felt that FES made performing dual-tasks either 
‘easier’ or ‘the same’ and perceived that FES reduced the amount of concentration 
required to walk. The gait speed and task results were explored for this sub-group. 
When speed is compared between the two task conditions (see Figure 5.31), speed 
reduced for seven of the participants, remained constant for one and increased for 
another when walking without FES and task, which is broadly in agreement with 
group results. Furthermore, task performance without FES was higher than with FES 
for only two participants (see Figure 5.32) with the remaining participants’ task 
performance at its lowest without FES. 
The two participants who performed the task better without FES (I and M) walked 
slower under the dual-task condition without FES. Conversely, the participant whose 
speed increased without FES under the dual-task condition (i.e. K) had less success 
with task performance without FES than with FES. For these three participants there 
is evidence of a positive effect of FES upon motor-cognitive interference, but both 
task and speed do not concurrently improve with FES. Other measures for these 
participants do not distinguish them from the others in this sub-group, with the 
exception of one (i.e. K) having moderate levels of concern about falling. There was 
one other participant in this sub-group of nine, who scored the same on the FES-I (all 
others had high concern). Interestingly, this participant’s (i.e. N) task performance 
dropped only without FES during dual-task conditions, and gait speed was not 
affected by FES under dual-task. It is possible that concern for falling influenced their 
approach to the dual-task; that is, they may not have perceived the dual-task as 
threatening to walking safety and felt they could maintain gait speed whilst achieving 
good task performance. This is of course only an assumption as data concerning the 
approach to the task that participants took was not collected. 
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Fig 5.31: Change in gait speed for each participant with task for both FES and no 
FES. 
 
 
 
Figure 5.32: Task performance for each participant for each condition. 
 
The other measures collected for these participants do not distinguish them as a 
group from the other participants. Barthel scores indicated that they had attained high 
levels of independence. One participant had the lowest score of all the study 
participants. Their gait speed was slow and with addition of task reduced by only a 
small amount without FES (see participant O), whilst they had more difficulty 
maintaining task score without FES. In this case it possible that the participant’s 
reduced level of overall independence, in comparison to the rest of the group, meant 
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that gait speed only showed small amounts of change whilst the dual-task effect was 
shown by a drop in task performance without FES. 
Predicted pre-morbid IQ scores were within the average range and above, and 
forward digit span scores were within normal limits. Whilst the others had backward 
digit scores within normal limits, one participant was borderline for cognitive deficit. 
This test is a measure of working memory, therefore it is not surprising that this 
particular participant (i.e. P) exhibited a drop in speed, which was one of the largest 
for this group, and a reduction in task performance under both dual-task conditions, 
with both outcomes lower without FES than with FES. These results indicate that the 
expected motor-cognitive interference experienced by this participant was reduced by 
FES. 
Participant descriptors and FES usage did not distinguish this group of participants 
from the other participants.  
d) Actual responders  
Finally, the results for all of the participants were analysed to identify those for whom, 
when walking with FES, both gait speed and visual task performance increased when 
compared with walking without FES. From the Figures 5.27 to 5.32 results for 
participants A, D, E, J, O and P show that FES reduced the effect of task on gait 
speed and visual task performance whilst walking. 
The other data collected for this sub-group was collated. The average age was higher 
than that of the study group at 65.5 ± 20.4 (25, 81) years. In addition the time since 
stroke was longer at 128.0 ± 122.3 (14, 348) months and the time of FES use was 
also longer 42.3 ± 33.9 (3, 97) months. Even though these descriptors were higher 
than for the study group they exhibited a similar large range of values. Females were 
more numerous at 4:2.  
The ratio of hemisphere affected by the stroke was 5:1 (left:right) which was in 
contrast to the group ratio of 9:7. Thus there was a disproportionate representation of 
left hemisphere affected participants compared with the study group. When stroke- 
related health issues were reviewed the sub-group exhibited the same range as the 
study group with none that were common to all in the group.   
The Barthel score approximated that of the group at 17.8 ± 1.5 and the predicted 
premorbid IQ score was 108 ± 10, indicative that this sub-group were not below the 
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UK average. Scores for the forward and backward digit span identified one 
participant as below normal limits for both and another one participant was borderline 
for cognitive deficit for the backwards span only. All of the sub-group had high 
concern for falls and all except one participant were at high risk of falls; both of these 
outcomes were in agreement with group results. 
Finally, questionnaire results for this group were reviewed. All except for one 
participant identified FES as reducing the amount of concentration required to walk. 
Four participants felt that FES made performing all dual-tasks ‘easier’ or ‘the same’ 
whilst two participants both identified one as being ‘harder’ with FES compared to 
without FES. 
Participants, who measured an improvement in both speed and visual task with FES 
under dual-task, did not appear to have any traits exhibited by the variables collected 
to distinguish them from the group as a whole, apart from a disproportionate 
representation of left hemisphere stroke. 
5.5 Conclusion 
 
The primary outcomes of this study indicate that the visual memory task produced 
motor-cognitive interference during gait; both gait speed and success of visual task 
performance were reduced during the dual-task conditions. FES did not reduce the 
effect of the task on gait speed, as there was no significant difference between gait 
speed with task when walking with FES compared to without FES.  
Visual task performance did not significantly differ between walking with and without 
FES, indicating that FES does not improve performance of this cognitive task whilst 
walking. This finding is in contrast to effects of FES perceived by users. In particular 
users, both in this study and in the previous questionnaire study, have noted their 
ability to perform concurrent cognitive functions improved when walking with FES. 
This finding is also in contrast to the positive effect that FES has on reducing the 
perceived levels of concentration required to walk with a foot drop, expressed by the 
participants in this study and again by the respondents to the previous questionnaire 
study. In addition, prior qualitative studies, although of small numbers of FES users, 
had reported that their participants perceived a reduction in the amount of 
concentration required to walk with FES (Malone, 2002, Bulley et al., 2011). Finally, 
FES users have perceived that FES reduces the effort of walking over three 
questionnaire studies (Taylor et al., 1999b, Taylor, 2004, McAdam, 2006), which has 
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been suggested as including a cognitive component. The results for visual task 
performance do not support this concept in this case. 
The other gait parameters analysed to assess the effect of FES on a reduction in 
motor-cognitive interference did not yield much insight into this research question. 
Only stance time of the paretic leg under dual-task conditions statistically significantly 
reduced with FES, even though this represented a small change in the percentage of 
the gait cycle of 3%. Thus, FES did alter the effect of the cognitive task on this gait 
parameter. Furthermore, the subsequent reduction in double support time of 4% 
facilitated by FES under a dual-task condition, although not strictly statistically 
significant, suggested that FES has a positive effect on balance during gait when 
circumstances create motor-cognitive interference. 
Sub-analysis of the questionnaire results, when compared with gait speed and visual 
task performance outcomes indicated an inconsistency in agreement between 
qualitative and quantitative outcomes for some participants. There were some 
participants who recognised the positive effect of FES on dual-tasks and 
concentration but did not always provide a measure of this perceived effect in 
reduced speed and poorer cognitive performance without FES. The converse was 
also true, in that some participants did not perceive FES to have an effect on 
indicators of motor-cognitive interference however, their speed and task results 
showed clear evidence of the effect. The overall suggestion is that variation in results 
for the primary outcomes masked the group effect, and sub-analysis using the 
questionnaire results provides evidence of this variation. In addition, analysis of the 
sub-group of participants, who exhibited a positive effect of FES on both gait speed 
and visual task performance, did not provide a common group variable to explain 
their response. 
The lack of measured effects of FES on motor-cognitive interference could be due to 
a few points about the design of the study. It is possible that a different cognitive task 
would show the effects of FES on cognitive performance more clearly. It is also 
possible that gait speed, whilst commonly used as an outcome measure in dual-task 
studies, is not the most appropriate measure of the effect of FES in these 
circumstances, as it is not reflective of patient-centred outcomes for FES users. This 
study was designed to collect speed as a primary outcome; choice of other gait 
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parameters as primary outcomes (e.g. variability measures) would require an 
alternative study protocol.   
The number of participants recruited was below the sample size of 19, to capture all 
differences in performance. This was calculated based on a small number of trials 
with largely new users for gait speed, as 7 trials were used in the calculation with 5 of 
these by FES users after 14 weeks of device use and the remaining two from long-
term users. More trials were used to calculate sample size for task performance; 10 
walking trials with 5 from both new and long-term users. In particular, based on the 
sample size calculation of 19, the study was under-powered in relation to the 
comparison between the speed with and without FES under dual-task, whilst the 
other comparisons were calculated as able to be made with 16 participants. It is 
possible then, that the results from piloting the protocol did not reflect the behaviour 
of a larger group of FES users, and this may be due to using data from both new and 
experienced FES users, with the majority of the data obtained from the new users. If 
so, the conclusion is that the study outcomes were affected by the number of 
participants. It must also be remembered that the study was exploratory. 
Subsequently there was a potential for the results to be inconclusive, but to positively 
add to knowledge of the effects perceived by FES users. 
Stride time variability was analysed using data from 11 of the participants, following 
removal of data for those where insufficient steps had been collected. This removed 
data for participants who walked at faster speeds, as the length of data capture area 
was fixed and the number of trials was restricted due to the inherent limitations of the 
hosting clinical service. There were no significant differences for this measure across 
the four walking conditions. It may be that analysis of stride time variability was 
compromised by the reduction in the number of participants included. Further dual-
task studies with an aim of analysing these gait parameters would need to address 
the issue of collection of a sufficient data for all participants, in the study design. 
Although the results of this study are not conclusive of an effect of FES on motor-
cognitive interference, from the primary outcomes, there is a suggestion that FES 
may improve speed and task performance under dual-task conditions. There is also a 
suggestion that gait stability and rhythmicity measures are improved by FES under 
dual-task conditions. Furthermore, this group of FES users clearly recognised that 
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FES affected their ability to perform other tasks whilst walking and reduced the 
amount of concentration required to walk.  
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Chapter 6 – Summary and future work 
This final chapter presents an overview of the thesis, describing the work presented 
with a focus on the key novel aspects and the results obtained. Conclusions are 
drawn, within the context of the limitations of the studies, and future approaches to 
research in this field of work are suggested and discussed. 
6.1 Summary 
6.1.1 Overview of the thesis 
The primary aim of the work presented in this thesis was to explore the contribution 
of FES to the cognitive control of gait. This concept, upon which this body of work 
was based, was initially driven by outcomes reported in the FES literature indicating 
that patients perceived the effects of FES to be broader and more numerous than an 
improvement in gait speed. There had been little focus on patient-centred outcomes 
in the literature, but one study that did report these suggested that patients felt their 
walking ‘required less effort, as they did not have to concentrate so much on their 
walking’. The idea that effort was affected by FES use had also been noted in two 
large questionnaire studies of patient perceptions, reporting that the most highly 
rated effect of FES use was a reduction in effort.  
Taking the view that ‘effort’ can be indicative of both physical and mental effort, the 
latter was subsequently explored within the framework of the interaction between the 
motor and cognitive neural processes involved in the control of gait. Through the 
process of exploration three studies were designed and implemented. The focus 
throughout was to keep the FES user at the centre of the process and explore effects 
expressed by the users. With this focus, the first study explored and gathered data 
concerning the effects of FES on concentration and secondary tasks when walking, 
via a questionnaire completed by established FES users. Outcomes from this study 
clearly indicated that FES users perceived walking with their device to require less 
concentration and that FES had a positive effect on the execution of other tasks 
whilst walking e.g. talking. 
These results supported the concept of a contribution of FES to the cognitive control 
of gait and provided sufficient confidence to implement further exploration of this 
main aim of the thesis via a dual-task study. This novel approach proved to be the 
first reported dual-task study of FES for foot drop following stroke, and was applied in 
187 
 
both a longitudinal and cross-sectional study design. Outcomes of these studies, 
whilst not conclusive, suggest that FES can reduce the motor-cognitive interference 
experienced during a dual-task situation. In addition, they indicate that the effects 
perceived by FES users can be quantified and there is merit in further studies to 
define this effect and broaden the outcome measures used to assess FES to reflect 
effects that are important to patients. 
6.1.2 Summary of each chapter  
Chapter 1 provided a brief introduction to the thesis. It presented a background to 
the work of the thesis, introducing the key issues. The limited FES literature focusing 
on patient-reported outcomes was introduced briefly, highlighting the possibility of an 
effect on motor-cognitive interference during gait. The small number of studies 
reporting this effect formed the basis of the main thesis aim which is explained. 
Finally, at the end of Chapter 1 an overview of the thesis was provided.  
A detailed literature review of the background to the thesis was provided in Chapter 
2. It began with an overview of the neuromuscular system, in the context of neural 
processes involved in the production and control of gait. The functional anatomy of 
the neuromuscular system was described, leading to a description of normal gait. 
Key current concepts concerning the contribution of higher level cognitive processes 
to the control of gait were then reviewed, with evidence from brain imaging studies 
and gait studies provided as support. There then followed an overview of stroke, 
covering incidence and the clinical features, with a focus on motor, sensory and 
cognitive effects. In particular, the effect of stroke on gait was described in detail, 
highlighting the subsequent high rate of falls post-stroke by a review of the relevant 
falls literature. The interaction between physical and cognitive impairments following 
stroke that affect gait were then discussed, concluding with a brief review of the 
growing literature on dual-task studies which focus on outcomes assessing this 
interaction. FES was then introduced in the chapter, initially describing the device, 
including its mode of action at a local level to produce functional movement. The 
effect of FES at a central level on spinal mechanisms and cortical neuroplasticity is 
also reviewed based on emerging evidence. A detailed review of the FES literature 
that reports the effects of FES on gait and other outcomes was then presented, with 
a focus on gait measures associated with stability and linked with fall risk and on 
patient-reported outcomes. The chapter concluded with a critique of the mismatch 
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between patient-reported outcomes and those chosen by researchers when 
assessing the effect of FES, highlighting those most important to users from the small 
number of qualitative studies reported. This led finally to a discussion of the aim of 
the thesis; to explore the contribution of FES to the cognitive control of gait   
Chapter 3 focused on the first study undertaken to explore the thesis aim. It began 
with a brief review of the FES literature and the growing dual-task literature that was 
reported at the time of initiation of the thesis, in order to provide a context for 
development of the questionnaire study. At this time there were a limited number of 
FES studies reporting patient perceptions and there were a small number of dual-
task studies of stroke groups. Furthermore there were just a handful of studies using 
a dual-task approach to assess devices. Thus, there was a suggestion from the 
literature that a dual-task design would facilitate investigation of patient-reported FES 
effects on concentration and effort. The limited evidence initiated a decision to firstly 
use a questionnaire to explore these reported effects of FES and to provide some 
evidence to support a subsequent dual-task study. The process of formulation of the 
questionnaire content and design was explained. Whilst existing FES and AFO 
literature was used, informal discussions with FES users in particular initiated 
formulation of the question concerning the effect of FES on secondary tasks 
associated with effort of walking. A secondary aim of this study was to inform the 
choice of task in the subsequent dual-task study. Thus, the available dual-task 
literature was mapped against statements, expressed in everyday language, used in 
the questionnaire content. Attention was paid to the structure and design of the 
questionnaire, to encourage responses and to facilitate statistical analysis. In 
addition, the questions devised were simple, unambiguous and not too long. The 
questionnaire was piloted and then finalised before being posted to a group of FES 
users attending an FES clinical service in Salisbury, UK.   
Results from the questionnaire study were reported in Chapter 3 with confidence due 
to a response rate and results that were in agreement with previous studies. The FES 
users in this study placed a high importance on the effect FES had on reducing effort, 
improving the quality of their gait and their increased confidence and independence. 
The reduction in the perceived amount of concentration required to walk with FES 
was statistically significant. Furthermore, the respondents recognised that FES had 
an effect on the execution of secondary tasks whilst walking. In agreement with the 
result for perceived concentration, the majority of respondents felt that FES made it 
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easier to ‘walk without thinking about walking’. Thus, the study provided patient-
reported evidence of the effect of FES on reducing the cognitive load of gait in this 
post-stroke group, which was sufficient to support further exploration of this effect in 
the thesis. In addition, the study results gave an indication of the type of task that 
would be appropriate for use in a dual-task study of FES users. This was taken 
forward to the process of task selection that was a key factor in the design of the 
study. 
The first dual-task study is reported in this thesis in Chapter 4. The study design and 
subsequent piloting work were key issues covered in this chapter. The study was 
conceptualised as a longitudinal repeated measures design, recruiting new FES 
users, with the aim of exploring motor-cognitive interference over time. Choice of 
cognitive task was a key factor in this study, leading to a review of the dual-task 
literature which revealed a lack of standardisation of task amongst reported studies, 
including those of stroke groups. The majority of tasks previously used in dual-task 
methodologies have required the participant to verbally respond whilst walking, thus 
introducing a further motor component to the motor-cognitive interference assessed. 
This important point had been addressed in one study of a stroke group by 
application of a memory task that required a response after walking was complete 
(Hyndman et al., 2006). This point was one of the drivers for choice of a suitable task. 
Further points that informed this process were the outcome of the Chapter 3 study 
which concluded that FES users would respond to a task that required them to walk 
without thinking about walking and/or look around whilst walking, the ability to 
measure the outcomes of the cognitive task as a primary outcome concurrently with 
gait speed and the feasibility of application of the task whilst walking. These points 
led to an exploration of existing neuropsychological tests to inform the development 
of two new tasks, which had their basis in validated recognition memory tests and 
used verbal and visual input. The tasks tested short-term recognition memory and 
were used in pilot work to finalise the protocol, focusing on the best mode of delivery 
for the cognitive task, feasibility of the protocol and safety of the participants. After 
considering several options for delivery of the memory tasks, a format that fixed the 
duration and number of targets delivered was chosen for use in a laboratory of fixed 
length. Pilot work showed that the protocol, including the collection of other 
measures, was safe and feasible. Issues raised during this work concerning 
participant fatigue identified that using one task would be less burdensome. The 
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visual task was chosen to take forward to the final protocol as it satisfied the effects 
of FES as identified by the questionnaire outcomes (i.e. a task that created a 
distraction from the perceived thinking associated with walking and from looking at 
the walking surface whilst walking) and during piloting there were no problems 
experienced with application of the visual task whilst walking, in contrast to the verbal 
task. 
The study conducted in Chapter 4 suffered from recruitment difficulties, despite 
several attempts to address the issue. The results for the participants recruited were 
analysed showing that under dual-task conditions, using the visual task, FES users 
showed evidence of motor-cognitive interference in a reduction in gait speed and 
visual task performance. Furthermore, FES appeared to have reduced the effect of 
this interference and the responses to the questionnaire used in the study supported 
these primary outcome measures. Confidence in the protocol and the results 
obtained were key outcomes from this study that instigated further work to implement 
a further study to apply this novel and now tested methodology. This work was 
discussed in Chapter 5. 
In Chapter 5 a cross-sectional dual-task study was conducted of established users of 
FES. This group was both representative of the general FES user population and the 
respondents to the questionnaire study, reported in Chapter 3, who had clearly 
identified a positive effect of FES on concentration and dual-tasks. The study protocol 
was followed as in Chapter 4, with the primary aim of exploring the effect of FES on 
motor-cognitive interference, by collecting measures of gait speed and visual task 
performance. In addition, in this study the analysis of gait performance was extended 
to investigate how gait parameters that are reflective of gait stability and balance may 
be affected by FES and motor-cognitive interference. This further analysis was based 
on Chapter 3 results showing that FES users reported other effects of FES linked to 
the quality of their gait e.g. 80% agreed that their walking was more balanced and 
even. The primary outcomes of this study indicated that the visual task produced 
motor-cognitive interference during gait as both gait speed and task performance 
were reduced during the dual-task condition. FES did not have a measured effect on 
motor-cognitive interference; the effect of visual task on gait speed was not reduced 
by FES and visual task performance did not improve when walking with FES. This 
latter finding is in contrast to the effect of FES perceived by users, as evidenced by 
the questionnaire results from this study and those reported in Chapter 3.  
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Analysis of other gait parameters in Chapter 5 revealed that FES reduced stance 
time on the paretic leg under dual-task. Even though this was a small change of 3% 
of the percentage of the gait cycle it was statistically significant (p=0.044), providing 
evidence that FES reduced the effect of motor-cognitive interference for this gait 
parameter. In addition, although not statistically significant (p=0.51), FES also 
reduced double support time during dual-task by 4% of the gait cycle, thus 
suggesting that FES had a positive effect on balance under circumstances of motor-
cognitive interference. Sub-analysis of the questionnaire results when compared with 
the primary outcome measures, indicated inconsistency in agreement between these 
outcomes for some participants. Conclusions drawn from this analysis suggests that 
variation in the primary outcome results masked the group effect. 
6.2 Limitations and future work 
In this section the limitations of the thesis work are discussed and proposals to 
address them are offered to build on the outcomes of this exploratory work.  
Interpretation of the results from the questionnaire study, reported in Chapter 3, 
should be approached with some cautions. Firstly, as with all self-administered 
questionnaires there was no guarantee that the questions were answered as 
requested. The careful ordering of the questions could have been negated by the 
respondent answering the questions in any order that they wished (Bowling, 2005). It 
is also possible that the person for whom the questionnaire was intended did not 
actually answer the questions. Secondly, some questions were omitted by 
respondents, even though the questions were structured to encourage completion 
and to allow for those respondents for whom each question did not apply. The results 
did include rates of non-completion for individual questions. Finally, there is the 
possibility of positively biased responses from respondents as the study had the co-
operation of the clinical service from which they received their care. However, in 
contrast to the two previous FES studies by Taylor et al (1999, 2004) the study was 
implemented by an organisation independent of this clinical service. It could be 
assumed that the possibility of positively biased responses may have been reduced. 
 
The longitudinal study reported in Chapter 4 suffered from recruitment difficulties and 
in hindsight may have been overly ambitious in the context of the absence of a well-
established local FES service. Future work to investigate the effect of FES on motor-
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cognitive with increasing use of FES would need to address this issue, perhaps via a 
recruitment from large well-established multiple clinical services over several years. It 
was concluded that the cross-sectional study outcomes, reported in Chapter 5, were 
affected by the number of participants. Even though the thesis aim was exploratory, 
the conclusions drawn could have been strengthened by a larger number of 
participants. For future work the results from the cross-sectional study could now be 
used to calculate sample size. 
 
The improvement in gait speed, in the cross-sectional study, with FES compared with 
walking without FES was lower than in reported studies. It is difficult to define why 
this might have been the case as the inclusion and exclusion criteria were not 
restrictive. This result may limit the generalisation of the results to the broader FES 
user population. 
 
Future work with an aim of capturing gait parameters dependent upon number of 
steps (i.e. measures of variability) would need to take into consideration participants 
with faster gait speeds and the choice of length of walkway. In this study, the 
minimum number of steps required to calculate stride time variability resulted in 
inclusion of a smaller sub-group of the entire study group. It is possible that this may 
have compromised analysis of the data. Thus, to represent all FES users, including 
those with faster gait speeds, future dual-task studies would need to address the 
issue of capturing sufficient number of steps to calculate step-dependent parameters. 
 
Measures of changes in toe clearance and ankle joint angles were not collected in 
this thesis. It is of course possible that this data may have helped to identify the effect 
of FES on motor-cognitive interference and variation in responses to the dual-task. 
Future work could include these measures, and those associated with compensatory 
strategies for foot drop involving knee and hip motion, to explore the effect of FES 
under dual-task. Furthermore, the studies relied upon self-reported fall events data. 
Further work could include strengthening this aspect by inclusion of more robust 
measures of falls both retrospectively and prospectively, utilising validated methods 
from the falls literature.  
 
Whilst the visual task used in the dual-task studies was developed in the context of a 
critique of reported studies, outcomes from the questionnaire and existing 
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neuropsychological tests, it is possible that those participants who did not show 
evidence of motor-cognitive interference did not find that the task created a sufficient 
cognitive load. There is some indication of this from results for the task whilst seated, 
as there appeared to be a ceiling effect. To address this and reduce variation in 
group results there may be some merit in further work using an alternative task or a 
battery of several tasks to further explore and define the dual-task effect that is 
evident for a sub-group of FES users. The type and difficulty of task has been 
suggested as affecting different aspects of gait in stroke populations (Plummer-
D'Amato et al., 2008, Plummer-D'Amato and Altmann, 2012) and this could also be 
true of FES user groups. Thus, use of different tasks could be incorporated into a 
dual-task design to define these potential effects. It is recommended that tasks 
chosen for future work have a link with perceived effects reported by FES users.  
Finally, it is possible that a dual-task approach may provide a measurable difference 
between the effect of FES and AFOs that reflects user preference for FES. However, 
before this type of study is pursued the effect of FES on motor-cognitive interference 
needs to be more clearly defined. 
6.3 Conclusion 
The primary aim of the work presented in this thesis was to explore the contribution 
of FES to the cognitive control of gait. This was achieved initially via a questionnaire 
study of established FES users. Evidence of a positive effect of FES was provided by 
a significant reduction in the amount of concentration required when walking with 
FES and recognition of an effect on secondary tasks whilst walking. These results 
informed and provided confidence in the pursuit of a dual-task study to explore the 
effect of FES further. 
This thesis reports on the first dual-task study of FES users. This approach was 
established as feasible and safe for FES users via piloting work. Application of a 
dual-task study, to assess the effect of FES, was novel in several aspects. Firstly, 
whilst there have been a large number of dual-task studies reported, there are a 
much smaller number involving stroke groups and only a handful involving the 
assessment of device effects. Secondly, this study reported on both gait speed and 
visual task performance as primary outcome measures, in the context of the dual-
task literature where both are not consistently analysed. This required that the task 
be measurable as an indicator of motor-cognitive interference, bringing complexity to 
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the study design that was addressed. Finally, the visual recognition memory task 
which was developed for this thesis represents a task not requiring a verbal response 
whilst walking and thus avoiding the motor interference of articulation whilst walking. 
The use of a purely cognitive task was rare in the dual-task literature, as was the use 
of visual input. Thus, this visual task was novel in its design and application. 
The thesis achieved the overall aim of exploring the contribution of FES to the 
cognitive control of gait. Whilst not conclusive, results suggest that FES can reduce 
the motor-cognitive interference experienced during a dual-task situation and indicate 
that there is merit in further studies to define this effect. 
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FES Questionnaire 
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Questionnaire 
 
 
Section A : A few questions about you 
 
 
1) What is your sex? Please circle. 
 
Male 
 
Female 
 
 
 
2) What is your date of birth? ………………………………… 
 
 
 
3) When did you have your stroke? An approximate date or month and year is 
sufficient if you do not know an exact date e.g. May 2003. 
 
 
…………………………………………………………………………………….…. 
 
  
4) Does your stroke affect one side of your body more than the other side?      
    Please circle. 
 
Yes, the right 
 
Yes, the left No 
 
 
5) Please list in the space below any problems with your health or any disabilities? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please go to the section overleaf. 
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Section B : About your use of the stimulator (ODFS) 
 
1) Do you continue to use the stimulator? Please circle 
 
Yes 
 
Please continue 
No 
Please go to page 7. You are not 
required to answer any further 
questions 
 
2) How many days a week do you use the stimulator?…………………………... 
 
3) On the days that you use the stimulator, for how many hours do you usually    
    wear it?  
                 …….…………………………………. 
 
4) When do you use your stimulator? For each of the following activities, please tell 
us which answer applies to you, by placing a tick in one of the four columns.  
 
 I always 
do this 
with the 
stimulator 
I always 
do this 
without 
the 
stimulator 
I do this 
with and 
without 
the 
stimulator 
I don’t 
do this 
Walking around the home  
 
    
Walking indoors 
 
    
Walking outdoors 
 
    
Longer walks 
 
    
Day trips 
 
    
Shopping 
 
    
Social events 
 
    
At work or college 
 
    
Exercising 
 
    
Physiotherapy 
 
    
Please specify any other activities that you do with the stimulator. 
 
 
 
 
Please go to the next page. 
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Section C : About the effect of the stimulator 
 
1) What are you able to do when you use your stimulator? For each of the following 
statements, please answer by placing a tick in one column. 
 
 Agree Disagree Doesn’t 
apply 
I am able to walk further  
 
   
I am able to walk faster 
 
   
It is less effort for me to walk  
 
   
I am less likely to trip and fall 
 
   
I am more able to walk on uneven ground 
 
   
I feel more confident when I walk 
 
   
I am more independent 
 
   
I am able to exercise more 
 
   
I need to use my stick, crutches or frame 
less often 
   
I am able to walk without assistance from 
another person more often 
   
My posture is better 
 
   
My walking is more balanced and even 
 
   
I am able to walk more safely 
 
   
Please specify any other effects of using the stimulator 
 
 
 
 
 
 
 
2) Of the statements that you have just agreed with, which one is the most 
important reason for using the stimulator? 
 
Please circle the statement on the above list. 
 
 
Please go to the questions overleaf. 
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3) Do you use other walking aids when walking with and without the stimulator? For 
each item, please answer by placing a tick in the columns that apply to you. 
 
 With the 
stimulator 
Without the 
stimulator 
 
Don’t use at all 
Walking stick   
 
 
Walking tripod   
 
 
Walking frame   
 
 
Crutches   
 
 
AFO, leg splint or 
calliper 
   
Assistance from 
another person 
   
Please specify 
any other walking 
aids that you use 
 
 
   
 
 
 
4) How much concentration do you have to use when walking? For each situation, 
please place a tick in the one column that corresponds to your experience. 
 
 
 None 
 
Some A lot 
With the 
stimulator 
 
 
 
  
Without the 
stimulator 
 
 
 
  
 
 
 
 
 
 
 
 
 
Please go to the next page. 
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5) Is there a difference to your walking when you use the stimulator? Please 
complete each of the following statements, by placing a tick in one column. 
 
 easier 
than 
without 
the 
stimulator 
the same 
as 
without 
the 
stimulator 
harder 
than 
without 
the 
stimulator 
When I use the stimulator, I find talking 
to someone whilst I walk……….. 
 
   
When I use the stimulator, I find thinking 
about something else whilst I walk….. 
 
   
When I use the stimulator, I find 
stepping up onto a kerb…………… 
 
   
When I use the stimulator, I find looking 
at the things around me when I walk…. 
 
   
When I use the stimulator, I find walking 
on uneven ground……. 
 
   
When I use the stimulator, I find walking 
without looking at the ground….. 
 
   
When I use the stimulator, I find walking 
in a noisy environment…… 
 
   
When I use the stimulator, I find 
avoiding a trip or a fall whilst I walk ……  
 
   
When I use the stimulator, I find 
answering questions whilst I walk…… 
 
   
When I use the stimulator, I find walking 
without thinking about walking…….. 
 
   
 
 
6) Which of the statements, that you have just agreed are easier with the 
stimulator, is the one that is most important to you? 
 
Please circle one statement on the above list. 
 
 
 
 
Please go to the section overleaf. 
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Section D : About your stimulator 
 
 
1) When did you first start to use the stimulator? An approximate date or month and 
year is sufficient if you do not know an exact date e.g. May 2003. 
 
………………………………………………………………………………… 
 
2) If you also use a splint, what type of splint do you use? Please circle the photo or 
description that most closely resembles your splint. 
 
 
          
 
  Hinged AFO            Supralite AFO             AFO                       Aircast   
  ankle brace 
 
 
                         
         
                 Speed brace               Foot-up 
 
 
3) If you also use a splint, which of the following has helped you to walk with the 
least effort? Please circle  
 
Stimulator 
 
Splint 
 
 
Please go to the next page. 
 
 
2.1No
ne 
of 
these 
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Thank you for taking the time to complete this 
questionnaire. 
 
Please use the space below to tell us about any further thoughts or comments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please use the stamped, addressed envelope to return to :- 
 
Jane McAdam – PhD Student 
C/- Dr. L.P.J. Kenney 
Research Fellow 
Centre for Rehabilitation and Human Performance Research 
Brian Blatchford Building 
University of Salford  
Salford M6 6PU 
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Ethical and Research and Development Approvals 
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Appendix Section A.3 
 
Participant Invitation Letter 
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             Centre for Rehabilitation and  
             Human Performance Research 
             The University of Salford 
             Brian Blatchford Building 
             Salford. M6 6PU 
 
 
  
July 2005  
 
Dear Sir/Madam 
 
 
RE : Study Title : An investigation into usage patterns, user perceptions and effects 
on effort of two orthotic devices. 
 
 
I believe that you have received a drop foot stimulator from the Department of 
Medical Physics and Biomedical Engineering at Salisbury Hospital. My name is Jane 
McAdam and I work in collaboration with Dr Paul Taylor from the Salisbury 
department. 
 
I would like to invite you to take part in a research study. This study fulfils part of the 
requirements for completion of my PhD. 
 
Before you decide to take part, it is important for you to understand why the research 
is being done and what it will involve. Please take time to read the enclosed 
information leaflet carefully and discuss it with others if you wish.  
 
You are welcome to contact myself or Paul Taylor if anything is not clear or if you 
would like more information. Our contact details are at the end of this letter. Please 
take some time to decide whether or not you wish to take part. 
  
 
Thanking you. 
 
 
Jane McAdam – PhD Student                       Dr Paul Taylor 
Clinical Specialist Podiatrist                          Principle Clinical Engineer  
C/- Dr. L.P.J. Kenney                                    Department of Medical Physics and               
Research Fellow                                           Biomedical Engineering 
Centre for Rehabilitation and                        Salisbury District Hospital 
Human Performance Research                    Wiltshire SP2 8BJ 
Brian Blatchford Building 
University of Salford                                      Ph : 01722 429 065 
Salford                                                           Email : p.taylor@mpbe-sdh.demon.co.uk 
Manchester M6 PU 
 
Ph : c/- 0161 206 4710  
Mobile :07715 005 843 
Email : Jane.McAdam@salford-pct.nhs.uk 
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Participant Information Sheet 
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             Centre for Rehabilitation and  
             Human Performance Research 
             The University of Salford 
             Brian Blatchford Building 
             Salford. M6 6PU 
 
 
  
 
July 2005 
  
INFORMATION LEAFLET 
 
 
Name of Researcher : Jane McAdam 
 
Study Title : An investigation into usage patterns, user perceptions and effects  
         on effort of two orthotic devices. 
 
 
What is the purpose of the study? 
 
This study is being conducted to clarify our understanding of the effectiveness of 
orthoses for patients like yourself. In particular, we would like to find out about your 
views on your orthosis and the ways in which you feel that it affects your function. In 
the longer term, we hope that the results from this study will help to inform clinical 
practice 
 
 
Why have I been chosen? 
 
I am sending this letter to all patients who have problems with walking as a result of a 
stroke, and received a single channel Odstock Dropped Foot Stimulator from the 
Department of Medical Physics and Biomedical Engineering at Salisbury District 
Hospital, between and including July 2002 to June 2004. This letter is being sent to 
approximately 120 patients.  
 
 
Do I have to take part? 
 
It is up to you to decide whether or not to take part. You do not have to give a reason 
for not taking part.  A decision not to take part will not affect the standard of care that 
you receive. 
 
 
What do I have to do? 
 
To take part in the study, you are asked to complete the enclosed consent form and 
questionnaire and return it in the enclosed addressed envelope. If a reply has not 
been received from you after 4 weeks, another questionnaire will be sent to you, to 
give you another opportunity to take part. 
 
Please read the information over the page. 
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What are the benefits of taking part? 
 
The information that is obtained from this study may help to provide better treatment 
for stroke patients in the future.  
 
 
Will my taking part in this study be kept confidential? 
 
All information that is collected about you will be kept strictly confidential. The 
questionnaire is anonymous and will be separated from the consent form upon 
receipt. 
 
 
What will happen to the results of the research study? 
 
I hope to present the results of this study at a conference in September 2005. The 
results of this study will help to inform a further study for completion of my PhD.  
 
You are welcome to contact me if you would like a copy of the results of this study 
when they are available. 
 
 
Who is organising the research? 
 
This research is organised through the University of Salford. 
 
 
Who has reviewed this study? 
 
Salford University and the Salford and Trafford Research Ethics Committee have 
reviewed this study. 
 
 
 
 
 
Thank you for taking the time to read this.  
 
If you are willing to take part in this study please complete the enclosed 
consent form and questionnaire and use the addressed envelope to return it to 
me.  
 
You are welcome to keep this information sheet. 
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Letter from Salisbury FES service 
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                                         Salisbury Health Care  
                                                 NHS Trust 
                              
                                        Department of Medical Physics and Biomedical Engineering 
Salisbury District Hospital 
Salisbury 
Wiltshire 
SP2 8BJ 
Tel: 01722 429 065 
E-mail: p.taylor@mpbe-sdh.demon.co.uk 
 
July 2005 
 
 
Dear Sir/Madam 
 
The Department of Medical Physics and Biomedical Engineering has been asked to 
assist researchers at the University of Salford with a research project.  The project 
aims to find out how the ODFS is used and how it affects the way users of the device 
live their life.  This information will be used to help future developments. 
 
Please read the enclosed information carefully.  If you wish to take part in the study, 
please complete the enclosed questionnaire and consent form, and return it in the 
stamped addressed envelope.  Participation is entirely voluntary and if you do not 
take part it will not affect in any way the treatment you receive from Salisbury District 
Hospital. 
 
Please be assured that no confidential information about you has been released to 
researchers outside Salisbury District Hospital.  All questionnaires are anonymous. 
 
If you have any questions please feel free to contact myself or Jane McAdam at 
Salford University. 
 
Thank you. 
 
Yours sincerely 
 
 
 
 
Paul Taylor 
Clinical Engineer 
Co-ordinator of FES research and clinical service 
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Appendix Section B.1 
 
FES Questionnaire 
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Questionnaire 
 
 
Section A : About your use of the stimulator (ODFS) 
 
1) When do you use your stimulator? For each of the following activities, please tell 
us which answer applies to you, by placing a tick in one of the four columns.  
 
 I always 
do this 
with the 
stimulator 
I always 
do this 
without 
the 
stimulator 
I do this 
with and 
without 
the 
stimulator 
I don’t 
do this 
Walking around the home  
 
    
Walking indoors 
 
    
Walking outdoors 
 
    
Longer walks 
 
    
Day trips 
 
    
Shopping 
 
    
Social events 
 
    
At work or college 
 
    
Exercising 
 
    
Physiotherapy 
 
    
Please specify any other activities that you do with the stimulator. 
 
 
 
 
 
 
 
 
 
 
Please go to the next page. 
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Section B : About the effect of the stimulator 
 
1) What are you able to do when you use your stimulator? For each of the following 
statements, please answer by placing a tick in one column. 
 
 Agree Disagree Doesn’t 
apply 
I am able to walk further  
 
   
I am able to walk faster 
 
   
It is less effort for me to walk  
 
   
I am less likely to trip and fall 
 
   
I am more able to walk on uneven ground 
 
   
I feel more confident when I walk 
 
   
I am more independent 
 
   
I am able to exercise more 
 
   
I need to use my stick, crutches or frame 
less often 
   
I am able to walk without assistance from 
another person more often 
   
My posture is better 
 
   
My walking is more balanced and even 
 
   
I am able to walk more safely 
 
   
Please specify any other effects of using the stimulator 
 
 
 
 
 
 
2) Of the statements that you have just agreed with, which one is the most 
important reason for using the stimulator?  
Please circle one statement on the above list. 
 
Please go to the next page. 
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3) Do you use other walking aids when walking with and without the stimulator? For 
each item, please answer by placing a tick in the columns that apply to you. 
 
 With the 
stimulator 
Without the 
stimulator 
 
Don’t use at all 
Walking stick   
 
 
Walking tripod   
 
 
Walking frame   
 
 
Crutches   
 
 
AFO, leg splint or 
calliper 
   
Assistance from 
another person 
   
Please specify 
any other walking 
aids that you use 
 
 
   
 
 
 
4) How much concentration do you have to use when walking? For each situation, 
please place a tick in the one column that corresponds to your experience. 
 
 
 None 
 
Some A lot 
With the 
stimulator 
 
 
 
  
Without the 
stimulator 
 
 
 
  
 
 
 
 
 
 
Please go to the next page. 
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5) Is there a difference to your walking when you use the stimulator? Please 
complete each of the following statements, by placing a tick in one column. 
 
 easier 
than 
without 
the 
stimulator 
the same 
as 
without 
the 
stimulator 
harder 
than 
without 
the 
stimulator 
When I use the stimulator, I find talking 
to someone whilst I walk……….. 
 
   
When I use the stimulator, I find thinking 
about something else whilst I walk….. 
 
   
When I use the stimulator, I find 
stepping up onto a kerb…………… 
 
   
When I use the stimulator, I find looking 
at the things around me when I walk…. 
 
   
When I use the stimulator, I find walking 
on uneven ground……. 
 
   
When I use the stimulator, I find walking 
without looking at the ground….. 
 
   
When I use the stimulator, I find walking 
in a noisy environment…… 
 
   
When I use the stimulator, I find 
avoiding a trip or a fall whilst I walk ……  
 
   
When I use the stimulator, I find 
answering questions whilst I walk…… 
 
   
When I use the stimulator, I find walking 
without thinking about walking…….. 
 
   
 
 
6) Which of the statements, that you have just agreed are easier with the 
stimulator, is the one that is most important to you? 
 
Please circle one statement on the above list. 
 
Please go to the next page. 
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7) If you also use a splint, which of the following has helped you to walk with the 
least effort? Please circle  
 
 
Stimulator 
 
Splint 
 
 
 
Thank you for taking the time to complete this 
questionnaire. 
 
Please use the space below to tell us about any further thoughts or comments. 
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Appendix Section B.2 
 
Verbal recognition memory test 
 
 
 
Example of target words 
 
Event 
Does 
Ease 
Since 
Were 
Below 
Why 
Anyone 
Less 
Affirm 
 
 
Example of target words paired with foils 
 
Get                 Does 
Gone              Below 
Plea               Why 
Ease              Once 
Known           Less 
Were             Useful 
Anyone         Best 
Event            Same 
Affirm            Hardly 
Audit             Since 
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Appendix Section B.3 
 
Visual recognition memory test 
 
 
 
 
 
 
Example of paired figures 
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Appendix Section B.4  
 
Falls Efficacy Scale (FES) 
 
 
 
 
Participant ID _______________________ 
 
TINETTI`S FALLS EFFICACY SCALE 
 
On a scale of 1 to 10 how confident are you? 
 
  1 = extremely confident 
10 = having no confidence at all (or don’t even try) 
Questions Circle the best answer 
Most Confident  -------------------------------------------------- Least confident 
Taking a bath or 
shower? 
1          2          3          4           5           6          7          8          9         10 
Reaching into 
cupboards? 
1          2          3          4           5           6          7          8          9         10 
Preparing a meal  
(not requiring carrying  
heavy or hot objects) 
 
1          2          3          4           5           6          7          8          9         10 
Walking around the 
house? 
1          2          3          4           5           6          7          8          9         10 
Getting in/ out of 
bed? 
1          2          3          4           5           6          7          8          9         10 
Answering the door or 
telephone? 
1          2          3          4           5           6          7          8          9         10 
Getting in/out of a 
chair? 
1          2          3          4           5           6          7          8          9         10 
Getting dressed or 
undressed? 
1          2          3          4           5           6          7          8          9         10 
Doing light 
housekeeping? 
 
1          2          3          4           5           6          7          8          9         10 
Doing simple 
shopping? 
1          2          3          4           5           6          7          8          9         10 
Score          /100 3  
 
 
 
Completed by _________________________   ________________________________ 
                      (printed name)                               (signature) 
 
Date _______________________ 
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Appendix Section B.5 
 
Falls Risk Assessment Tool (FRAT) 
 
 
 Participant ID _______________________ 
 
 
 
FALLS RISK ASSESSMENT TOOL - FRAT 
 
 
A fall is  "an event which results in a person coming to rest unintentionally on 
the ground or other lower level, not as a result of a major intrinsic event (such 
as a stroke) or overwhelming hazard”. 
 
If there is a positive response to three or more of the questions on the form, then the 
person should be considered as being at high risk of falling in the future. 
 
 
 
(Nandy et al 2004,2005) 
 
 
 
Completed by ______________________________     Date________________ 
                       (printed name) 
       
Completed by ______________________________ 
                       (signature) 
 
  YES NO 
1 
 
 
Is there a history of any fall in the previous year? 
 
How assessed?  Ask the person. 
  
2 
 
 
Is the participant on four or more medications per day? 
 
How assessed?  Identify number of prescribed medications 
  
3 
 
 
Does the participant have a diagnosis of stroke or Parkinson’s 
Disease? 
 
How assessed?  Ask the person. 
  
4 
 
 
Does the participant report any problems with their balance? 
 
How assessed?  Ask the person. 
  
5 
 
 
Is the participant unable to rise from a chair of knee height? 
 
How assessed?  Ask the person to stand up, from a chair of knee 
height, without using their arms. 
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Appendix Section B.6 
 
Fall and near fall history 
 
  
Participant ID _______________________ 
 
FALL and NEAR FALL HISTORY 
 
During the last year has the participant experienced any falls or near falls? (record 
approximate date) 
 
 
 
 
For each event record the following (tick the appropriate box) 
 
Where did you fall/nearly fall?                                   EVENT  1 2 3 4 
Inside On the one level     
 Getting out of bed     
 Getting out of a chair     
 Using the shower/bath     
 Using the toilet     
 Walking up/down stairs     
Home entrances or garden On the one level     
 Walking up/down steps/stairs     
 In the garden     
Away from home On the footpath     
 On a kerb/gutter     
 In a public building     
 Getting out of a vehicle     
 In another person’s home     
Other 
 
     
How did you fall/nearly fall? Trip     
 Slip     
 Loss of balance     
 Legs gave way     
 Faint/dizzy     
 Lost concentration     
 Not sure     
Did you suffer any injuries? NO     
 Bruises     
 Cuts/grazes     
 Fracture (specify)     
 Other 
 
    
(adapted from Lord et al 2001) 
 
Completed by _________________________   ________________________________ 
                      (printed name)                               (signature) 
 
Date _______________________ 
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Appendix Section B.7 
 
National Adult Reading Test (NART) 
 
SECOND EDITION 
 
Word Card 
 
  
         CHORD                                                                    SUPERFLUOUS   
   
                      ACHE                                                                                          SIMILE     
 
          DEPOT                                                                                        BANAL    
  
          AISLE                                                                                    QUADRUPED    
 
          BOUQUET                                                                                  CELLIST    
 
          PSALM                                                                                       FACADE    
 
                     CAPON                                                                                        ZEALOT    
 
          DENY                                                                                          DRACHM    
 
          NAUSEA                                                                                    AEON    
 
          DEBT                                                                                          PLACEBO    
 
          COURTEOUS                                                                             ABSTEMIOUS    
 
           RAREFY                                                                                     DETENTE    
 
          EQUIVOCAL                                                                               IDYLL    
 
          NAÏVE                                                                                         PUERPERAL    
 
          CATACOMB                                                                               AVER    
 
          GAOLED                                                                                    GAUCHE    
  
          THYME                                                                                    TOPIARY    
 
          HEIR                                                                                           LEVIATHAN    
 
          RADIX                                                                                        BEATIFY    
 
          ASSIGNATE                                                                              PRELATE    
 
          HIATUS                                                                                      SIDEREAL    
 
          SUBTLE                                                                                     DEMESNE    
 
          PROCREATE                                                                            SYNCOPE    
 
          GIST                                                                                           LABILE    
 
          GOUGE                                                                                     CAMPANILE    
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Appendix Section B.8  
 
Digit Span Test 
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Appendix Section B.9 
 
Barthel Score 
 
Participant ID _______________________ 
 
Barthel score 
 
The Barthel score consists of 10 measures of daily functioning.  The person receives 
a score depending on how much help they need to do a task – the higher the total 
score (maximum = 20), the more independent the person. 
 
Bowels                       0   Incontinent 
                                   1   Occasional accident 
                                   2   Continent 
Bladder                       0   Incontinent/catheterised and unable to manage 
1   Occasional accident 
2   Continent 
Grooming                   0   Needs help 
                                   1   Independent for face/hair/teeth/shaving 
Toilet use                   0   Dependent 
                                   1   Needs some help 
                                   2   Independent  
Feeding                      0   Dependent 
                                   1   Needs help, e.g. cutting food, spreading butter 
                                   2   Independent in all actions 
Transfer (bed-chair)   0   Unable 
                                   1   Major help, can sit 
                                   2   Minor help (verbal or physical) 
                                   3   Independent 
Walking                      0   Unable 
                                   1   Independent in wheelchair 
                                   2   Walks with help of person (verbal or physical) 
                                   3   Independent (may use aid) 
Dressing                     0   Dependent 
                                   1   Needs help but does half 
                                   2   Independent 
Stairs                          0   Unable 
                                   1   Needs help (verbal/physical) 
                                   2   Independent 
Bathing                       0   Dependent 
                                   1   Independent 
Total  
 
                                       Mahoney FT, Barthel DW. Functional evaluation : Barthel index. Md State Med J 1965; 14; 61-65. 
 
 
Completed by _________________________   ________________________________ 
                      (printed name)                               (signature) 
 
Date _______________________ 
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Appendix Section B.10 
 
Ethical and Research and Development Approvals 
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Appendix Section B.11 
 
Ethical and Research and Development Approvals –  
 
Amendment 1 
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Appendix Section B.12 
 
Participant Invitation Letter 
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                 Centre for Rehabilitation &                            
                   Human Performance Research                                       
                   The University of Salford                   
                   Brian Blatchford Building                    
                   Salford. M6 6PU 
 
February 2010 
 
Dear Sir/Madam 
 
Study Title: The effect of FES on gait variability under dual-task conditions, in post-
stroke drop foot subjects.  
 
Your physiotherapist has identified you as someone who will shortly be receiving a 
Functional Electrical Stimulation (FES) device to help with your walking. As such I 
would like to invite you to take part in a research study. My name is Jane McAdam. I 
am a Podiatrist, working for Salford Community Health NHS Trust. I am also studying 
part-time to complete a PhD, at the University of Salford. This study will help me to 
complete my PhD. 
 
You have agreed with your physiotherapist, that your contact details can be 
forwarded to myself. I shall be contacting you within the next week to ask if you 
would be willing to participate. If, at this point, you decide not to take part in the 
study, I will not contact you again. This decision will have no impact on your ongoing 
care.   
 
To take part in the study, I would like to see you four times over the next 3-4 months, 
for a total of up to 9 hours. Before you decide to take part, it is important for you to 
understand why the research is being done and what would happen at each visit. 
Please take time to read the attached information leaflet carefully and discuss it with 
others if you wish.  
 
When we first speak to each other, I will ask you a few questions about your 
availability, discuss any questions that you may have and arrange a convenient time 
to visit you at home. If you would prefer, you can attend the University of Salford for 
this first visit. Your partner, family member or a friend can be present. 
 
You are welcome to contact me, before deciding to take part, if anything is not clear 
or if you would like more information. Please take some time to decide whether or not 
you wish to take part.  
 
Thanking you. 
 
 
Jane McAdam – Principal Podiatrist and PhD Student 
C/- Dr. L.P.J. Kenney, Senior Research Fellow 
Centre for Rehabilitation and Human Performance Research 
Brian Blatchford Building, University of Salford, Salford M6 6PU 
Ph: c/- 0161 206 4710 (Podiatry Department - Hope Hospital) 
c/- 0161 212 5500 (Podiatry Department – Salford Community Health NHS Trust) 
Mobile: 07715 005 843 
Email: Jane.McAdam@salford.nhs.uk 
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Appendix Section B.13 
 
Participant Information Sheet 
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Centre for Rehabilitation &                  
Human Performance Research                  
The University of Salford                  
Brian Blatchford Building 
Salford. M6 6PU 
February 2010 
 
  
PARTICIPANT INFORMATION LEAFLET 
 
Study Title:  The effect of FES on gait variability under dual-task conditions, in post-
stroke drop foot subjects. 
 
What is the purpose of the study? 
 
This study is being conducted to improve our understanding of the effectiveness of 
Functional Electrical Stimulation (FES) for people like you. In particular, we would like 
to find out how it affects your ability to do other things whilst you walk. We would also 
like to know its affect on your daily life and activities. In the longer term, we hope that 
the results from this study will help to improve clinical practice. 
 
Why have I been chosen? 
 
All people, who your physiotherapist provides with FES because of a drop foot 
following a stroke, are being invited to take part in this study. We hope to have about 
12 people in the study. 
 
Do I have to take part? 
 
You will receive the FES device, whether you take part in this study or not. 
 
It is up to you to decide to take part. I will describe the study and go through this 
information leaflet when we meet. I will ask you to sign a consent form to show that 
you have agreed to take part. You are free to withdraw at any time, during the study, 
without giving a reason and without any affect upon your normal care. 
 
You do not have to give a reason for not taking part.  A decision not to take part will 
not affect the care that you receive. 
 
What do I have to do? 
 
If you take part in this study, in addition to the normal appointments with your 
physiotherapist, you will be seen four times by myself. These additional sessions will 
be spaced over the course of 3-4 months. Each of these sessions will be for 
approximately 2½ hours.  
 
 
First session : As this study requires a time commitment from yourself, we wish to 
ensure that your time is not wasted. We will use this first session to make sure that 
the particular tests that we will use in the study are appropriate for you. In order to do 
this, you will be asked to carry out a memory test and to answer questions about your 
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health, medications and any current treatment. If you find it very difficult to follow the 
memory test, or if there is a particular issue with your health, your involvement with 
the study will stop at this point. Your physiotherapist will be advised and will continue 
to provide your care. This part of the session should take approximately 40 minutes.  
 
Alternatively, if you are able to follow the memory test and there are no issues with 
your health, you can continue with the study. You will then be asked questions about 
your stroke and some further tests will be performed. During these tests you will be 
asked to recognise words, repeat numbers and answer questions about the things 
that you are able to do. You will also be asked about any falls that you may have had 
during the past year. The sensation in your feet and legs will also be tested with a 
tuning fork and a flexible filament. This part of the session should take approximately 
30 minutes. 
 
Second session : Will be at the University of Salford and within a week of receiving 
your FES device.  You will be asked to repeat the memory test from the first session, 
whilst sitting and when walking with and without the FES device. For the walking 
trials you will be asked to bring a pair of shorts or three-quarter length trousers to 
wear. A private changing area will be provided and help whilst changing can be 
provided. Small reflective markers will be placed on your feet, ankles and torso with 
hypoallergenic tape. You will walk in front of cameras that will collect the movement 
of the markers but no video image from which you can be recognised will be 
recorded. You will be asked to walk several times and be given as much time as 
needed to rest in between walks. This session should take up to 2½ hours. 
 
Third session : Will be approximately 6 weeks after the second session, and again 
will be at the University. You will be asked to perform the same walking tests as 
before. You will also be asked to repeat the questionnaires about your activities, from 
the first session, and to repeat the test of your sensation. You will be asked about the 
effect of FES during your normal daily activities and if you have had any falls since 
the last session. This session should take up to 2½ hours. 
 
Fourth session : Will be approximately 8 weeks after the third session and, again, will 
be at the University. You will be asked to do the same tests that were done during 
the previous session and asked the same questions. This visit should take up to 2½ 
hours. At the end of this session, your involvement in the study will be complete.  
 
Will the cost of my travel be paid? 
The cost of travel to and from the University for yourself and a companion can be 
reimbursed. If you wish to travel by taxi, this can be arranged for you.  
 
What are the possible disadvantages and risks of taking part? 
It is possible that, whilst performing the walking tasks in the gait laboratory at Salford 
University, you may have an increased risk of falling. This may occur when walking 
without the FES switched on or during walking whilst performing the memory tasks. 
To minimise the risk of falling we will assess your ability to walk safely whilst 
performing the walking tasks. A member of the research team will walk with you 
whilst we assess your safety. If it is not safe for you to do these tests, we will not ask 
you to continue to be involved in the study. 
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It is possible that you may feel concerned about how well you do in some of the tests. 
You are welcome to discuss these concerns with myself and to talk about ways of 
coping with your feelings. 
At the end of a visit to the University it is possible that you may feel physically and 
mentally tired. You may wish to make sure that a companion travels home with you, 
or drives you home or that a taxi is organised for you, to ensure that you arrive home 
safely. 
 
What are the benefits of taking part? 
The information that is obtained from this study may help to provide better treatment 
for stroke patients in the future.  
 
 
What happens when the research study stops? 
You will continue to be cared for by your physiotherapist. He/she will be advised of 
when your involvement in the study is complete. 
 
What will happen if I don’t want to carry on with the study? 
You are free to withdraw at any time, without giving a reason and without any affect 
upon your normal care. The information that has been collected about you, up until 
the point that you withdraw, will be kept and used.  
 
What circumstances will stop my involvement in the study? 
 
At each visit you will be asked if there have been any changes in your health. There 
may be some changes that would stop you from taking any further part in the study. If 
this does occur, the reasons will be explained to you. 
 
If you are unable to attend the visits, they can be re-scheduled within a reasonable 
time period. If this is not possible, your involvement in the study may have to be 
stopped. 
 
If your participation in the study is stopped, the information that has been collected 
about you, up until this point, will be kept and used 
 
Will my taking part in this study be kept confidential? 
 
All information that is collected about you will be kept confidential. It will be stored 
securely and separated from your personal information. The information will be used 
for this study. It will be kept for 5 years, after completion of the study, for use in future 
studies, for which ethical approval would be sought. I would also like to keep your 
personal details for this time, to be able to contact you for further research studies. 
Again, any further research would be subject to ethical approval. When you are 
asked to agree to take part in this study, by signing the consent form, you will be 
asked if you agree to your contact details being retained for this purpose. 
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My supervisors will have access to the data collected but will not have access to your 
names and personal details. I will be the only person, involved in the study, who will 
have access to your personal details. 
 
When the results of this study are presented or published, your identity will remain 
confidential. Five years after completion of the study your personal details and data 
collected will be disposed of safely and securely. 
   
Involvement of other health care professionals. 
 
Your physiotherapist will be informed of your involvement in the study, and of when 
this is complete. 
 
I would wish to inform your GP of your participation in this study. When you are 
asked to agree to take part in this study, by signing the consent form, you will also be 
asked if you agree to your GP being informed. 
 
It may be necessary to contact your GP or consultant to clarify medical details of your 
stroke and of your current health, if it is difficult for you to provide this information. 
You will be asked to agree to this contact being made, when you are asked to sign 
the consent form. This information is used to describe you and compare you with 
other participants. 
 
If any problems with your health are highlighted during the course of the study, I will 
discuss this with you and agree how you would like it to be addressed. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to 
myself (details following). If you remain unhappy and wish to complain formally, you 
can do this by contacting my supervisor – Dr Laurence Kenney (details following). 
 
You are also able to contact the following people at Salford Primary Care Trust, St. 
James House, Pendleton Way, Salford, M6 5FW. 
Kath Ainsworth - Patient Advice and Liaison Service (PALS) - 0161-212 4832  
Kath Lever - Customer Care Manager – 0161 212 4862. 
 
In the event that something goes wrong and you are harmed during the study, there 
are no special compensation arrangements. If this harm is due to someone’s 
negligence, then you may have grounds for a legal action for compensation against 
the University of Salford, but you may have to pay your legal costs.  
 
What will happen to the results of the research study? 
 
A summary of the results of this study can be sent to you. I would also be happy to 
discuss these with you if you wish. 
 
The results of this study will be used to complete my PhD. I also hope to present 
them at appropriate conferences, as well as publish the results in peer reviewed 
journals. The results will be forwarded to voluntary and charity stroke organisations. 
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Who is organising the research? 
 
This research is organised through the University of Salford. 
 
Who has reviewed this study? 
 
The University of Salford has reviewed this study. It has also been reviewed by an 
independent group of people, called a Research Ethics Committee, who protect your 
safety, rights, wellbeing and dignity. This study has been given a favourable opinion 
by Stockport Research Ethics Committee. 
 
 
 
 
Further information 
 
You are welcome to discuss this study with your physiotherapist.  
 
You are welcome to contact my PhD supervisor if you have any further questions 
about this study, any concerns or are unhappy with any aspect of the study. His 
details are as follows:- 
Dr. L.P.J. Kenney, Senior Research Fellow 
Centre for Rehabilitation and Human Performance Research 
Brian Blatchford Building 
University of Salford                           ph : 0161 295 2289 
Salford M6 6PU                                  email : L.P.J.Kenney@salford.ac.uk 
 
Thank you for taking the time to read this.  
 
 
Please keep this information sheet. You will be given a signed copy of the 
consent form. 
 
 
 
Chief Investigator  
Jane McAdam – Principal Podiatrist and PhD Student 
C/- Dr. L.P.J. Kenney, Senior Research Fellow 
Centre for Rehabilitation and Human Performance Research 
Brian Blatchford Building, University of Salford  
Salford M6 6PU 
 
Ph: c/- 0161 206 4710 (Podiatry Department - Hope Hospital) 
c/- 0161 212 5500 (Podiatry Department – Salford Community Health NHS Trust) 
Mobile: 07715 005 843 
Email: Jane.McAdam@salford.nhs.uk 
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Appendix Section B.14 
 
Participant Invite Letter 
 
(FES provided by CI) 
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                 Centre for Rehabilitation &              
                   Human Performance Research 
                   The University of Salford                                       
                   Brian Blatchford Building                                                                         
                   Salford. M6 6PU 
February 2010 
 
Dear Sir/Madam 
 
Study Title: The effect of FES on gait variability under dual-task conditions, in post-
stroke drop foot subjects.  
 
Your physiotherapist has identified you as someone who is suitable for a Functional 
Electrical Stimulation (FES) device to help with your walking. The device will be 
provided for the duration of the study by the University of Salford as part of my 
research study. My name is Jane McAdam. I am a Podiatrist, working for Salford 
Community Health NHS Trust. I am also studying part-time to complete a PhD at the 
University of Salford. This study will help me to complete my PhD. 
 
If you are interested in receiving the FES device and taking part in this study, I will be 
contacting you, within a week to ten days of seeing your physiotherapist.  
   
To take part in the study, I will need to see you four times over the next 3-4 months, 
for a total of up to 9 hours. Before you decide to take part in this study, it is important 
for you to understand why the research is being done and what would happen at 
each visit. Please take time to read the attached information leaflet carefully and 
discuss it with others if you wish.  
 
When we first speak to each other, I will ask you a few questions about your 
availability, discuss any questions that you may have and arrange a convenient time 
to visit you at home. If you would prefer, you can attend the University of Salford for 
this first visit. Your partner, family member or a friend can be present. 
 
You are welcome to contact me, before deciding to take part, if anything is not clear 
or if you would like more information. Please take some time to decide whether or not 
you wish to take part.  
 
Thanking you. 
 
 
Jane McAdam – Principal Podiatrist and PhD Student 
C/- Dr. L.P.J. Kenney, Senior Research Fellow 
Centre for Rehabilitation and Human Performance Research 
Brian Blatchford Building, University of Salford  
Salford M6 6PU 
Ph: c/- 0161 206 4710 (Podiatry Department - Hope Hospital) 
c/- 0161 212 5500 (Podiatry Department – Salford Community Health NHS Trust) 
Mobile: 07715 005 843 
Email: Jane.McAdam@salford.nhs.uk 
 
 
 
 
251 
 
 
Appendix Section B.15 
 
Participant Information Sheet 
 
(FES provided by CI) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
252 
 
 
                 
Centre for Rehabilitation &                  
Human Performance Research                  
The University of Salford                  
Brian Blatchford Building 
Salford. M6 6PU 
February 2010 
 
  
PARTICIPANT INFORMATION LEAFLET 
 
Study Title:  The effect of FES on gait variability under dual-task conditions, in post-
stroke drop foot subjects. 
 
What is the purpose of the study? 
 
This study is being conducted to improve our understanding of the effectiveness of 
Functional Electrical Stimulation (FES) for people like you. In particular, we would like 
to find out how it affects your ability to do other things whilst you walk. We would also 
like to know its effect on your daily life and activities. In the longer term, we hope that 
the results from this study will help to improve clinical practice. 
 
Why have I been chosen? 
 
All people, who your physiotherapist assesses as suitable to use an FES because of 
a drop foot following a stroke, will be invited to take part in this study. We hope to 
have about 12 people in the study. 
 
Do I have to take part? 
 
You will receive the FES device for the duration of your participation in this study. 
 
It is up to you to decide to take part. I will describe the study and go through this 
information leaflet when we meet. I will ask you to sign a consent form to show that 
you have agreed to take part. You are free to withdraw at any time, during the study, 
without giving a reason and without any affect upon your normal care. 
 
You do not have to give a reason for not taking part.  A decision not to take part will 
not affect the care that you receive. 
 
What do I have to do? 
 
If you take part in this study, in addition to the normal appointments with your 
physiotherapist, you will be seen four times by myself. These additional sessions will 
be spaced over the course of 3-4 months. Each of these sessions will be for 
approximately 2½ hours.  
 
First session : As this study requires a time commitment from yourself, we wish to 
ensure that your time is not wasted. We will use this first session to make sure that 
the particular tests that we will use in the study are appropriate for you. In order to do 
this, you will be asked to carry out a memory test and to answer questions about your 
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health, medications and any current treatment. If you find it very difficult to follow the 
memory test, or if there is a particular issue with your health, your involvement with 
the study will stop at this point. Your physiotherapist will be advised and will continue 
to provide your care. This part of the session should take approximately 40 minutes.  
 
Alternatively, if you are able to follow the memory test and there are no issues with 
your health, you can continue with the study. You will then be asked questions about 
your stroke and some further tests will be performed. During these tests you will be 
asked to recognise words, repeat numbers and answer questions about the things 
that you are able to do. You will also be asked about any falls that you may have had 
during the past year. The sensation in your feet and legs will also be tested with a 
tuning fork and a flexible filament. This part of the session should take approximately 
30 minutes. 
 
Second session : Will be at the University of Salford and within a week of receiving 
your FES device.  You will be asked to repeat the memory test from the first session, 
whilst sitting and when walking with and without the FES device. For the walking 
trials you will be asked to bring a pair of shorts or three-quarter length trousers to 
wear. A private changing area will be provided and help whilst changing can be 
provided. Small reflective markers will be placed on your feet, ankles and torso with 
hypoallergenic tape. You will walk in front of cameras that will collect the movement 
of the markers but no video image from which you can be recognised will be 
recorded. You will be asked to walk several times and be given as much time as 
needed to rest in between walks. This session should take up to 2½ hours. 
 
Third session : Will be approximately 6 weeks after the second session, and again 
will be at the University. You will be asked to perform the same walking tests as 
before. You will also be asked to repeat the questionnaires about your activities, from 
the first session, and to repeat the test of your sensation. You will be asked about the 
effect of FES during your normal daily activities and if you have had any falls since 
the last session. This session should take up to 2½ hours. 
 
Fourth session : Will be approximately 8 weeks after the third session and, again, will 
be at the University. You will be asked to do the same tests that were done during 
the previous session and asked the same questions. This visit should take up to 2½ 
hours. At the end of this session, your involvement in the study will be complete and 
you will be required to return your FES device to the researcher. 
 
Will the cost of my travel be paid? 
The cost of travel to and from the University for yourself and a companion can be 
reimbursed. If you wish to travel by taxi, this can be arranged for you.  
 
What are the possible disadvantages and risks of taking part? 
It is possible that, whilst performing the walking tasks in the gait laboratory at Salford 
University, you may have an increased risk of falling. This may occur when walking 
without the FES switched on or during walking whilst performing the memory tasks. 
To minimise the risk of falling we will assess your ability to walk safely whilst 
performing the walking tasks. A member of the research team will walk with you 
whilst we assess your safety. If it is not safe for you to do these tests, we will not ask 
you to continue to be involved in the study. 
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It is possible that you may feel concerned about how well you do in some of the tests. 
You are welcome to discuss these concerns with myself and to talk about ways of 
coping with your feelings. 
At the end of a visit to the University it is possible that you may feel physically and 
mentally tired. You may wish to make sure that a companion travels home with you, 
or drives you home or that a taxi is organised for you, to ensure that you arrive home 
safely. 
 
What are the benefits of taking part? 
The information that is obtained from this study may help to provide better treatment 
for stroke patients in the future.  
 
 
What happens when the research study stops? 
You will continue to be cared for by your physiotherapist. He/she will be advised of 
when your involvement in the study is complete. 
You will be contacted by your physiotherapist to discuss further use of the device on 
a private or NHS- funded basis. As the device used in the study is owned by the 
University, not the NHS, you will be required to return the FES device supplied by the 
chief investigator at the completion of the study.   
 
What will happen if I don’t want to carry on with the study? 
You are free to withdraw at any time, without giving a reason and without any affect 
upon your normal care. The information that has been collected about you, up until 
the point that you withdraw, will be kept and used. You will be required to return the 
FES device.  
 
What circumstances will stop my involvement in the study? 
 
At each visit you will be asked if there have been any changes in your health. There 
may be some changes that would stop you from taking any further part in the study. If 
this does occur, the reasons will be explained to you. 
 
If you are unable to attend the visits, they can be re-scheduled within a reasonable 
time period. If this is not possible, your involvement in the study may have to be 
stopped. 
 
If your participation in the study is stopped, the information that has been collected 
about you, up until this point, will be kept and used. As the FES device is owned by 
the University, not the NHS, you will be required to return the FES device. 
 
Will my taking part in this study be kept confidential? 
 
All information that is collected about you will be kept confidential. It will be stored 
securely and separated from your personal information. The information will be used 
for this study. It will be kept for 5 years, after completion of the study, for use in future 
studies, for which ethical approval would be sought. I would also like to keep your 
personal details for this time, to be able to contact you for further research studies. 
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Again, any further research would be subject to ethical approval. When you are 
asked to agree to take part in this study, by signing the consent form, you will be 
asked if you agree to your contact details being retained for this purpose. 
 
My supervisors will have access to the data collected but will not have access to your 
names and personal details. I will be the only person, involved in the study, who will 
have access to your personal details. 
 
When the results of this study are presented or published, your identity will remain 
confidential. Five years after completion of the study your personal details and data 
collected will be disposed of safely and securely. 
   
Involvement of other health care professionals. 
 
Your physiotherapist will be informed of your involvement in the study, and of when 
this is complete. 
 
I would wish to inform your GP of your participation in this study. When you are 
asked to agree to take part in this study, by signing the consent form, you will also be 
asked if you agree to your GP being informed. 
 
It may be necessary to contact your GP or consultant to clarify medical details of your 
stroke and of your current health, if it is difficult for you to provide this information. 
You will be asked to agree to this contact being made, when you are asked to sign 
the consent form. This information is used to describe you and compare you with 
other participants. 
 
If any problems with your health are highlighted during the course of the study, I will 
discuss this with you and agree how you would like it to be addressed. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to 
myself (details following). If you remain unhappy and wish to complain formally, you 
can do this by contacting my supervisor – Dr Laurence Kenney (details following). 
 
You are also able to contact the following people at Salford Primary Care Trust, St. 
James House, Pendleton Way, Salford, M6 5FW. 
Kath Ainsworth - Patient Advice and Liaison Service (PALS) - 0161-212 4832  
Kath Lever - Customer Care Manager – 0161 212 4862. 
 
In the event that something goes wrong and you are harmed during the study, there 
are no special compensation arrangements. If this harm is due to someone’s 
negligence, then you may have grounds for a legal action for compensation against 
the University of Salford, but you may have to pay your legal costs.  
 
What will happen to the results of the research study? 
 
A summary of the results of this study can be sent to you. I would also be happy to 
discuss these with you if you wish. 
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The results of this study will be used to complete my PhD. I also hope to present 
them at appropriate conferences, as well as publish the results in peer reviewed 
journals. The results will be forwarded to voluntary and charity stroke organisations. 
   
Who is organising the research? 
 
This research is organised through the University of Salford. 
 
Who has reviewed this study? 
 
The University of Salford has reviewed this study. It has also been reviewed by an 
independent group of people, called a Research Ethics Committee, who protect your 
safety, rights, wellbeing and dignity. This study has been given a favourable opinion 
by Stockport Research Ethics Committee. 
 
 
 
Further information 
 
You are welcome to discuss this study with your physiotherapist.  
 
You are welcome to contact my PhD supervisor if you have any further questions 
about this study, any concerns or are unhappy with any aspect of the study. His 
details are as follows:- 
Dr. L.P.J. Kenney, Senior Research Fellow 
Centre for Rehabilitation and Human Performance Research 
Brian Blatchford Building 
University of Salford                           ph : 0161 295 2289 
Salford M6 6PU                                  email : L.P.J.Kenney@salford.ac.uk 
 
Thank you for taking the time to read this.  
 
 
Please keep this information sheet. You will be given a signed copy of the 
consent form. 
 
 
 
 
 
Chief Investigator  
Jane McAdam – Principal Podiatrist and PhD Student 
C/- Dr. L.P.J. Kenney, Senior Research Fellow 
Centre for Rehabilitation and Human Performance Research 
Brian Blatchford Building, University of Salford  
Salford M6 6PU 
 
Ph: c/- 0161 206 4710 (Podiatry Department - Hope Hospital) 
c/- 0161 212 5500 (Podiatry Department – Salford Community Health NHS Trust) 
Mobile: 07715 005 843 
Email: Jane.McAdam@salford.nhs.uk 
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Centre for Rehabilitation &                          
Human Performance Research                          
The University of Salford                          
Brian Blatchford Building 
Salford. M6 6PU 
 
CONSENT FORM 
 
Study Title: The effect of FES on gait variability under dual-task conditions, in post-
stroke drop foot subjects.  
 
Name of Chief Investigator: Jane McAdam 
 
Please read each of these statements. Please initial in the box at the end of the 
statements with which you agree. 
 
1. I confirm that I have read and understand the information leaflet dated October 
2008 (Version 2) for the above study and have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily.                                                                                                            
                                                                                                                                   
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time without giving any reason, without my medical care or legal rights being 
affected.  
 
3. I understand that if I withdraw from the study or if my involvement is stopped by 
the researcher, the information that has been collected about me, up until my point of 
withdrawal, will be kept and used in the analysis of the study.  
                                                     
4. I agree to my GP being informed of my participation in the study. 
5. I agree to my GP or named consultant being contacted for further information 
about my health and past medical history.                                      
 
6. I agree to take part in the above study.                                                         
 
7. I agree to my personal contact details being retained by the chief investigator, for a 
period of 5 years after completion of this study, for use in future studies that would be 
subject to ethical approval. 
                                                                
 
…………………………………  ………………………                       …….…………………….. 
Name of participant                  Date                                            Signature 
 
…………………………..……     ………..…………...                     ………………………….. 
Name of person                        Date                                            Signature 
taking consent 
 
(1 copy for participant and 1 copy for chief investigator’s file) 
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                                                                                                            Centre for Rehabilitation &                          
                                                                                                                        Human Performance Research 
                                                                                                                        The University of Salford                   
                                                                                                                        Brian Blatchford Building                   
                                                                                                                        Salford. M6 6PU 
 
 
Date 
 
 
GP/Health professional 
 
 
Dear  
 
RE : ………………………………… 
 
As you may know, the above mentioned patient has recently been assessed for 
provision of FES to improve their gait following a stroke. Their treating 
physiotherapist has forwarded their contact details to me, as a possible participant in 
a study. Upon recent successful screening for inclusion in the study, your patient has 
agreed to take part. 
 
The study will assess the effectiveness of FES using a dual-task methodology during 
gait laboratory studies to measure gait parameters. The measures will be taken on 
three occasions – at baseline, at six weeks and at a further eight weeks. The study 
will not require the patient to change any aspect of their current care. 
 
The study has been approved by Stockport Research Ethics Committee – REC Ref 
No. 08/H1012/80. 
Study title: The effect of FES on gait variability under dual-task conditions, in post-
stroke drop foot subjects.  
 
 
I hope that this information is of benefit to you. 
 
 
Yours sincerely, 
 
 
 
Jane McAdam 
PhD Student  
Principal Podiatrist – Salford Community Health 
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                                                                                                                                                  FES Clinic  
                                                                                          Mobility and Specialised Rehabilitation Centre 
Northern General Hospital, Herries Rd, Sheffield S5 7AU 
Tel:  0114 271 5577 
Date:                                                                                                    Fax: 0114 243 1646 
 
Dear  
 
The clinical staff, at the FES Clinic, have been asked to assist the University of 
Salford with a research study. The study is being conducted to improve 
understanding of the benefits of Functional Electrical Stimulation (FES) for people 
like you.  
 
We have identified you as someone who may be suitable to take part in the study 
and we would like to invite you to take part. The information that is needed for the 
study would be collected from you at the same time as your clinical review, which is 
due soon. Please take time to read the enclosed information leaflet carefully and 
discuss the study with others if you wish. Before you decide to take part, it is 
important for you to understand why the research is being done and what would 
happen at the clinic visit.  
 
If you are interested in taking part in the study please complete the enclosed reply 
slip and send it in the stamped addressed envelope to the researcher. Alternatively 
you can ring the researcher. Her name is Jane McAdam and her phone number is 
07715 005 843. She will contact you to ask a few simple questions about your health 
and she will be able to answer any questions you may have about the study. If you 
can take part in the study an appointment will be made for you to attend the FES 
clinic for your clinical review and collection of information. 
 
If you are not able or do not wish to take part in the study please complete the 
enclosed reply slip or ring the researcher. An appointment will be made for your 
clinical review only. Your name will not be retained by the researcher, you will not be 
contacted again about the study and your decision will have no impact on your 
ongoing care.   
 
If we do not hear from you, after two weeks, we will ring you to ask if you are 
interested in taking part in the study. If you are interested we will ask if you are happy 
for your contact details to be forwarded to the researcher. If you are not able or do 
not wish to take part we will book your clinical review. 
 
You are welcome to contact ourselves or the researcher (contact details in the 
information sheet) before deciding to take part, if anything is not clear or if you would 
like more information. Please take some time to decide whether or not you wish to 
take part.  
 
Many thanks. 
Alison Clarke                                               Jill van der Meulen 
Clinical Specialist Physiotherapist                 Lead Clinical Scientist  
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 Centre for Health, Sport &                   
              Rehabilitation Sciences Research  
              The University of Salford 
             Brian 
Blatchford Building 
              Salford. M6 6PU 
August 2012 
  
PARTICIPANT INFORMATION SHEET 
 
Study Title:  The effect of Functional Electrical Stimulation (FES) on gait and 
cognitive task, in post-stroke drop foot. 
 
 
We would like to invite you to take part in our research study. Before you decide if 
you wish to take part, we would like to explain why the research is being done and 
what it would involve for you.  
 
This information sheet explains the study. Please read this information carefully and 
discuss it with others if you wish. You are welcome to contact us if anything is unclear 
or if you would like more information. Our contact details are at the end of this sheet. 
 
Please take your time in deciding whether or not to take part. 
 
Part 1 tells you the purpose of this study and what will happen to you if you 
take part. Part 2 gives you more detailed information about the conduct of the 
study. 
 
Part 1 
What is the purpose of the study? 
This study is being conducted to improve our understanding of the effectiveness of 
Functional Electrical Stimulation (FES) for people like you. In particular, we would like 
to find out how it affects your ability to do other things whilst you walk. We would also 
like to know how it affects your daily life and activities. In the longer term, we hope 
that the results from this study will help to improve clinical practice. 
 
The study is also being conducted to complete the PhD of the chief investigator, Jane 
McAdam. 
 
Why have I been invited? 
All people who attend the Sheffield clinic and have been using FES for three months 
or more, because of a drop foot following a stroke, are being invited to take part in 
this study. We hope to have about 21 people in the study. 
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Do I have to take part? 
It is up to you to decide to take part in the study. We will describe the study and go 
through this information leaflet before you make your final decision. We will ask you 
to sign a consent form to show that you have agreed to take part. You are free to 
withdraw at any time, during the study, without giving a reason and without any affect 
upon your normal care. 
 
You do not have to give a reason for not taking part.  A decision not to take part will 
not affect the care that you receive. 
 
What will happen to me if I take part? 
If you take part in this study, at your normal review appointment at the FES clinic, 
where you will be seen by the clinical staff at Sheffield, you will also be seen by the 
chief investigator, Jane McAdam. As well as the time that it takes to complete your 
clinical review, you will be in the clinic for an additional hour to complete the 
measurements needed for the study. 
 
Firstly, we will make sure that the particular tests that are used in the study are 
appropriate for you. In order to do this, you will be asked to carry out a memory test 
and to answer questions about your health, medications and any current treatment. If 
you find it very difficult to follow the memory test, or if there is a particular issue with 
your health, your involvement with the study will stop at this point.  
 
Alternatively, if you are able to follow the memory test and there are no issues with 
your health, you can continue with the study. You will then be asked questions about 
your stroke and some further tests will be performed. During these tests you will be 
asked to recognise words, repeat numbers and answer questions about the things 
that you are able to do. You will also be asked about any falls that you may have had 
during the past year and the effect of FES during your normal daily activities. The 
sensation in your feet and legs will also be tested.  
 
You will be asked to repeat the memory test when walking with and without your FES 
device. For the walking trials you will be asked to bring a pair of shorts or three-
quarter length trousers to wear. There will be a private changing area and help whilst 
changing can be provided. Small removable reflective markers will be placed on your 
shoes. You will walk in front of cameras that will collect the movement of the markers 
and video images of you walking. No recordings will be taken from which you can be 
recognised. You will be asked to walk several times.  
 
What are the possible disadvantages and risks of taking part?  
It is possible that, whilst performing the walking tasks in the clinic, you may have an 
increased risk of falling. This may occur when walking without your FES switched on 
or whilst performing the memory task. To minimise the risk of falling we will assess 
your ability to walk safely whilst performing the walking tasks. We will walk with you 
whilst we assess your safety. If it is not safe for you to do these tests, we will not ask 
you to continue to be involved in the study. 
It is possible that you may feel concerned about how well you do in some of the tests. 
You are welcome to discuss these concerns with us and to talk about ways of coping 
with your feelings. 
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At the end of your visit to the clinic it is possible that you may feel physically and 
mentally tired. You may wish to make sure that a companion travels home with you, 
or drives you home, to ensure that you arrive home safely. 
What are the possible benefits of taking part? 
The information that is obtained from this study may help to provide better treatment 
for stroke patients in the future.  
 
What happens when the research study stops? 
At the end of the collection of measurements you will remain in the care of the clinical 
staff at Sheffield. 
 
Will my taking part in the study be kept confidential? 
If you decide to take part in the study, the information that is collected about you will 
be handled in confidence, following ethical and legal practice. Please refer to Part 2 
for further details. 
 
This completes Part 1 of the information sheet. If the information in Part 1 has 
interested you and you are considering participation, please continue to read 
the additional information in Part 2 before making any decision. 
 
Part 2 
What will happen if I don’t want to carry on with the study? 
You are free to withdraw at any time, without giving a reason and without any affect 
upon your normal care. The information that has been collected about you, up until 
the point that you withdraw, will be kept and included in the study report. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
chief investigator, Jane McAdam (details at the end of this sheet). If you remain 
unhappy and wish to complain formally, you can do this by contacting the study co-
investigator, Dr Laurence Kenney (details at the end of this sheet). 
 
What if something goes wrong? 
In the event that something does go wrong and you are harmed during the study, and 
this harm is due to someone’s negligence then you may have grounds for a legal 
action. The University of Salford has insurance in place to cover indemnity and 
compensation for a claim. You may have to pay your legal costs. The normal 
National Health Service complaints mechanisms will still be available to you. 
 
Will my taking part in this study be kept confidential?  
All information that is collected about you will be handled in accordance with the 
consent that you have given and will be kept strictly confidential and securely stored.  
 
Your consent form will be part of the study information and leave the clinic. This will 
only include your full name. All other information about you that leaves the clinic will 
be identified by a number and will have your name removed from it. 
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The co-investigator will have access to the information collected but will not have 
access to your name. The chief investigator will be the only person, involved in the 
study, who will have access to your personal details. 
 
Information collected during the study, may be looked at by responsible individuals 
from the University of Salford, from regulatory authorities or from Sheffield Teaching 
Hospitals NHS Trust.  This would be done to check that the study is being carried out 
correctly.  
 
When the results of this study are presented or published, your identity will remain 
confidential. We would like to use any quotes that are made by you in the results. We 
will ask you to agree to this when we ask you to consent to taking part in the study. 
The quotes will be anonymised and thus will not able to be identified as made by you.  
 
Five years after completion of the study information collected will be disposed of 
safely and securely. 
 
Involvement of the other health care professionals. 
We would wish to inform your GP of your participation in this study. When you are 
asked to agree to take part in this study, by signing the consent form, you will also be 
asked if you agree to your GP being informed. 
 
It may be necessary to contact your GP or consultant to clarify medical details of your 
stroke and of your current health, if it is difficult for you to provide this information. 
You will be asked to agree to this contact being made, when you are asked to sign 
the consent form. This information is used to describe you and compare you with 
other participants. 
 
If any problems with your health are highlighted during the course of the study, we 
will discuss this with you and agree how you would like it to be addressed. 
 
What will happen to the results of the research study? 
The results of this study will be used to complete the chief investigator’s PhD. They 
may be presented at appropriate conferences, as well as published in medical or 
clinical journals. The results will be forwarded to voluntary and charity stroke 
organisations. Your name will not be published.  
 
A summary of the results of this study can be sent to you or discussed with you if you 
wish. 
 
 
Who is organising the research? 
This research is organised through the University of Salford. 
 
 
Who has reviewed this study? 
The University of Salford and Sheffield Teaching Hospitals NHS Trust Research and 
Development Department have both reviewed this study. It has also been reviewed 
by an independent group of people, called a Research Ethics Committee, to protect 
your interests. This study has been given a favourable opinion by Southampton A 
Research Ethics Committee. 
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Further information and contact details 
If you have any questions about the study please contact the chief investigator as 
follows:- 
 
Jane McAdam – Principal Podiatrist and PhD Student 
Salford Royal Foundation NHS Trust, Department of Podiatry, Hope Hospital, Stott 
Lane, Salford M6 8HD. 
Ph: c/- 0161 206 4710 Mobile: 07715 005 843 Email: Jane.McAdam@srft.nhs.uk 
 
If you have any further questions about this study, any concerns or are unhappy with 
any aspect of the study, please contact the co-investigator and PhD supervisor as 
follows:- 
 
Dr Laurence Kenney – Reader in Rehabilitation Technologies 
Centre for Health, Sport & Rehabilitation Sciences Research, Brian Blatchford 
Building, University of Salford, Salford M6 6PU.                                
Ph : 0161 295 2289 Email : L.P.J.Kenney@salford.ac.uk 
 
If you would like further information about clinical research, The UK Clinical Research 
Collaboration has published a booklet entitled ‘Understanding Clinical Trials’. Contact 
UKCRC ph: 0207 670 5452 website: www.ukcrc.org. 
 
 
Thank you for taking the time to read this information sheet and considering 
taking part in this study. 
 
Please keep this information sheet. You will be given a signed copy of the 
consent form. 
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REPLY SLIP 
 
 
Study Title:  The effect of Functional Electrical Stimulation (FES) on gait and 
cognitive task, in post-stroke drop foot. 
 
 
 
Your name:……………………………………… 
 
 
Please tick one of the boxes 
 
 
 
                  YES, I am interested in taking part in this study. 
 
         Please contact me on this phone number …………………………….. 
 
                  The best times to ring me are …………………………………………… 
 
 
 
                  NO, I am not able nor interested in taking part in this study. 
 
                  Please arrange an appointment at the FES clinic in Sheffield  
                  for my routine clinical review.  
 
 
 
 
Please note, if you would rather ring the researcher with your response, her phone 
number is 07715 005 843 and her name is Jane McAdam.  
 
 
 
 
 
Please put this reply slip in the enclosed stamped addressed envelope. 
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Centre for Health, Sport &                   
              Rehabilitation Sciences Research  
The University of Salford 
Brian Blatchford Building 
Salford M6 6PU 
CONSENT FORM                             
 
Title of Project: The effect of Functional Electrical Stimulation (FES) on gait and cognitive 
task, in post-stroke drop foot. 
 
Name of Researcher: Jane McAdam 
 
Participant ID: 
 
Please read each of these statements. Please initial in the box at the end of the 
statements with which you agree. 
 
1. I confirm that I have read and understand the information leaflet dated May 2012 (Version 
2) for the above study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily.  
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my medical care or legal rights being affected.  
 
3. I understand that if I withdraw from the study or if my involvement is stopped by the 
researcher, the information that has been collected about me, up until my point of 
withdrawal, will be kept and used in the analysis of the study. 
 
4. I agree that any quotes I may give can be used and that my identity will be anonymised. 
 
5. I agree to my GP being informed of my participation in the study. 
 
6. I agree to my GP or named consultant being contacted for further information about my 
health and past medical history, if necessary.     
 
7. I understand that data collected during the study, may be looked at by responsible 
individuals from the University of Salford, from regulatory authorities or from the NHS 
Trust, where it is relevant to my taking part in this research. I give permission for these 
individuals to have access to my data.  
 
8. I agree to take part in the above study. 
 
…………………………                              ……………………     …………………………………….. 
Name of participant                                Date                         Signature 
 
…………………………..                         ………………….      ……………………………………... 
Name of person                                     Date                           Signature 
taking  consent 
(1 copy for participant, 1 copy for medical notes and 1 copy for chief investigator’s file) 
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Centre for Health, Sport &                   
              Rehabilitation Sciences Research  
                                The University of Salford                  
Brian Blatchford Building 
              Salford. M6 6PU 
 
Health Professional Name 
And Address 
 
Date : 
 
 
Dear  …………………. 
 
RE : Participant’s name, d.o.b., address 
 
As you will know, the above mentioned patient is currently using a Functional 
Electrical Stimulation (FES) device supplied by the FES clinic at the Northern 
General Hospital in Sheffield.  
 
Your patient has very kindly taken part in a study, during which collection of data was 
performed at their ………….. month review at the FES clinic. 
 
The study assesses the effectiveness of FES using a dual-task methodology 
designed to assess performance of both gait and cognitive task.  The measures were 
taken on only one occasion. The study does not require the patient to change any 
aspect of their current care. 
 
The study has been approved by the Southampton A Research Ethics Committee –  
REC Ref No 12/SC/0253. 
Study title: The effect of Functional Electrical Stimulation (FES) on gait and cognitive 
task, in post-stroke drop foot. 
 
I hope that this information is of benefit to you. 
 
Yours sincerely, 
 
 
Jane McAdam 
PhD Student  
Principal Podiatrist – Salford Royal Foundation NHS Trust 
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Falls Efficacy Scale – International (FES-I) 
 
  Participant ID _______________________ 
FALLS EFFICACY SCALE - INTERNATIONAL 
 Not at all 
concerned 
Somewhat 
concerned 
Fairly 
concerned 
Very 
concerned 
Cleaning the house (e.g. sweep, 
vacuum or dust) 
    
Getting dressed or undressed     
Preparing simple meals      
Taking a bath or shower     
Going to the shop     
Getting in or out of a chair     
Going up or down stairs     
Walking around in the 
neighbourhood 
    
Reaching for something above your 
head or on the ground 
    
Going to answer the telephone 
before it stops ringing 
    
Walking slippery surface (e.g. wet or 
icy) 
    
Visiting a friend or relative     
Walking in a place with crowds     
Walking on an uneven surface ( e.g. 
rocky ground, poorly maintained 
pavement) 
    
Walking up or down a slope     
Going out to a social event (e.g. 
religious service, family gathering or 
club meeting) 
    
Score          /64     
 
Completed by _________________________   _____________________________ 
                      (printed name)                               (signature) 
 
Date _______________________ 
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University of Salford Ethical Approval 
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NHS Ethical Approval - Amendment 
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